<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Vitamin D Binding on VitaminDWiki</title><link>/tags/vitamin-d-binding.html</link><description>Recent content in Vitamin D Binding on VitaminDWiki</description><generator>Hugo</generator><language>en-us</language><lastBuildDate>Sat, 08 Apr 2017 00:00:00 +0000</lastBuildDate><atom:link href="/tags/vitamin-d-binding/index.xml" rel="self" type="application/rss+xml"/><item><title>Bones need at least 30 nanograms of Vitamin D – 2 medical groups in Japan</title><link>/posts/bones-need-at-least-30-nanograms-of-vitamin-d-2-medical-groups-in-japan.html</link><pubDate>Sat, 08 Apr 2017 00:00:00 +0000</pubDate><guid>/posts/bones-need-at-least-30-nanograms-of-vitamin-d-2-medical-groups-in-japan.html</guid><description>&lt;h4 id="assessment-criteria-for-vitamin-d-deficiencyinsufficiency-in-japan--proposal-by-an-expert-panel-supported-by-research-program-of-intractable-diseases-ministry-of-health-labour-and-welfare-japan-the-japanese-society-for-bone-and-mineral-research-and-the-japan-endocrine-society">Assessment criteria for vitamin D deficiency/insufficiency in Japan — proposal by an expert panel supported by Research Program of Intractable Diseases, Ministry of Health, Labour and Welfare, Japan, The Japanese Society for Bone and Mineral Research and The Japan Endocrine Society&lt;/h4>
&lt;p>Endocrine Journal 2017, 64 (1), 1-6, Opinion&lt;/p>
&lt;img src="/attachments/d3.mock.jpg" alt="image">
&lt;p>Ryo Okazaki1), Keiichi Ozono, Seiji Fukumoto, Daisuke Inoue, Mika Yamauchi,&lt;/p>
&lt;p>Masanori Minagawa5), Toshimi Michigami6), Yasuhiro Takeuchi7), Toshio Matsumoto3) and Toshitsugu Sugimoto4)&lt;/p>
&lt;p>1 Third Department of Medicine, Teikyo University Chiba Medical Center, Ichihara 299-0111, Japan&lt;/p></description></item><item><title>Vitamin D and pregnancy workshop in South Carolina</title><link>/posts/vitamin-d-and-pregnancy-workshop-in-south-carolina.html</link><pubDate>Sat, 08 Apr 2017 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-and-pregnancy-workshop-in-south-carolina.html</guid><description>&lt;p>&lt;strong>&lt;a href="http://academicdepartments.musc.edu/sctr/programs/retreats/2017_Scientific_Workshop_Vitamin_D/2017_Scientific_Workshop_Vitamin_D">2017 Scientific Workshop on Vitamin D&lt;/a>&lt;/strong>&lt;/p>
&lt;p>&lt;strong>Full Video and slides prevented are all online&lt;/strong>&lt;/p>
&lt;p>&lt;strong>Vitamin D in the Prevention of Health Disparities During Pregnancy and Early Infancy&lt;/strong>&lt;/p>
&lt;p>&lt;strong>Abstracts and Posters&lt;/strong>&lt;/p>
&lt;p>&lt;strong>&lt;i class="fas fa-file-pdf" style="margin-right: 0.3em;">&lt;/i>&lt;a href="https://d378j1rmrlek7x.cloudfront.net/attachments/pdf/sc-workshop-abstracts.pdf">Download the PDF from VitaminDWiki&lt;/a>&lt;/strong>&lt;/p>
&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#moving-vitamin-d-research-into-practice-through-nutrient-field-trials">Moving Vitamin D Research Into Practice Through Nutrient Field Trials&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#a-survey-of-placental-pathologic-findings-observed-in-123-singleton-placentas">A Survey of Placental Pathologic Findings Observed in 123 Singleton Placentas&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#nutrigenomic-profiling-for-early-risk-stratification-and-preventive-intervention-to-decrease-disparities-in-spontaneous-preterm-birth">Nutrigenomic Profiling for Early Risk Stratification and Preventive Intervention to Decrease Disparities in Spontaneous Preterm Birth&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-and-the-placenta-two-sides-to-the-story">Vitamin D and the Placenta: Two Sides to the Story&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#mouse-models-to-characterize-the-impact-of-maternal-vitamin-d-deficiency-on-offspring-epigenetic-outcomes">Mouse models to characterize the impact of maternal vitamin D deficiency on offspring epigenetic outcomes&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#adiponectin-and-vitamin-d-binding-protein-are-independently-associated-at-birth-in-both-mothers-and-neonates">Adiponectin and Vitamin D-binding Protein are Independently Associated at Birth in Both Mothers and Neonates&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#immune-mediators-and-vitamin-d-status-in-the-development-of-comorbidities-of-pregnancy">Immune Mediators and Vitamin D Status in the Development of Comorbidities of Pregnancy&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#improved-vitamin-d3-status-is-associated-with-increases-in-circulating-t-regulatory-cells-during-pregnancy">Improved Vitamin D3 Status is Associated with Increases in Circulating T-regulatory Cells during Pregnancy&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#preliminary-results-from-a-vitamin-d-screening-and-supplementation-field-trial-to-prevent-preterm-birth">Preliminary Results from a Vitamin D Screening and Supplementation Field Trial to Prevent Preterm Birth&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#association-of-bacterial-vaginosis-and-vitamin-d-deficiency-in-pregnancy">Association of Bacterial Vaginosis and Vitamin D Deficiency in Pregnancy&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#maternal-vitamin-d3-supplementation-during-pregnancy-and-pediatric-dental-enamel-hypoplasia">Maternal Vitamin D3 Supplementation during Pregnancy and Pediatric Dental Enamel Hypoplasia&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#technology-assisted-medication-adherence-in-pregnancy">Technology Assisted Medication Adherence in Pregnancy&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#maternal-obesity-25ohd-concentration-and-bone-density-in-breastfeeding-dyads">Maternal Obesity, 25(OH)D Concentration and Bone Density in Breastfeeding Dyads&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#functional-indicators-of-vitamin-d-adequacy-for-very-low-birth-weight-infants">Functional Indicators of Vitamin D Adequacy for Very Low Birth Weight Infants&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-and-asthma-health-disparities">Vitamin D and Asthma Health Disparities&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#------------posters--------------">- - - - - - Posters: – – – – – – – – – – – – -&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-vitd-and-other-factors-effects-on-bone-mineral-density-bmd-in-lactating-women">Vitamin D (VitD) and other factors&amp;rsquo; effects on bone mineral density (BMD) in lactating women&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#effects-of-maternal-vitamin-d-vitd-supplementation-on-bone-mineral-content-bmcbone-mineral-density-bmd-in-the-first-year-of-life">Effects of Maternal Vitamin D (VitD) Supplementation on Bone Mineral Content (BMC)/Bone Mineral Density (BMD) in the First Year of Life&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#the-relationship-between-physical-activity-and-vitamin-d-status-in-lactating-women">The Relationship Between Physical Activity and Vitamin D Status in Lactating Women&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#the-effects-of-vitamin-d-binding-protein-genotypes-on-circulating-25ohd-and-vdbp-levels-during-pregnancy">The Effects of Vitamin D Binding Protein Genotypes on Circulating 25(OH)D and VDBP Levels During Pregnancy&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#preventing-health-disparities-during-pregnancy-through-vitamin-d-vitd-supplementation-preliminary-results-of-an-rct">Preventing Health Disparities During Pregnancy Through Vitamin D (VITD) Supplementation: Preliminary Results of an RCT&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;h4 id="moving-vitamin-d-research-into-practice-through-nutrient-field-trials">Moving Vitamin D Research Into Practice Through Nutrient Field Trials&lt;/h4>
&lt;p>Carole Baggerly, Director, Grassroots Health&lt;/p></description></item><item><title>NHL discovers Vitamin D – their ideal is 40-120 ng – 2016</title><link>/posts/nhl-discovers-vitamin-d-their-ideal-is-40-120-ng-2016.html</link><pubDate>Fri, 24 Mar 2017 00:00:00 +0000</pubDate><guid>/posts/nhl-discovers-vitamin-d-their-ideal-is-40-120-ng-2016.html</guid><description>&lt;ul>
&lt;li>
&lt;p>&lt;a href="/posts/athletes-national-level-with-less-than-10-ng-of-vitamin-d-had-smaller-hearts">Athletes (national-level) with less than 10 ng of vitamin D had smaller hearts – Jan 2014&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/sports-benefits-from-up-to-50-ng-of-vitamin-meta-analysis">Sports benefits from up to 50 ng of Vitamin – meta-analysis - Nov 2012&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/collegiate-swimmers-getting-4000-iu-of-vitamin-d-had-fewer-injuries">Collegiate Swimmers getting 4000 IU of vitamin D had fewer injuries – March 2013&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/recent-increase-in-vitamin-d-levels-in-elite-irish-athletes">Recent increase in Vitamin D levels in Elite Irish Athletes – Aug 2016&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/most-olympic-class-dutch-athletes-nudged-vitamin-d-levels-above-30-nanograms-with-2200-iu-daily-rct">Most Olympic-class Dutch athletes nudged Vitamin D levels above 30 nanograms with 2200 IU daily – RCT July 2016&lt;/a>&lt;/p></description></item><item><title>Second stroke 8X more likely if very low vitamin D</title><link>/posts/second-stroke-8x-more-likely-if-very-low-vitamin-d.html</link><pubDate>Tue, 20 Dec 2016 00:00:00 +0000</pubDate><guid>/posts/second-stroke-8x-more-likely-if-very-low-vitamin-d.html</guid><description>&lt;h4 id="vitamin-d-status-and-the-risk-of-recurrent-stroke-and-mortality-in-ischemic-stroke-patients-data-from-a-24-month-follow-up-study-in-china">Vitamin D status and the risk of recurrent stroke and mortality in ischemic stroke patients: Data from a 24-month follow-up study in China&lt;/h4>
&lt;p>The journal of nutrition, health &amp;amp; aging, pp 1–6, First Online: 13 October 2016&lt;/p>
&lt;p>DOI: 10.1007/s12603-016-0821-z&lt;/p>
&lt;p>H. QiuM. WangD. MiJizong ZhaoEmail authorW. TuQ. Liu&lt;/p>
&lt;div class="border" style="background-color:#FF9;padding:15px;margin:10px 0;border-radius:5px;width:700px">
&lt;p>&lt;strong>This was a 24 month followup of strokes in China&lt;/strong>&lt;/p>
&lt;ul>
&lt;li>&lt;a href="/posts/second-stroke-2x-more-likely-if-low-vitamin-d">Second stroke 2X more likely if low vitamin D – Feb 2015&lt;/a> - 3.2 year followup in Singapore&lt;/li>
&lt;/ul>
&lt;/div>
&lt;p>&lt;strong>PDF is behind a $36 paywall&lt;/strong>&lt;/p></description></item><item><title>Bio-available Vitamin D is reduced by half during pregnancy</title><link>/posts/bio-available-vitamin-d-is-reduced-by-half-during-pregnancy.html</link><pubDate>Sun, 13 Nov 2016 00:00:00 +0000</pubDate><guid>/posts/bio-available-vitamin-d-is-reduced-by-half-during-pregnancy.html</guid><description>&lt;h4 id="fig-2-comparison-of-total-25-hydroxyvitamin-d-span25ohdspan-vitamin-d-binding-protein-vdbp-and-calculated-bioavailable-25ohd-by-gestational-stage">Fig. 2. Comparison of total 25-hydroxyvitamin D &lt;span>[25(OH)D]&lt;/span>, vitamin D-binding protein (VDBP), and calculated bioavailable 25(OH)D by gestational stage.&lt;/h4>
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/compare-pregnancy.jpg" alt="image" width="1000">
&lt;ul>
&lt;li>
&lt;p>(A) &lt;strong>Total 25(OH)D levels&lt;/strong> were not significantly different between the 1st and 2nd and 3rd trimesters (median, interquartile range: 1st trimester: 18.20, 15.07-23.87 ng/mL; 2nd and 3rd trimesters: 18.30, 13.75-25.70 ng/mL).&lt;/p>
&lt;/li>
&lt;li>
&lt;p>(B) &lt;strong>VDBP levels&lt;/strong> during the 2nd and 3rd trimesters were significantly higher than those during the 1st trimester (1st trimester: 102.20, 84.75-259.90 µg/mL, 2nd and 3rd trimesters: 273.65, 163.75-453.98 µg/mL).&lt;/p></description></item><item><title>Vitamin D review</title><link>/posts/vitamin-d-review.html</link><pubDate>Wed, 19 Oct 2016 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-review.html</guid><description>&lt;p>&lt;strong>Beneficial Effects of UV-Radiation: Vitamin D and beyond&lt;/strong>&lt;/p>
&lt;p>International Journal of Environmental Research and Public Health; 2016,13,1028; doi:10.3390/ijerph13101028&lt;/p>
&lt;p>Christian Trammer, Marlene Pandis 1, Nicolas Verheyen , Martin R. Grubler 1,s,&lt;/p>
&lt;p>Martin Gaksch 1, Barbara Obermayer-Pietsch 1, Andreas Tomaschitz , Thomas R. Pieber 1, Stefan Pilz h* and Verena Schwetz 1&lt;/p>
&lt;p>Division of Endocrinology and Diabetology, Department of Internal Medicine, Medical University of Graz, Auenbruggerplatz 15, Graz 8036, Austria; &lt;a href="mailto:christian.trummer@medunigraz.at">christian.trummer@medunigraz.at&lt;/a> (C.T.); &lt;a href="mailto:marlene.pandis@medunigraz.at">marlene.pandis@medunigraz.at&lt;/a> (M.P.); &lt;a href="mailto:martin.gruebler@gmx.net">martin.gruebler@gmx.net&lt;/a> (M.R.G.); &lt;a href="mailto:martin.gaksch@gmail.com">martin.gaksch@gmail.com&lt;/a> (M.G.); &lt;a href="mailto:barbara.obermayer@medunigraz.at">barbara.obermayer@medunigraz.at&lt;/a> (B.O.-P.); &lt;a href="mailto:thomas.pieber@medunigraz.at">thomas.pieber@medunigraz.at&lt;/a> (T.R.P.); &lt;a href="mailto:verena.schwetz@medunigraz.at">verena.schwetz@medunigraz.at&lt;/a> (V.S.)&lt;/p></description></item><item><title>Vitamin D Loading dose - 20,000 IU daily is not enough if obese, etc. (Cancer) great table and chart</title><link>/posts/vitamin-d-loading-dose-20000-iu-daily-is-not-enough-if-obese-etc-cancer-great-table-and-chart.html</link><pubDate>Sat, 08 Oct 2016 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-loading-dose-20000-iu-daily-is-not-enough-if-obese-etc-cancer-great-table-and-chart.html</guid><description>&lt;h4 id="appropriate-vitamin-d-loading-regimen-for-patients-with-advanced-lung-cancer">Appropriate vitamin D loading regimen for patients with advanced lung cancer.&lt;/h4>
&lt;p>Nutr J. 2016 Oct 6;15(1):84.&lt;/p>
&lt;p>Hoffer LJ1, Robitaille L2, Swinton N3, Agulnik J2,3, Cohen V2,3, Small D2,3, Pepe C2,3, Eintracht S4.&lt;/p>
&lt;ul>
&lt;li>
&lt;p>1Lady Davis Institute for Medical Research, McGill University and Jewish General Hospital, 3755 Cote Sainte Catherine, Montreal, QC H3T 1E2, Canada. &lt;a href="mailto:l.hoffer@mcgill.ca">l.hoffer@mcgill.ca&lt;/a>.&lt;/p>
&lt;/li>
&lt;li>
&lt;p>2Lady Davis Institute for Medical Research, McGill University and Jewish General Hospital, 3755 Cote Sainte Catherine, Montreal, QC H3T 1E2, Canada.&lt;/p></description></item><item><title>Obesity linked to 13 cancers, the linkage is probably vitamin D</title><link>/posts/obesity-linked-to-13-cancers-the-linkage-is-probably-vitamin-d.html</link><pubDate>Fri, 26 Aug 2016 00:00:00 +0000</pubDate><guid>/posts/obesity-linked-to-13-cancers-the-linkage-is-probably-vitamin-d.html</guid><description>&lt;p>&lt;strong>Fact:&lt;/strong> Obesity lowers vitamin D&lt;/p>
&lt;p>&lt;strong>Fact:&lt;/strong> Low vitamin D increases the risk of many diseases – such as cancers&lt;/p>
&lt;p>&lt;strong>Examples of web reporting&lt;/strong>&lt;/p>
&lt;ul>
&lt;li>
&lt;p>&lt;a href="http://khn.org/news/another-reason-to-diet-experts-find-additional-evidence-of-obesity-cancer-link/">Another Reason To Diet: Experts Find Additional Evidence Of Obesity-Cancer Link&lt;/a> Kaiser&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="http://well.blogs.nytimes.com/2016/08/24/obesity-linked-to-at-least-13-types-of-cancer/?_r=0">Obesity Is Linked to at Least 13 Types of Cancer&lt;/a> New York Times&lt;/p>
&lt;/li>
&lt;/ul>
&lt;table>
 &lt;thead>
 &lt;tr>
 &lt;th>&lt;/th>
 &lt;th>&lt;/th>
 &lt;/tr>
 &lt;/thead>
 &lt;tbody>
 &lt;tr>
 &lt;td>Type of Cancer&lt;/td>
 &lt;td>Some studies in VitaminDWiki&lt;/td>
 &lt;/tr>
 &lt;tr>
 &lt;td>adenocarcinoma of the esophagus&lt;/td>
 &lt;td>&lt;a href="/posts/cancer-of-glands-adenocarcinoma-associated-with-2x-lower-vitamin-d-levels">Cancer of glands (Adenocarcinoma) associated with 2X lower vitamin D levels – Aug 2013&lt;/a>&lt;/td>
 &lt;/tr>
 &lt;tr>
 &lt;td>colorectal cancer&lt;/td>
 &lt;td>&lt;a href="/posts/overview-cancer-colon-and-vitamin-d" style="color: red; text-decoration: underline;" title="This post/category does not exist yet: Overview Cancer-Colon and vitamin D">Overview Cancer-Colon and vitamin D&lt;/a>&lt;/td>
 &lt;/tr>
 &lt;tr>
 &lt;td>breast cancer in postmenopausal women&lt;/td>
 &lt;td>&lt;a href="/posts/overview-breast-cancer-and-vitamin-d">Overview Breast Cancer and Vitamin D&lt;/a>&lt;/td>
 &lt;/tr>
 &lt;tr>
 &lt;td>uterine cancer&lt;/td>
 &lt;td>&lt;a href="/posts/endometrial-cancer-and-vitamin-d-many-studies">Endometrial cancer and Vitamin D – many studies&lt;/a>&lt;/td>
 &lt;/tr>
 &lt;tr>
 &lt;td>kidney cancers&lt;/td>
 &lt;td>&lt;a href="/posts/5x-less-risk-of-kidney-cancer-if-good-ratio-of-vitamin-d-binding-protein-to-circulating-vitamin-d">5X less risk of Kidney cancer if good ratio of Vitamin D binding protein to circulating vitamin D – Nov 2013&lt;/a>&lt;/td>
 &lt;/tr>
 &lt;tr>
 &lt;td>&lt;strong>The study added the following cancers&lt;/strong>&lt;/td>
 &lt;td>&lt;/td>
 &lt;/tr>
 &lt;tr>
 &lt;td>gastric cardia, a cancer of the part of the &lt;br>stomach closest to the esophagus;&lt;/td>
 &lt;td>&lt;/td>
 &lt;/tr>
 &lt;tr>
 &lt;td>liver cancer&lt;/td>
 &lt;td>&lt;a href="/posts/liver-cancer-half-as-likely-if-high-level-of-vitamin-d">Liver cancer half as likely if high level of vitamin D – Feb 2014&lt;/a>&lt;/td>
 &lt;/tr>
 &lt;tr>
 &lt;td>gallbladder cancer&lt;/td>
 &lt;td>&lt;/td>
 &lt;/tr>
 &lt;tr>
 &lt;td>pancreatic cancer&lt;/td>
 &lt;td>&lt;a href="/posts/cancer-pancreatic">Cancer - Pancreatic&lt;/a>&lt;/td>
 &lt;/tr>
 &lt;tr>
 &lt;td>thyroid cancer&lt;/td>
 &lt;td>&lt;a href="/posts/overview-thyroid-and-vitamin-d" style="color: red; text-decoration: underline;" title="This post/category does not exist yet: Overview Thyroid and Vitamin D">Overview Thyroid and Vitamin D&lt;/a>&lt;/td>
 &lt;/tr>
 &lt;tr>
 &lt;td>ovarian cancer&lt;/td>
 &lt;td>&lt;a href="/posts/cancer-ovarian">Cancer - Ovarian&lt;/a>&lt;/td>
 &lt;/tr>
 &lt;tr>
 &lt;td>meningioma, a usually benign&lt;br> type of brain cancer;&lt;/td>
 &lt;td>&lt;a href="/posts/brain-cancer-in-175-countries-related-to-low-uvb-and-low-vitamin-d" style="color: red; text-decoration: underline;" title="This post/category does not exist yet: Brain cancer in 175 countries related to low UVB and low vitamin D – Oct 2010">Brain cancer in 175 countries related to low UVB and low vitamin D – Oct 2010&lt;/a>&lt;/td>
 &lt;/tr>
 &lt;tr>
 &lt;td>multiple myeloma, a blood cancer&lt;/td>
 &lt;td>&lt;a href="/posts/multiple-myeloma-blood-cell-cancer-treated-by-vitamin-d-many-studies">Multiple Myeloma (blood cell cancer) treated by vitamin D - many studies&lt;/a>&lt;/td>
 &lt;/tr>
 &lt;/tbody>
&lt;/table>
&lt;p>&lt;strong>&lt;a href="http://www.nejm.org/doi/full/10.1056/NEJMsr1606602">Publisher wants $20 for the study&lt;/a>&lt;/strong>&lt;/p></description></item><item><title>Pancreatitis and Vitamin D - many studies</title><link>/posts/pancreatitis-and-vitamin-d-many-studies.html</link><pubDate>Mon, 18 Jul 2016 00:00:00 +0000</pubDate><guid>/posts/pancreatitis-and-vitamin-d-many-studies.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#effect-of-serum-vitamin-d-levels-on-the-severity-of-acute-pancreatitis-a-prospective-study-detiails-behind-paywall---march-2024">Effect of serum vitamin D levels on the severity of acute pancreatitis: A prospective study (detiails behind paywall) - March 2024&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-a-potential-star-for-treating-chronic-pancreatitis---june-2022">Vitamin D: A Potential Star for Treating Chronic Pancreatitis - June 2022&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-and-pancreatitis-a-narrative-review-of-current-evidence---may-2022">Vitamin D and Pancreatitis: A Narrative Review of Current Evidence - May 2022&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#osteoporosis-is-19x-more-likely-if-have-acute-pancreatitis---2020">Osteoporosis is 1.9X more likely if have Acute Pancreatitis - 2020&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#systematic-review-and-meta-analysis-on-the-prevalence-of-vitamin-d-deficiency-in-patients-with-chronic-pancreatitis---2016">Systematic review and meta-analysis on the prevalence of vitamin D deficiency in patients with chronic pancreatitis - 2016&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#fat-soluble-vitamin-deficiency-and-exocrine-pancreatic-insufficiency-among-adults-with-chronic-pancreatitis-is-routine-monitoring-necessary-for-all-patients---oct-2023">Fat-soluble vitamin deficiency and exocrine pancreatic insufficiency among adults with chronic pancreatitis: Is routine monitoring necessary for all patients? - Oct 2023&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#fat-soluble-vitamin-deficiencies-and-disruption-of-the-immune-system-in-pancreatic-cancer--a-vicious-cycle---sept-2022">Fat-Soluble Vitamin Deficiencies and Disruption of the Immune System in Pancreatic Cancer- A Vicious Cycle - Sept 2022&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#pancreatitis-associated-with-poor-vitamin-d-binding-protein-and-receptor-in-dogs-july-2023">Pancreatitis associated with poor Vitamin D Binding Protein and Receptor (in dogs) July 2023&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-and-pancreatitis-a-narrative-review-of-current-evidence---may-2022-1">Vitamin D and Pancreatitis: A Narrative Review of Current Evidence - May 2022&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="effect-of-serum-vitamin-d-levels-on-the-severity-of-acute-pancreatitis-a-prospective-study-detiails-behind-paywall---march-2024">Effect of serum vitamin D levels on the severity of acute pancreatitis: A prospective study (detiails behind paywall) - March 2024&lt;/h4>
&lt;p>Pancreatology Volume 24, Issue 2, March 2024, Pages 206-210 &lt;a href="https://doi.org/10.1016/j.pan.2024.01.004">https://doi.org/10.1016/j.pan.2024.01.004&lt;/a> brhind paywall&lt;/p></description></item><item><title>Fluid in lung (pleural effusion) associated with low vitamin D</title><link>/posts/fluid-in-lung-pleural-effusion-associated-with-low-vitamin-d.html</link><pubDate>Sun, 10 Jul 2016 00:00:00 +0000</pubDate><guid>/posts/fluid-in-lung-pleural-effusion-associated-with-low-vitamin-d.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#vitamin-d-nutritional-status-and-vitamin-d-regulated-antimicrobial-peptides-in-serum-and-pleural-fluid-of-patients-with-infectious-and-noninfectious-pleural-effusions---july-2016">Vitamin D nutritional status and vitamin D regulated antimicrobial peptides in serum and pleural fluid of patients with infectious and noninfectious pleural effusions. - July 2016&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#25-hydroxyvitamin-d-in-malignant-pleural-disease-a-prospective-cohort-study---aug-2016">25-hydroxyvitamin D in malignant pleural disease: A prospective cohort study. - Aug 2016&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#fluid-on-the-lungs-cleared-by-active-vitamin-d-mice-shows-how--jan-2016">Fluid on the lungs cleared by active vitamin D (mice, shows how) – Jan 2016&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;h4 id="vitamin-d-nutritional-status-and-vitamin-d-regulated-antimicrobial-peptides-in-serum-and-pleural-fluid-of-patients-with-infectious-and-noninfectious-pleural-effusions---july-2016">Vitamin D nutritional status and vitamin D regulated antimicrobial peptides in serum and pleural fluid of patients with infectious and noninfectious pleural effusions. - July 2016&lt;/h4>
&lt;p>BMC Pulm Med. 2016 Jul 8;16(1):99.&lt;/p></description></item><item><title>Vitamin D deficiency 4X more likely if illiterate or have bone pain – Lahore Pakistan</title><link>/posts/vitamin-d-deficiency-4x-more-likely-if-illiterate-or-have-bone-pain-lahore-pakistan.html</link><pubDate>Sat, 09 Jul 2016 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-deficiency-4x-more-likely-if-illiterate-or-have-bone-pain-lahore-pakistan.html</guid><description>&lt;h4 id="high-prevalence-of-vitamin-d-deficiency-among-women-of-child-bearing-age-in-lahore-pakistan-associating-with-lack-of-sun-exposure-and-illiteracy">High prevalence of vitamin D deficiency among women of child-bearing age in Lahore Pakistan, associating with lack of sun exposure and illiteracy.&lt;/h4>
&lt;p>BMC Womens Health. 2015 Oct 12;15:83. &lt;a href="https://doi.org/10.1186/s12905-015-0242-x.">doi: 10.1186/s12905-015-0242-x.&lt;/a>&lt;/p>
&lt;p>Junaid K1, Rehman A2, Jolliffe DA3, Wood K4, Martineau AR5.&lt;/p>
&lt;p>1Department of Microbiology and Molecular Genetics, University of the Punjab, Quaid-e-Azam Campus, Lahore, 5400, Pakistan. &lt;a href="mailto:kashaf_junaid@hotmail.com">kashaf_junaid@hotmail.com&lt;/a>.&lt;/p>
&lt;p>2Department of Microbiology and Molecular Genetics, University of the Punjab, Quaid-e-Azam Campus, Lahore, 5400, Pakistan. &lt;a href="mailto:rehman_mmg@yahoo.com">rehman_mmg@yahoo.com&lt;/a>.&lt;/p>
&lt;p>3Centre for Primary Care and Public Health, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, E1 2AB, UK. &lt;a href="mailto:d.a.jolliffe@qmul.ac.uk">d.a.jolliffe@qmul.ac.uk&lt;/a>.&lt;/p></description></item><item><title>Vitamin D charts from GrassrootsHealth</title><link>/posts/vitamin-d-charts-from-grassrootshealth.html</link><pubDate>Wed, 29 Jun 2016 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-charts-from-grassrootshealth.html</guid><description>&lt;p>&lt;strong>Update 2023&lt;/strong>&lt;/p>
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/webp/all-forms-of-d-grh.webp" alt="image" width="800">
&lt;h4 id="i-classfas-fa-file-pdf-stylemargin-right-03emia-hrefhttpsd378j1rmrlek7xcloudfrontnetattachmentspdfgrassroots-may2016pdfdownload-all-40-of-the-charts-from-vitamindwikia">&lt;i class="fas fa-file-pdf" style="margin-right: 0.3em;">&lt;/i>&lt;a href="https://d378j1rmrlek7x.cloudfront.net/attachments/pdf/grassroots-may2016.pdf">Download all ~40 of the charts from VitaminDWiki&lt;/a>&lt;/h4>
&lt;p>&lt;strong>Here are a few of the ~40 charts&lt;/strong>&lt;/p>
&lt;h4 id="alternately-browse-grassroots-health-for-chartshttpsgrassrootshealthnetdocumentation">Alternately: &lt;a href="https://grassrootshealth.net/documentation/">Browse Grassroots Health for Charts&lt;/a>&lt;/h4>
&lt;h3 id="hypertension-during-pregnancy---none-above-60-nanograms">Hypertension during pregnancy - none above 60 nanograms?&lt;/h3>
&lt;p>&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/hypertension-and-pregnancy.jpg" alt="image" width="600">}&lt;/p>
&lt;p>See also &lt;a href="/posts/preeclampsia-changes-to-vitamin-d-binding-protein-reduces-vitamin-d-in-placenta">Preeclampsia changes to Vitamin D Binding Protein reduces Vitamin D in placenta – Dec 2016&lt;/a>&lt;/p>
&lt;hr>
&lt;h3 id="without-a-loading-dose-it-takes-5-months-20-weeks-to-get-adequate-vitamin-d-levels">Without a loading dose it takes ~5 months (20 weeks) to get adequate vitamin D levels&lt;/h3>
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/pregnancy-without-loading-dose.jpg" alt="image" width="600">
&lt;hr>
&lt;h3 id="see-also-some-grassroothealth-charts-on-vitamindwiki">See also some GrassrootHealth Charts on VitaminDWiki&lt;/h3>
&lt;ul>
&lt;li>
&lt;p>&lt;a href="/posts/grassroots-health-participants-vitamin-d-vs-age-intake-and-resulting-level">Grassroots Health participants Vitamin D vs age, intake, and resulting level – Sept 2013&lt;/a>&lt;/p></description></item><item><title>Fibromyalgia helped by Vitamin D – still not sure how much, and why</title><link>/posts/fibromyalgia-helped-by-vitamin-d-still-not-sure-how-much-and-why.html</link><pubDate>Wed, 08 Jun 2016 00:00:00 +0000</pubDate><guid>/posts/fibromyalgia-helped-by-vitamin-d-still-not-sure-how-much-and-why.html</guid><description>&lt;h4 id="vitamin-d-in-fibromyalgia-a-causative-or-confounding-biological-interplay">Vitamin D in Fibromyalgia: A Causative or Confounding Biological Interplay?&lt;/h4>
&lt;p>Nutrients 2016, 8(6), 343; doi:10.3390/nu8060343&lt;/p>
&lt;p>Spyridon Karras * , Eleni Rapti, Stauros Matsoukas and Kalliopi Kotsa&lt;/p>
&lt;p>First Department of Internal Medicine, Division of Endocrinology and Metabolism, AHEPA Hospital, Thessaloniki 54636, Greece&lt;/p>
&lt;p>&lt;strong>FM suplementation with Vitamin D&lt;/strong>&lt;/p>
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/fm-supplementation.jpg" alt="image" width="900">
&lt;p>Fibromyalgia (FM) is a chronic syndrome with an increasing prevalence, characterized by widespread musculoskeletal pain in combination with a variety of cognitive symptoms and fatigue. A plethora of scientific evidence that has accumulated during the last decades, resulted in a significant improvement of the understanding of the pathophysiology of the disease. However, current therapeutic approaches in patients with FM remains a multidimensional approach including patient education, behavioral therapy, exercise, pain management, and relief of chronic symptoms, rather than the use drug therapies, based on the mechanisms of disease development. Vitamin D, a fat-soluble vitamin derived mainly from skin synthesis through ultraviolet radiation, has been recognized to manifest a plethora of extraskeletal actions, apart from its fundamental role in skeletal and calcium homeostasis, including modulation of cell growth, neuromuscular actions, and potential anti-inflammatory properties. Recent findings indicate that hypovitaminosis D to be highly prevalent in patients with FM. Supplementation studies are limited so far, indicating potential beneficial effects on pain and severity of the disease, however specific recommendations are lacking. This review aims to summarize and critically appraise data regarding the pathophysiological interplay between vitamin D and FM, available results from observational and supplementation studies so far, with a clinical discourse on current knowledge gaps and future r&lt;/p></description></item><item><title>Dengue, Vitamin D and microRNAs</title><link>/posts/dengue-vitamin-d-and-micrornas.html</link><pubDate>Thu, 19 May 2016 00:00:00 +0000</pubDate><guid>/posts/dengue-vitamin-d-and-micrornas.html</guid><description>&lt;p>Vitamin D-Regulated MicroRNAs: Are They Protective Factors against Dengue Virus Infection?&lt;/p>
&lt;p>Hindawi Publishing Corporation Advances in Virology, Volume 2016, Article ID 1016840, 14 pages &lt;a href="http://dx.doi.org/10.1155/2016/1016840">http://dx.doi.org/10.1155/2016/1016840&lt;/a>&lt;/p>
&lt;p>John F. Arboleda and Silvio Urcuqui-Inchima&lt;/p>
&lt;p>Grupo Inmunovirologia, Facultad de Medicina, Universidad de Antioquia (UdeA), Calle 70 No. 52-51, Medellin, Colombia Correspondence should be addressed to Silvio Urcuqui-Inchima; &lt;a href="mailto:silvio.urcuqui@udea.edu.co">silvio.urcuqui@udea.edu.co&lt;/a> Received 22 December 2015; Revised 7 April 2016; Accepted 20 April 2016 Academic Editor: Subhash C. Verma&lt;/p>
&lt;p>Copyright © 2016 J. F. Arboleda and S. Urcuqui-Inchima. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.&lt;/p></description></item><item><title>Infectious diseases and vitamin D – update</title><link>/posts/infectious-diseases-and-vitamin-d-update.html</link><pubDate>Sun, 24 Apr 2016 00:00:00 +0000</pubDate><guid>/posts/infectious-diseases-and-vitamin-d-update.html</guid><description>&lt;h4 id="an-update-on-the-association-of-vitamin-d-deficiency-with-common-infectious-diseases">An update on the association of vitamin D deficiency with common infectious diseases.&lt;/h4>
&lt;p>Can J Physiol Pharmacol. 2015 May;93(5):363-8. &lt;a href="https://doi.org/10.1139/cjpp-2014-0352.">doi: 10.1139/cjpp-2014-0352.&lt;/a> Epub 2015 Jan 26.&lt;/p>
&lt;p>Watkins RR1, Lemonovich TL, Salata RA.&lt;/p>
&lt;p>1Department of Internal Medicine, Northeast Ohio Medical University, Rootstown, OH 44272, USA., Division of Infectious Diseases, Akron General Medical Center, Akron, OH 44302, USA.&lt;/p>
&lt;p>Vitamin D plays an important role in modulating the immune response to infections. Deficiency of vitamin D is a common condition, affecting both the general population and patients in health care facilities. Over the last decade, an increasing body of evidence has shown an association between vitamin D deficiency and an increased risk for acquiring several infectious diseases, as well as poorer outcomes in vitamin D deficient patients with infections.&lt;/p></description></item><item><title>Kidney failure 1.7X more likely - Vitamin D Binding Protein</title><link>/posts/kidney-failure-17x-more-likely-vitamin-d-binding-protein.html</link><pubDate>Tue, 05 Apr 2016 00:00:00 +0000</pubDate><guid>/posts/kidney-failure-17x-more-likely-vitamin-d-binding-protein.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#biomarkers-of-vitamin-d-status-and-risk-of-esrd---feb-2016">Biomarkers of Vitamin D Status and Risk of ESRD - Feb 2016&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#kideny-cancer-3x-more-likely-if-poor-vitamin-d-binding-protein---july-2018">Kideny Cancer 3X more likely if poor Vitamin D Binding Protein - July 2018&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="biomarkers-of-vitamin-d-status-and-risk-of-esrd---feb-2016">Biomarkers of Vitamin D Status and Risk of ESRD - Feb 2016&lt;/h4>
&lt;p>American Journal of Kidney Diseases, Volume 67, Issue 2, February 2016, Pages 235–242, doi:10.1053/j.ajkd.2015.08.026&lt;/p>
&lt;p>Casey M. Rebholz, PhD, MS, MPH1, , , Morgan E. Grams, MD, PhD, MHS1, 2, Pamela L. Lutsey, PhD, MPH3, Andrew N. Hoofnagle, MD, PhD4, Jeffrey R. Misialek, MPH3, Lesley A. Inker, MD, MS5, Andrew S. Levey, MD5, Elizabeth Selvin, PhD, MPH1, 6, Chi-yuan Hsu, MD, MSc7, Paul L. Kimmel, MD8, Ramachandran S. Vasan, MD9, 10, John H. Eckfeldt, MD, PhD11, Josef Coresh, MD, PhD, MHS1, 6, on behalf of the Chronic Kidney Disease Biomarkers&lt;/p></description></item><item><title>Kidney cancer 22 percent less likely if high vitamin D – meta-analysis</title><link>/posts/kidney-cancer-22-percent-less-likely-if-high-vitamin-d-meta-analysis.html</link><pubDate>Wed, 30 Mar 2016 00:00:00 +0000</pubDate><guid>/posts/kidney-cancer-22-percent-less-likely-if-high-vitamin-d-meta-analysis.html</guid><description>&lt;h4 id="examining-the-association-of-circulating-25-hydroxyvitamin-d-with-kidney-cancer-risk-a-meta-analysis">Examining the association of circulating 25-hydroxyvitamin D with kidney cancer risk: a meta-analysis&lt;/h4>
&lt;p>Int J Clin Exp Med. 2015; 8(11): 20499–20507. Published online 2015 Nov 15, PMCID: PMC4723811&lt;/p>
&lt;p>Guangzheng Lin,1,* Ling Ning,2,* Di Gu,1,* Shi Li,1 Zhe Yu,1 Qicheng Long,1 Li-Na Hou,3 and Wan-Long Tan1&lt;/p>
&lt;div class="border" style="background-color:#FF9;padding:15px;margin:10px 0;border-radius:5px;width:650px">
&lt;p>&lt;strong>Note:&lt;/strong>&lt;/p>
&lt;ol>
&lt;li>
&lt;p>No indication of how many years elapsed (if any) between Vitamin D test and kidney cancer diagnosis&lt;/p>
&lt;/li>
&lt;li>
&lt;p>No indication if kidney was failing before kidney cancer, and thus not producing active vitamin D needed to fight cancer&lt;/p></description></item><item><title>Premature infants need 400 to 800 IU of vitamin D</title><link>/posts/premature-infants-need-400-to-800-iu-of-vitamin-d.html</link><pubDate>Mon, 14 Mar 2016 00:00:00 +0000</pubDate><guid>/posts/premature-infants-need-400-to-800-iu-of-vitamin-d.html</guid><description>&lt;h4 id="preterm-babies-have-low-vitamin-d-but-recover-with-800-iu">Preterm babies have low vitamin D, but recover with 800 IU&lt;/h4>
&lt;ul>
&lt;li>(Preterm babies have low vitamin D, but recover in 6 weeks with 800 IU supplementation – Jan 2019))&lt;/li>
&lt;/ul>
&lt;hr>
&lt;h4 id="400-or-800-iu---letter-to-editor-march-2015">400 or 800 IU - Letter to Editor March 2015&lt;/h4>
&lt;p>&lt;strong>Vitamin D Supplementation in Premature Infants&lt;/strong>&lt;/p>
&lt;p>Am Fam Physician. 2015 Mar 15;91(6):352-353. Letters to the Editor&lt;/p>
&lt;p>Original article: Common Questions About Outpatient Care of Premature Infants&lt;/p>
&lt;p>Issue date: August 15, 2014&lt;/p></description></item><item><title>Multiple Sclerosis much more likely if low vitamin D during pregnancy –many studies</title><link>/posts/multiple-sclerosis-much-more-likely-if-low-vitamin-d-during-pregnancy-many-studies.html</link><pubDate>Mon, 07 Mar 2016 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-much-more-likely-if-low-vitamin-d-during-pregnancy-many-studies.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#meta-analysis-found-40-more-likely-for-offspring-to-develop-ms-if-low-vitamin-d-during-pregnancy---jan-2020">Meta-analysis found 40% more likely for offspring to develop MS if low Vitamin D during pregnancy - Jan 2020&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#multiple-sclerosis-19x-more-likely-if-low-vitamin-d-during-pregnancy--march-2016">Multiple Sclerosis 1.9X more likely if low vitamin D during pregnancy – March 2016&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#see-also-vitamindwiki">See also VitaminDWiki&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="meta-analysis-found-40-more-likely-for-offspring-to-develop-ms-if-low-vitamin-d-during-pregnancy---jan-2020">Meta-analysis found 40% more likely for offspring to develop MS if low Vitamin D during pregnancy - Jan 2020&lt;/h4>
&lt;p>&lt;strong>Gestational Vitamin D and Offspring Risk of Multiple Sclerosis: A Systematic Review and Meta-Analysis&lt;/strong>&lt;/p>
&lt;p>&lt;strong>&lt;i class="fas fa-file-pdf" style="margin-right: 0.3em;">&lt;/i>&lt;a href="https://d378j1rmrlek7x.cloudfront.net/attachments/pdf/pregnancy-ms-meta.pdf">Download the PDF from VitaminDWiki&lt;/a>&lt;/strong>&lt;/p></description></item><item><title>Pregnancy and placenta: benefits of vitamin D – 2010</title><link>/posts/pregnancy-and-placenta-benefits-of-vitamin-d-2010.html</link><pubDate>Sun, 06 Mar 2016 00:00:00 +0000</pubDate><guid>/posts/pregnancy-and-placenta-benefits-of-vitamin-d-2010.html</guid><description>&lt;h4 id="vitamin-d-effects-on-pregnancy-and-the-placenta">Vitamin D effects on pregnancy and the placenta&lt;/h4>
&lt;p>J.S. Shina,b, M.Y. Choib, M.S. Longtineb, D.M. Nelson b &lt;a href="mailto:nelsondm@wudosis.wustl.edu">nelsondm@wudosis.wustl.edu&lt;/a>&lt;/p>
&lt;p>a Department of Obstetrics and Gynecology, CHA University School of Medicine, Seoul, Republic of Korea b Department of Obstetrics and Gynecology, Washington University School of Medicine, 4566 Scott Ave, St. Louis, MO 63110, USA&lt;/p>
&lt;div class="border" style="background-color:#FF9;padding:15px;margin:10px 0;border-radius:5px;width:700px">
&lt;ul>
&lt;li>
&lt;p>&lt;a href="/posts/healthy-pregnancies-need-lots-of-vitamin-d">Healthy pregnancies need lots of vitamin D&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/the-placenta-and-vitamin-d">The placenta and vitamin D – July 2012&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="https://www.VitaminDWiki.com/Search+Results?hl=en&amp;amp;oe=UTF-8&amp;amp;ie=UTF-8&amp;amp;btnG=Google+Search&amp;amp;googles.x=0&amp;amp;googles.y=0&amp;amp;q=placenta&amp;amp;domains=VitaminDWiki.com&amp;amp;sitesearch=VitaminDWiki.com">Search VitaminDWiki for PLACENTA&lt;/a> 339 items as of Aug 2016&lt;/p></description></item><item><title>Myasthenia Gravis remission with 100,000 IU vitamin D daily – one person</title><link>/posts/myasthenia-gravis-remission-with-100000-iu-vitamin-d-daily-one-person.html</link><pubDate>Sat, 30 Jan 2016 00:00:00 +0000</pubDate><guid>/posts/myasthenia-gravis-remission-with-100000-iu-vitamin-d-daily-one-person.html</guid><description>&lt;h4 id="remission-of-severe-myasthenia-gravis-after-massive-dose-vitamin-d-treatment">Remission of Severe Myasthenia Gravis After Massive-Dose Vitamin D Treatment.&lt;/h4>
&lt;p>Am J Case Rep. 2016 Jan 29;17:51-4.&lt;/p>
&lt;p>Cadegiani FA Endocrinology Unit, Corpometria, Brasilia, Brazil.&lt;/p>
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/mg.jpg" alt="image">
&lt;p>BACKGROUND Vitamin D has been shown to be related to autoimmune diseases, such as multiple sclerosis and psoriasis. Correlations have been reported between vitamin D levels and prevalence and severity of other autoimmune disorders, and also between vitamin D therapy and disease improvement and remission.&lt;/p>
&lt;p>CASE REPORT This is a case report of a patient with severe and refractory myasthenia gravis (MG) who followed a &amp;ldquo;high-dose vitamin D treatment&amp;rdquo;, a massive-dose treatment (80 000 to 120 000 IU/day) promoted by a medical center in Brazil (but still not proven), and she had her first complete remission after this type of treatment with increased vitamin D serum levels ( &lt;strong>400 to 700 ng/mL&lt;/strong> ).&lt;/p></description></item><item><title>Is a health problem associated with Low vitamin D, Low Magnesium, or too much Calcium</title><link>/posts/is-a-health-problem-associated-with-low-vitamin-d-low-magnesium-or-too-much-calcium.html</link><pubDate>Sun, 17 Jan 2016 00:00:00 +0000</pubDate><guid>/posts/is-a-health-problem-associated-with-low-vitamin-d-low-magnesium-or-too-much-calcium.html</guid><description>&lt;h4 id="essential-nutrient-interactions-does-low-or-suboptimal-magnesium-status-interact-with-vitamin-d-andor-calcium-status">Essential Nutrient Interactions: Does Low or Suboptimal Magnesium Status Interact with Vitamin D and/or Calcium Status?&lt;/h4>
&lt;p>Adv Nutr. 2016 Jan 15;7(1):25-43. &lt;a href="https://doi.org/10.3945/an.115.008631.">doi: 10.3945/an.115.008631.&lt;/a> Print 2016 Jan.&lt;/p>
&lt;p>Rosanoff A1, Dai Q2, Shapses SA3.&lt;/p>
&lt;p>1 &lt;a href="http://www.magnesiumeducation.com/">Center for Magnesium Education and Research&lt;/a>, Pahoa, HI; &lt;a href="mailto:arosanoff@gmail.com">arosanoff@gmail.com&lt;/a>.&lt;/p>
&lt;p>2 Vanderbilt Epidemiology Center, Department of Medicine, School of Medicine, Vanderbilt University, Nashville, TN&lt;/p>
&lt;p>3 Rutgers University, New Brunswick, NJ.&lt;/p>
&lt;div class="border" style="background-color:#FF9;padding:15px;margin:10px 0;border-radius:5px;width:750px">
&lt;p>Optimum Calcium somewhere 1.7 - 2.5 X Magnesium &lt;a href="/posts/calcium-2x-of-magnesium-seems-good-china">China says 2.0 X&lt;/a>&lt;/p></description></item><item><title>Vitamin D – millions of years more ancient than Calcium</title><link>/posts/vitamin-d-millions-of-years-more-ancient-than-calcium.html</link><pubDate>Fri, 08 Jan 2016 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-millions-of-years-more-ancient-than-calcium.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#vitamin-d-a-dynamic-molecule-how-relevant-might-the-dynamism-for-a-vitamin-be">Vitamin D: a dynamic molecule. How relevant might the dynamism for a vitamin be?&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#see-also-vitamindwiki">See also VitaminDWiki&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#history-of-vitamin-by-lorenz-borsche---written-to-a-friend---march-2022">History of Vitamin by Lorenz Borsche - written to a friend - March 2022&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="vitamin-d-a-dynamic-molecule-how-relevant-might-the-dynamism-for-a-vitamin-be">Vitamin D: a dynamic molecule. How relevant might the dynamism for a vitamin be?&lt;/h4>
&lt;p>Nephrology Dialysis Transplantation Volume 31, Issue 1Pp. 23-30.&lt;/p>
&lt;p>Sandro Mazzaferro1, &lt;a href="mailto:sandro.mazzaferro@uniroma1.it">sandro.mazzaferro@uniroma1.it&lt;/a> and Marzia Pasquali1&lt;/p>
&lt;p>1Department of Cardiovascular Respiratory Nephrologic Anesthetic and Geriatric Sciences, Sapienza University of Rome, Rome, Italy&lt;/p></description></item><item><title>Hip fracture 3X more likely if low vitamin D</title><link>/posts/hip-fracture-3x-more-likely-if-low-vitamin-d.html</link><pubDate>Sat, 26 Dec 2015 00:00:00 +0000</pubDate><guid>/posts/hip-fracture-3x-more-likely-if-low-vitamin-d.html</guid><description>&lt;h3 id="low-25oh-d-serum-levels-are-related-with-hip-fracture-in-postmenopausal-women-a-matched-casecontrol-study">Low 25(OH) D serum levels are related with hip fracture in postmenopausal women: a matched case–control study&lt;/h3>
&lt;p>Journal of Translational Medicine 2015, 13:388 doi:10.1186/s12967-015-0756-x&lt;/p>
&lt;p>Xing-Mao Fu*†, Shao-Guang Fan†, Shu-Liang Li, Yi-Sheng Chen, Hai Wu and Yan-Long Guo&lt;/p>
&lt;ul>
&lt;li>Corresponding author:	Xing-Mao Fu &lt;a href="mailto:fxm70xe@126.com">fxm70xe@126.com&lt;/a>; † Equal contributors&lt;/li>
&lt;/ul>
&lt;p>Institute of Traumatic Orthopedics, The 89th Hospital of People’s Liberation Army, No. 256 Beigongxi Str, Weifang 261021, Shandong Province, People’s Republic of China&lt;/p>
&lt;div class="border" style="background-color:#FF9;padding:15px;margin:10px 0;border-radius:5px;width:700px">
&lt;ul>
&lt;li>
&lt;p>&lt;a href="/posts/vitamin-d-and-fractures-24-meta-analyses-and-counting">Vitamin D and fractures – 24 meta-analyses and counting – Dec 2014&lt;/a>&lt;/p></description></item><item><title>Thyroid diseases and vitamin D – review 2015</title><link>/posts/thyroid-diseases-and-vitamin-d-review-2015.html</link><pubDate>Sat, 19 Dec 2015 00:00:00 +0000</pubDate><guid>/posts/thyroid-diseases-and-vitamin-d-review-2015.html</guid><description>&lt;h3 id="vitamin-d-and-thyroid-diseases">Vitamin D and thyroid diseases.&lt;/h3>
&lt;p>Physiol Res. 2015;64 Suppl 2:S95-S100.&lt;/p>
&lt;p>Vondra K1, Stárka L, Hampl R.&lt;/p>
&lt;p>1Institute of Endocrinology, Prague, Czech Republic. &lt;a href="mailto:kvondra@endo.cz">kvondra@endo.cz&lt;/a>.&lt;/p>
&lt;p>In this review we summarize recent opinions on the possible role of vitamin D in the risk of thyroid diseases development. It may be concluded from the available data that vitamin D deficiency, &lt;strong>particularly levels below 12.5 ng/ml&lt;/strong> should be considered as an additional, but important risk factor for development of thyroid autoimmunity, both chronic autoimmune thyroiditis and Graves´ disease. A higher risk of Graves´ disease development is also associated with several polymorphisms in the gene encoding for vitamin D binding protein and for the specific receptor of active form of vitamin D - 1,25-(OH)(2)D(3) in the respective target cells. Important for development of thyroid cancer appeared polymorphisms of genes encoding for vitamin D receptors and of genes encoding for the participating hydroxylating enzymes in thyroid tissue, leading to a diminished local 1,25-(OH)(2)D(3) formation capacity with following alteration of antiproliferatory, antiapoptotic and prodifferentiating efficacy of the latter. Whether supplementation with high doses of vitamin D or its analogues possesses preventive or therapeutic effect is an object of intensive studies.&lt;/p></description></item><item><title>Congenital Heart problems - vitamin D levels drop even lower after surgery, loading dose probably required - thesis 2015</title><link>/posts/congenital-heart-problems-vitamin-d-levels-drop-even-lower-after-surgery-loading-red-thesis-2015.html</link><pubDate>Sun, 06 Dec 2015 00:00:00 +0000</pubDate><guid>/posts/congenital-heart-problems-vitamin-d-levels-drop-even-lower-after-surgery-loading-red-thesis-2015.html</guid><description>&lt;h4 id="table-of-contents-in-thesis">Table of contents in thesis&lt;/h4>
&lt;p>&lt;strong>Chapter 1 - Thesis overview&lt;/strong>&lt;/p>
&lt;p>Summary&lt;/p>
&lt;p>Hypotheses&lt;/p>
&lt;p>Objectives&lt;/p>
&lt;p>Global Objectives&lt;/p>
&lt;p>Specific Objectives for the thesis&lt;/p>
&lt;p>Presentation of thesis work	3&lt;/p>
&lt;p>&lt;strong>Chapter 2 - Background&lt;/strong>&lt;/p>
&lt;p>Population and problem	5&lt;/p>
&lt;p>Overview of Vitamin D	5&lt;/p>
&lt;p>Vitamin D axis&lt;/p>
&lt;p>Evaluation of vitamin D status&lt;/p>
&lt;p>Vitamin D deficiency in CHD	patients	7&lt;/p>
&lt;p>Factors contributing to post-operative VDD	9&lt;/p>
&lt;p>Primary vitamin D deficiency&lt;/p>
&lt;p>Secondary vitamin D deficiency&lt;/p>
&lt;p>Role of vitamin D deficiency in	CHD patients	11&lt;/p></description></item><item><title>Vitamin D Binding Protein Sept 2016 - call for papers</title><link>/posts/vitamin-d-binding-protein-sept-2016-call-for-papers.html</link><pubDate>Mon, 09 Nov 2015 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-binding-protein-sept-2016-call-for-papers.html</guid><description>&lt;h4 id="vitamin-d-binding-protein-and-vitamin-d-metabolites-from-analytical-issues-to-emerging-clinical-applications">Vitamin D Binding Protein and Vitamin D Metabolites: From Analytical Issues to Emerging Clinical Applications&lt;/h4>
&lt;p>&lt;a href="http://www.hindawi.com/journals/ije/si/230410/cfp/">http://www.hindawi.com/journals/ije/si/230410/cfp/&lt;/a> &lt;strong>Dead link May 2018&lt;/strong>&lt;/p>
&lt;p>&lt;strong>Potential topics include, but are not limited to:&lt;/strong>&lt;/p>
&lt;p>Hormone regulation of DBP and vitamin D metabolites&lt;/p>
&lt;p>DBP and vitamin D metabolite levels in various disease conditions&lt;/p>
&lt;p>DBP and vitamin D levels in different ethnic populations&lt;/p>
&lt;p>Pathologic conditions potentially able to alter DBP levels and vitamin D bioactivity&lt;/p>
&lt;p>Association of DBP and vitamin D metabolites with the etiology of different diseases&lt;/p></description></item><item><title>COPD strongly associated with Vitamin D Binding Protein problems – meta-analysis</title><link>/posts/copd-strongly-associated-with-vitamin-d-binding-protein-problems-meta-analysis.html</link><pubDate>Wed, 04 Nov 2015 00:00:00 +0000</pubDate><guid>/posts/copd-strongly-associated-with-vitamin-d-binding-protein-problems-meta-analysis.html</guid><description>&lt;h4 id="vitamin-d-binding-protein-gene-polymorphisms-and-chronic-obstructive-pulmonary-disease-a-meta-analysis">Vitamin D binding protein gene polymorphisms and chronic obstructive pulmonary disease: a meta-analysis&lt;/h4>
&lt;p>J Thorac Dis. 2015 Aug; 7(8): 1423–1440., &lt;a href="https://doi.org/10.3978/j.issn.2072-1439.2015.08.16">doi: 10.3978/j.issn.2072-1439.2015.08.16&lt;/a>&lt;/p>
&lt;p>Huan Chen, Lei Zhang, Zhiyi He,corresponding author Xiaoning Zhong, Jianquan Zhang, Meihua Li, and Jing Bai&lt;/p>
&lt;p>Department of Respiratory Medicine, The First Affiliated Hospital of Guangxi Medical University, Nanning 530021, China&lt;/p>
&lt;p>Contributions: (I) Conception and design: H Chen, L Zhang, J Zhang, X Zhong, Z He; (II) Administrative support: Z He; (III) Collection and assembly of data: H Chen, L Zhang; (IV) Data analysis and interpretation: H Chen, L Zhang, J Bai; (V) Manuscript writing: All authors; (VI) Final approval of manuscript: All authors.&lt;/p></description></item><item><title>Vitamin D papers from European Vitamin D Association Conference</title><link>/posts/vitamin-d-papers-from-european-vitamin-d-association-conference.html</link><pubDate>Mon, 26 Oct 2015 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-papers-from-european-vitamin-d-association-conference.html</guid><description>&lt;p>Most of the ENGLISH presentations of the conference follow&lt;/p>
&lt;p>Polish Presentations and Polish abstracts are in the &lt;span>[dl3144]&lt;/span>&lt;/p>
&lt;p>Graphics and table are generally in the &lt;span>[dl3144]&lt;/span>&lt;/p>
&lt;p>References are generally in the &lt;span>[dl3144]&lt;/span> as well&lt;/p>
&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#vitamin-d-update-2015-what-we-need-to-know-about-its-health-benefits-and-potential-for-toxicity">Vitamin D Update 2015: What We Need to Know about Its Health Benefits and Potential for Toxicity?&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#spanskin-synthesis-of-vitamin-d---pros-and-consspan-english-abstract">&lt;span>[Skin synthesis of vitamin D - pros and cons]&lt;/span> English Abstract&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#nutritional-rickets---global-guidelines-for-prevention-and-treatment">Nutritional Rickets - global guidelines for prevention and treatment&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#the-role-of-vitamin-d-supplementation-in-treating-health-conditions-and-diseases-common-among-those-with-intellectual-andor-developmental-disabilities">The role of vitamin D supplementation in treating health conditions and diseases common among those with intellectual and/or developmental disabilities&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#spanvitamin-d-in-dermatologists-practicespan-english-abstract">&lt;span>[Vitamin D in dermatologists&amp;rsquo; practice]&lt;/span> English abstract&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#the-role-of-vdr-gene-polymorphisms-in-basal-cell-carcinoma-development">The role of VDR gene polymorphisms in basal cell carcinoma development&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-and-melanoma">Vitamin D and melanoma&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#potential-use-of-vitamin-d-analogs-in-the-treatment-of-skin-diseases">Potential use of vitamin D analogs in the treatment of skin diseases&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#biomarkers-of-vitamin-d-metabolism-current-state-of-knowledge">Biomarkers of Vitamin D Metabolism: Current State of Knowledge&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#standardization-of-vitamin-d-assays">Standardization of Vitamin D Assays:&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#assays-for-vitamin-d-metabolites-performance-in-the-real-world">Assays for vitamin D metabolites; performance in the real world&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#comparison-of-two-immunoassays-for-vitamin-d-measurement-is-age-a-confounder">Comparison of two immunoassays for vitamin D measurement is age a confounder?&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#pleiotropic-action-of-vitamin-d-in-light-of-recent-meta-analyzes">Pleiotropic action of vitamin D in light of recent meta-analyzes&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-requirements-during-pregnancy-and-lactation">Vitamin D Requirements during Pregnancy and Lactation&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#25-hydroxyvitamin-d-insufficiency-in-extraskeletal-diseases">25-hydroxyvitamin D insufficiency in extraskeletal diseases&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-and-cardiovascular-disorders">Vitamin D and Cardiovascular disorders&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#endothelial-function-and-pulse-wave-velocity-in-patients-with-chronic-heart-failure-and-d-deficiency">Endothelial function and pulse wave velocity in patients with chronic heart failure and D-deficiency&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-insufficiency-in-young-children-in-russia-the-results-of-the-multicentre-cohort-study-rodnichok-2013-2014">Vitamin D Insufficiency in Young Children in Russia: the Results of the Multicentre Cohort Study RODNICHOK (2013-2014)&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-status-in-residents-of-belarus-analysis-of-the-three-year-data">Vitamin D status in residents of Belarus: analysis of the three-year data&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-deficiency-correction-in-elderly-people">Vitamin D deficiency correction in elderly people&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;li>&lt;a href="#span-stylecolorf00postersspan">&lt;span style="color:#F00;">POSTERS&lt;/span>&lt;/a>
 &lt;ul>
 &lt;li>&lt;a href="#vitamin-d-status-in-north-west-russian-region">Vitamin D status in north-west russian region&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#the-ways-of-vitamin-d-deficiency-correction-in-ukraine">The ways of vitamin d deficiency correction in ukraine&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#high-dose-vitamin-d3-supplementation-as-a-novel-strategy-in-clinical-management-of-wintertime-preeclampsia">High-dose vitamin D3 supplementation as a novel strategy in clinical management of wintertime preeclampsia&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#association-of-bsmi-polymorphism-of-vdr-gene-with-vitamin-d-status-in-children-with-vitamin-d---deficient-rickets">Association of BsmI polymorphism of VDR gene with vitamin D status in children with vitamin D - deficient rickets&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-levels-may-influence-microarchitecture-of-bone-tissue-in-men">Vitamin D levels may influence microarchitecture of bone tissue in men&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#ameliorative-effect-of-vitamin-d3-against-liver-disorders-and-impaired-bone-remodeling-associated-with-experimental-type-1-diabetes">Ameliorative effect of vitamin D3 against liver disorders and impaired bone remodeling associated with experimental type 1 diabetes&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-status-and-inflammation-in-copd-patients-preliminary-findings-from-a-seasonal-observation-study">Vitamin D status and inflammation in COPD patients: preliminary findings from a seasonal observation study&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#effect-of-a-primary-prevention-program-incorporating-vitamin-and-mineral-supplementation-on-glycemic-status-an-observational-study">Effect of a primary prevention program incorporating vitamin and mineral supplementation on glycemic status: an observational study&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-supplementation---positive-effects-on-lipid-profile-in-patients-with-hypertension">Vitamin D supplementation - positive effects on lipid profile in patients with hypertension&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#the-effects-of-a-preventive-health-program-and-vitamin-d-status-on-metabolic-syndrome">The Effects of a Preventive Health Program and Vitamin D Status on Metabolic Syndrome&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#serum-vitamin-d-status-a-threat-neither-for-hypercalcemia-nor-for-inflammation">Serum Vitamin D Status, a Threat neither for Hypercalcemia nor for Inflammation&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#synthesis-of-novel-vitamin-d-analogs-and-their-biological-evaluation">Synthesis of novel vitamin D analogs and their biological evaluation&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#tissue-in-children-with-ergocalciferol-deficiency-in-anamnesis">Tissue in children with ergocalciferol deficiency in anamnesis&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#correlation-between-vitamin-d-level-and-behcets-disease-activity-in-patients-in-west-region-of-ukraine">Correlation between Vitamin D level and Behcet&amp;rsquo;s disease activity in patients in West region of Ukraine&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#dynamics-of-the-vitamin-d-and-of-the-bones-metabolism-other-indicators-in-the-pregnant-women-with-perinatal-infection">Dynamics of the vitamin D and of the bone&amp;rsquo;s metabolism other indicators in the pregnant women with perinatal infection&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-intakes-among-pregnant-women-in-an-urban-and-rural-population-of-western-ukraine">Vitamin d intakes among pregnant women in an urban and rural population of Western Ukraine&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#the-curious-situation-of-europeans-and-vitamin-d---an-environmental-mismatch">The Curious Situation of Europeans and Vitamin D - an Environmental Mismatch?&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-status-among-healthy-infants-in-poland---assessment-based-on-randomly-selected-sample-from-the-population">Vitamin D status among healthy infants in Poland - assessment based on randomly selected sample from the population&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#the-protective-effect-of-vitamin-d3-against-prednisolone-induced-liver-injury-in-rats">The protective effect of vitamin D3 against prednisolone-induced liver injury in rats&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#effect-of-cholecalciferol-on-plasma-rennin-activity-in-women-with-arterial-hypertension-in-premenopausal-and-early-postmenopausal-periods">Effect of cholecalciferol on plasma rennin activity in women with arterial hypertension in premenopausal and early postmenopausal periods&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#multiple-mechanisms-by-which-both-vitamin-d-deficiency-and-toxicity-affect-cardiovascular-health">Multiple mechanisms by which both vitamin D deficiency and toxicity affect cardiovascular health&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#the-undifferentiated-connective-tissue-dysplasia-provide-the-vitamin-d3-for-adolescent-children">The undifferentiated connective tissue dysplasia provide the vitamin D3 for adolescent children&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#prevalence-of-25-hydroxyvitamin-d-deficiency-in-children-on-dialysis-and-after-kidney-transplantation">Prevalence of 25-Hydroxyvitamin D Deficiency in Children on Dialysis and After Kidney Transplantation&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-status-in-children-with-bronchial-asthma">Vitamin D status in children with bronchial asthma&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#prevalence-of-vitamin-d-deficiency-in-adult-outpatients-with-schizophrenia-or-bipolar-disorder">Prevalence of vitamin D deficiency in adult outpatients with schizophrenia or bipolar disorder&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#rickets-in-premature-infants-with-very-low-birth-weight-clinical-features-and-course-of-the-disease">Rickets in Premature Infants with Very Low Birth Weight: Clinical Features and Course of the Disease&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#the-undifferentiated-connective-tissue-dysplasia-provide-the-vitamin-d3-for-adolescent-children-1">The undifferentiated connective tissue dysplasia provide the vitamin D3 for adolescent children&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#influence-of-125oh2d3-and-its-derivatives---pri-2191-and-pri-2205">Influence of 1,25(OH)2D3 and its derivatives - PRI-2191 and PRI-2205&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-deficiency-in-patients-with-subclinical-and-overt-hypothyroidism">Vitamin d deficiency in patients with subclinical and overt hypothyroidism&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d3-supplementation-using-an-oral-spray-solution-resolves-deficiency-but-has-no-significant-effect-on-vo2max-in-gaelic-athletes-results-from-a-randomised-doubleblind-placebo-controlled-trial__">Vitamin D3 supplementation using an oral spray solution resolves deficiency but has no significant effect on VO2max in Gaelic athletes:** results from a randomised, doubleblind, placebo-controlled trial__&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#maternal-obesity-and-associated-vitamin-d-status-in-pregnancy-data-from-the-fasstt-study">Maternal obesity and associated vitamin D status in pregnancy: data from the FASSTT study&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#immunoglobulin-g-in-children-with-recurrent-respiratory-infections">immunoglobulin G in children with recurrent respiratory infections&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-and-cancer-diseases">Vitamin d and cancer diseases&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#correction-of-hypovitaminosis-d-with-vitamin-d-supplements-in-patients-with-psoriasis">Correction of hypovitaminosis D with vitamin D supplements in patients with psoriasis&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#association-between-vitamin-d-and-lipid-accumulation-product-in-community-dwelling-elderly-persons">Association Between Vitamin D and Lipid Accumulation Product in Community Dwelling Elderly Persons&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-supplementary-intake-throughout-3rd-trimester-of-pregnancy">Vitamin D supplementary intake throughout 3rd trimester of pregnancy&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#evaluation-of-the-current-vitamin-d-content-of-ni-milk-and-its-efficacy-to-increase-vitamin-d-intake-of-the-population-through-fortification">Evaluation of the current vitamin D content of NI milk and its efficacy to increase vitamin D intake of the population through fortification&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#can-vitamin-d-influence-bmd-in-hyperthyroid-patients-with-and-without-silent-vertebral-fractures">Can Vitamin D influence BMD in hyperthyroid patients with and without silent vertebral fractures?&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;h4 id="vitamin-d-update-2015-what-we-need-to-know-about-its-health-benefits-and-potential-for-toxicity">Vitamin D Update 2015: What We Need to Know about Its Health Benefits and Potential for Toxicity?&lt;/h4>
&lt;p>Michael F. Holick&lt;/p></description></item><item><title>Rotterdam Vitamin D dissertation text</title><link>/posts/rotterdam-vitamin-d-dissertation-text.html</link><pubDate>Sun, 18 Oct 2015 00:00:00 +0000</pubDate><guid>/posts/rotterdam-vitamin-d-dissertation-text.html</guid><description>&lt;p>&lt;strong>Summary and PDF is at &lt;a href="/posts/more-vitamin-d-makes-for-better-health-dissertation-based-on-rotterdam-studies">More vitamin D makes for better health – dissertation based on Rotterdam studies – Oct 2015&lt;/a>&lt;/strong>&lt;/p>
&lt;p>The following is a rough dump of the text from the dissertation - for ease of translation&lt;/p>
&lt;p>&lt;strong>Vitamin D and Cardio-metabolic Health in the Elderly - The Rotterdam Study&lt;/strong>&lt;/p>
&lt;p>Vitamine D en cardiometabole gezondheid in ouderen: De - Rotterdam Studie&lt;/p>
&lt;p>Thesis&lt;/p>
&lt;p>to obtain the degree of Doctor from the&lt;/p>
&lt;p>Erasmus University Rotterdam&lt;/p></description></item><item><title>Bio-available Vitamin D following mega-doses (up to 500,000 IU) – Clinical trial due 2018</title><link>/posts/bio-available-vitamin-d-following-mega-doses-up-to-500000-iu-clinical-trial-due-2018.html</link><pubDate>Thu, 17 Sep 2015 00:00:00 +0000</pubDate><guid>/posts/bio-available-vitamin-d-following-mega-doses-up-to-500000-iu-clinical-trial-due-2018.html</guid><description>&lt;h4 id="change-in-free-25ohd-after-high-dose-in-vitamin-d-deficient-postmenopausal-women">Change in Free 25(OH)D After High Dose in Vitamin D Deficient Postmenopausal Women&lt;/h4>
&lt;p>This study is not yet open for participant recruitment. (see Contacts and Locations)&lt;/p>
&lt;p>Verified September 2015 by Sheffield Teaching Hospitals NHS Foundation Trust&lt;/p>
&lt;p>Sponsor: Sheffield Teaching Hospitals NHS Foundation Trust&lt;/p>
&lt;p>Collaborator: National Osteoporosis Society&lt;/p>
&lt;p>Information provided by (Responsible Party):&lt;/p>
&lt;p>Sheffield Teaching Hospitals NHS Foundation Trust&lt;/p>
&lt;p>ClinicalTrials.gov Identifier: NCT02553044, First received: September 16, 2015&lt;/p>
&lt;p>We currently use total 25(OH)D as a biomarker of vitamin D status. However, there is some debate as to whether total 25(OH)D is the best marker to use.&lt;/p></description></item><item><title>Vitamin D is more bio-available when children are critically ill (less Binding Protein)</title><link>/posts/vitamin-d-is-more-bio-available-when-children-are-critically-ill-less-binding-protein.html</link><pubDate>Tue, 15 Sep 2015 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-is-more-bio-available-when-children-are-critically-ill-less-binding-protein.html</guid><description>&lt;h4 id="critically-ill-children-have-low-vitamin-d-binding-protein-influencing-bioavailability-of-vitamin-d">Critically Ill Children Have Low Vitamin D Binding Protein, Influencing Bioavailability of Vitamin D&lt;/h4>
&lt;p>Annals ATS.(Annals of the American Thoracic Society) First published online 10 Sep 2015 as DOI: 10.1513/AnnalsATS.201503-160OC&lt;/p>
&lt;p>Kate Madden &lt;a href="mailto:kate.madden@childrens.harvard.edu">kate.madden@childrens.harvard.edu&lt;/a> , Henry A. Feldman, Rene F. Chun, Ellen M Smith, Ryan M Sullivan, Anna A Agan, Shannon M Keisling, Angela Panoskaltsis-Mortari, and Adrienne G Randolph&lt;/p>
&lt;div class="border" style="background-color:#FF9;padding:15px;margin:10px 0;border-radius:5px;width:600px">
&lt;ul>
&lt;li>
&lt;p>The infant body allows more vitamin D to get to cells during critical illness.&lt;/p></description></item><item><title>Cancer risk weakly associated with vitamin D-binding protein – meta-analysis</title><link>/posts/cancer-risk-weakly-associated-with-vitamin-d-binding-protein-meta-analysis.html</link><pubDate>Mon, 14 Sep 2015 00:00:00 +0000</pubDate><guid>/posts/cancer-risk-weakly-associated-with-vitamin-d-binding-protein-meta-analysis.html</guid><description>&lt;h4 id="meta-analysis-of-vitamin-d-binding-protein-and-cancer-risk">Meta-analysis of vitamin D-binding protein and cancer risk.&lt;/h4>
&lt;p>Cancer Epidemiol Biomarkers Prev. 2015 Sep 12. pii: cebp.0262.2015. &lt;span>[Epub ahead of print]&lt;/span>&lt;/p>
&lt;p>Tagliabue E1, Raimondi S2, Gandini S3.&lt;/p>
&lt;p>BACKGROUND:&lt;/p>
&lt;p>Epidemiologic evidence supported a role for vitamin D and vitamin D receptor (VDR) polymorphisms in cancer risk. Beyond VDR, the biological effects of vitamin D are mediated by the vitamin D binding protein (DBP), a key protein in vitamin D metabolism. Furthermore, the gene encoding the DBP (GC, Group-specific component) has an important role in vitamin D pathway. Several studies investigated DBP serological levels and GC polymorphisms in association with cancer risk with controversial results. Thus we carried out a meta-analysis to investigate these associations.&lt;/p></description></item><item><title>Vitamin D Binding Protein</title><link>/posts/vitamin-d-binding-protein.html</link><pubDate>Mon, 07 Sep 2015 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-binding-protein.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#vitamin-d-binding-protein-and-its-gene-polymorphisms-the-risk-of-malignant-tumors-and-other-diseases---oct-2020">Vitamin D Binding Protein and Its Gene Polymorphisms —The Risk of Malignant Tumors and Other Diseases - Oct 2020&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#low-response-to-vitamin-d-can-be-improved-in-many-ways">Low response to Vitamin D can be improved in many ways&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#see-also-web">See also web&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-binding-protein-mutations-are-not-noticed-by-the-vitamin-d-test--march-2024">Vitamin D Binding Protein mutations are not noticed by the Vitamin D Test – March 2024&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="vitamin-d-binding-protein-and-its-gene-polymorphisms-the-risk-of-malignant-tumors-and-other-diseases---oct-2020">Vitamin D Binding Protein and Its Gene Polymorphisms —The Risk of Malignant Tumors and Other Diseases - Oct 2020&lt;/h4>
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/vdbp1.jpg" alt="image" width="800">
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/vdbp2.jpg" alt="image" width="800">
&lt;p>&lt;strong>&lt;i class="fas fa-file-pdf" style="margin-right: 0.3em;">&lt;/i>&lt;a href="https://d378j1rmrlek7x.cloudfront.net/attachments/pdf/vdbp-tumors-etc..pdf">PDF &lt;/a>&lt;/strong>&lt;/p></description></item><item><title>Hip Fracture 2.5 times more likely if poor Vitamin D Binding Protein gene</title><link>/posts/hip-fracture-25-times-more-likely-if-poor-vitamin-d-binding-protein-gene.html</link><pubDate>Thu, 27 Aug 2015 00:00:00 +0000</pubDate><guid>/posts/hip-fracture-25-times-more-likely-if-poor-vitamin-d-binding-protein-gene.html</guid><description>&lt;p>INTRODUCTION: Vitamin D deficiency has been reported to be common in patients with rheumatoid arthritis (RA) who have a higher prevalence of osteoporosis and hip fracture than healthy individuals. Genetic variants affecting serum 25-hydroxyvitamin D (25(OH)D) concentration, an indicator of vitamin D status, were recently identified by genome-wide association studies of Caucasian populations. The purpose of this study was to validate the association and to test whether the serum 25(OH)D-linked genetic variants were associated with the occurrence of hip fracture in Japanese RA patients.&lt;/p></description></item><item><title>Genes make Multiple Sclerosis 2X more likely unless get more vitamin D</title><link>/posts/genes-make-multiple-sclerosis-2x-more-likely-unless-get-more-vitamin-d.html</link><pubDate>Wed, 26 Aug 2015 00:00:00 +0000</pubDate><guid>/posts/genes-make-multiple-sclerosis-2x-more-likely-unless-get-more-vitamin-d.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#vitamin-d-and-risk-of-multiple-sclerosis-a-mendelian-randomization-study---2015">Vitamin D and Risk of Multiple Sclerosis: A Mendelian Randomization Study - 2015&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#plos-editors-summary">(PLOS) Editors&amp;rsquo; Summary&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#introduction">Introduction&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#methods">Methods&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#association-of-sunlight-snps-with-multiple-sclerosis-susceptibility">Association of SUNLIGHT SNPs with Multiple Sclerosis Susceptibility&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#results">Results&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#mendelian-randomization-analysis-for-the-association-of-25ohd-with-multiple-sclerosis-risk">Mendelian Randomization Analysis for the Association of 25OHD with Multiple Sclerosis Risk&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#discussion">Discussion&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#59-references">59 References&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#expert-reaction-to-new-study-on-vitamin-d-deficiency-and-ms">Expert reaction to new study on vitamin D deficiency and MS&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#extensive-positive-comments-on-study-in-neurology-today---sept-2015">Extensive positive comments on study in Neurology Today - Sept 2015&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h3 id="vitamin-d-and-risk-of-multiple-sclerosis-a-mendelian-randomization-study---2015">Vitamin D and Risk of Multiple Sclerosis: A Mendelian Randomization Study - 2015&lt;/h3>
&lt;p>PLOS ONE&lt;/p></description></item><item><title>Review of Osteoarthritis and vitamin D</title><link>/posts/review-of-osteoarthritis-and-vitamin-d.html</link><pubDate>Sun, 02 Aug 2015 00:00:00 +0000</pubDate><guid>/posts/review-of-osteoarthritis-and-vitamin-d.html</guid><description>&lt;p>&lt;strong>Role of Vitamin D in Osteoarthritis: Molecular, Cellular, and Clinical Perspectives&lt;/strong>&lt;/p>
&lt;p>International Journal of Endocrinology, Volume 2015 (2015), Article ID 383918, 14 pages, &lt;a href="http://dx.doi.org/10.1155/2015/383918">http://dx.doi.org/10.1155/2015/383918&lt;/a>&lt;/p>
&lt;p>Thomas Mabey1 and Sittisak Honsawek1,2&lt;/p>
&lt;p>1Department of Biochemistry, Faculty of Medicine, Chulalongkorn University, King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok 10330, Thailand&lt;/p>
&lt;p>2Department of Orthopaedics, Faculty of Medicine, Chulalongkorn University, King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok 10330, Thailand&lt;/p>
&lt;p>&lt;strong>Figure 4&lt;/strong>&lt;/p>
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/oa-f2.jpg" alt="image" width="800">
&lt;p>Osteoarthritis is a debilitating and degenerative disease which affects millions of people worldwide. The causes and mechanisms of osteoarthritis remain to be fully understood. Vitamin D has been hypothesised to play essential roles in a number of diseases including osteoarthritis. Many cell types within osteoarthritic joints appear to experience negative effects often at increased sensitivity to vitamin D. These findings contrast clinical research which has identified vitamin D deficiency to have a worryingly high prevalence among osteoarthritis patients. Randomised-controlled trial is considered to be the most rigorous way of determining the effects of vitamin D supplementation on the development of osteoarthritis. Studies into the effects of low vitamin D levels on pain and joint function have to date yielded controversial results. Due to the apparent conflicting effects of vitamin D in knee osteoarthritis, further research is required to fully elucidate its role in the development and progression of the disease as well as assess the efficacy and safety of vitamin D supplementation as a therapeutic strategy.&lt;/p></description></item><item><title>Links between Vitamin D Deficiency and Cardiovascular Diseases</title><link>/posts/links-between-vitamin-d-deficiency-and-cardiovascular-diseases.html</link><pubDate>Wed, 10 Jun 2015 00:00:00 +0000</pubDate><guid>/posts/links-between-vitamin-d-deficiency-and-cardiovascular-diseases.html</guid><description>&lt;p>Biomed Res Int. 2015;2015:109275. Epub 2015 Apr 27.&lt;/p>
&lt;p>Mozos I1, Marginean O2&lt;/p>
&lt;p>1 Department of Functional Sciences, &amp;ldquo;Victor Babes&amp;rdquo; University of Medicine and Pharmacy, 300173 Timisoara, Romania.&lt;/p>
&lt;p>2 Department of Pediatrics, &amp;ldquo;Victor Babes&amp;rdquo; University of Medicine and Pharmacy, 300173 Timisoara, Romania.&lt;/p>
&lt;div class="border" style="background-color:#FF9;padding:15px;margin:10px 0;border-radius:5px;width:400px">
&lt;p>&lt;a href="/posts/overview-cardiovascular-and-vitamin-d" style="color: red; text-decoration: underline;" title="This post/category does not exist yet: Overview Cardiovascular and vitamin D">Overview Cardiovascular and vitamin D&lt;/a>&lt;/p>
&lt;p>&lt;a href="/posts/overview-stroke-and-vitamin-d" style="color: red; text-decoration: underline;" title="This post/category does not exist yet: Overview Stroke and vitamin D">Overview Stroke and vitamin D&lt;/a>&lt;/p></description></item><item><title>Cardiovascular Diseases and Vitamin D – Review</title><link>/posts/cardiovascular-diseases-and-vitamin-d-review.html</link><pubDate>Sun, 31 May 2015 00:00:00 +0000</pubDate><guid>/posts/cardiovascular-diseases-and-vitamin-d-review.html</guid><description>&lt;p>&lt;strong>Links between Vitamin D Deficiency and Cardiovascular Diseases - Review Article&lt;/strong>&lt;/p>
&lt;p>BioMed Research International, Volume 2015 (2015), Article ID 109275, 12 pages&lt;/p>
&lt;p>&lt;a href="http://dx.doi.org/10.1155/2015/109275">http://dx.doi.org/10.1155/2015/109275&lt;/a>&lt;/p>
&lt;p>Ioana Mozos 1 and Otilia Marginean 2&lt;/p>
&lt;p>1Department of Functional Sciences, “Victor Babes” University of Medicine and Pharmacy, 300173 Timisoara, Romania&lt;/p>
&lt;p>2Department of Pediatrics, “Victor Babes” University of Medicine and Pharmacy, 300173 Timisoara, Romania&lt;/p>
&lt;p>Received 31 October 2014; Accepted 8 February 2015&lt;/p>
&lt;p>&lt;strong>Abstract&lt;/strong>&lt;/p>
&lt;p>The aim of the present paper was to review the most important mechanisms explaining the possible association of vitamin D deficiency and cardiovascular diseases, focusing on recent experimental and clinical data. Low vitamin D levels favor atherosclerosis enabling vascular inflammation, endothelial dysfunction, formation of foam cells, and proliferation of smooth muscle cells. The antihypertensive properties of vitamin D include suppression of the renin-angiotensin-aldosterone system, renoprotective effects, direct effects on endothelial cells and calcium metabolism, inhibition of growth of vascular smooth muscle cells, prevention of secondary hyperparathyroidism, and beneficial effects on cardiovascular risk factors. Vitamin D is also involved in glycemic control, lipid metabolism, insulin secretion, and sensitivity, explaining the association between vitamin D deficiency and metabolic syndrome. Vitamin D deficit was associated in some studies with the number of affected coronary arteries, postinfarction complications, inflammatory cytokines and cardiac remodeling in patients with myocardial infarction, direct electromechanical effects and inflammation in atrial fibrillation, and neuroprotective effects in stroke. In peripheral arterial disease, vitamin D status was related to the decline of the functional performance, severity, atherosclerosis and inflammatory markers, arterial stiffness, vascular calcifications, and arterial aging. Vitamin D supplementation should further consider additional factors, such as phosphates, parathormone, renin, and fibroblast growth factor 23 levels.&lt;/p></description></item><item><title>COPD getting worse is associated with very low vitamin D</title><link>/posts/copd-getting-worse-is-associated-with-very-low-vitamin-d.html</link><pubDate>Sun, 12 Apr 2015 00:00:00 +0000</pubDate><guid>/posts/copd-getting-worse-is-associated-with-very-low-vitamin-d.html</guid><description>&lt;h3 id="vitamin-d-vitamin-d-binding-protein-and-longitudinal-outcomes-in-copd">Vitamin D, Vitamin D Binding Protein, and Longitudinal Outcomes in COPD&lt;/h3>
&lt;p>PLOS ONE: March 24, 2015DOI: 10.1371/journal.pone.0121622&lt;/p>
&lt;p>Louise J. P. Persson , Marianne Aanerud, Pieter S. Hiemstra, Annika E. Michelsen, Thor Ueland, Jon A. Hardie, Pål Aukrust, Per S. Bakke, Tomas M. L. Eagan&lt;/p>
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/copd-f3.jpg" alt="image">
&lt;p>Background: Associations between Vitamin D3 &lt;span>[25(OH)D]&lt;/span>, vitamin D binding protein (VDBP) and chronic obstructive pulmonary disease (COPD) are previously reported. We aimed to further investigate these associations on longitudinal outcomes.&lt;/p></description></item><item><title>Pregnancy and Vitamin D – meta-analysis</title><link>/posts/pregnancy-and-vitamin-d-meta-analysis.html</link><pubDate>Sat, 11 Apr 2015 00:00:00 +0000</pubDate><guid>/posts/pregnancy-and-vitamin-d-meta-analysis.html</guid><description>&lt;h4 id="figure-2--meta-analysis-of-maternal-serum-25ohd-in-pregnancy-and-gestational-diabetes">Figure 2: Meta-analysis of maternal serum 25(OH)D in pregnancy and gestational diabetes.&lt;/h4>
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/pregnancy-gdm.jpg" alt="image">
&lt;hr>
&lt;h4 id="table-1-meta-analyses-of-maternal-vitamin-d-status-intake-and-serum-25-hydroxyvitamin-d-level-and-risk-of-pre-eclampsia">Table 1: Meta-analyses of maternal vitamin D status (intake and serum 25-hydroxyvitamin D level) and risk of pre-eclampsia&lt;/h4>
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/preg-t1.jpg" alt="image">
&lt;hr>
&lt;h4 id="table-2--intervention-studies-of-vitamin-d-supplementation-alone-and-in-combination-with-calcium-supplementation-in-pregnancy-to-reduce-obstetric-complications">Table 2: Intervention studies of vitamin D supplementation (alone, and in combination with calcium supplementation) in pregnancy to reduce obstetric complications&lt;/h4>
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/preg-t1.jpg" alt="image">
&lt;hr>
&lt;h4 id="table-3">Table 3&lt;/h4>
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/preg-t3.jpg" alt="image">
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/preg-t3b.jpg" alt="image">
&lt;hr>
&lt;h3 id="references">References&lt;/h3>
&lt;ol>
&lt;li>
&lt;p>National Institute for Health and Clincial Excellence. Antenatal care (NICE Clinical Guideline 62). &lt;a href="https://www.guidance.nice.org.uk/cg62">www.guidance.nice.org.uk/cg62&lt;/a>, 2010.&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Paxton GA, Teale GR, Nowson CA, Mason RS, McGrath JJ, Thompson MJ, Siafarikas A, Rodda CP &amp;amp; Munns CF. Vitamin D and health in pregnancy, infants, children and adolescents in Australia and New Zealand: a position statement. Med J Aust 2013 198 142-143.&lt;/p></description></item><item><title>Growth Hormone problem (Acromegaly) more likely if vitamin D gene problems</title><link>/posts/growth-hormone-problem-acromegaly-more-likely-if-vitamin-d-gene-problems.html</link><pubDate>Sun, 08 Mar 2015 00:00:00 +0000</pubDate><guid>/posts/growth-hormone-problem-acromegaly-more-likely-if-vitamin-d-gene-problems.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#vitamin-d-across-growth-hormone-gh-disorders-from-gh-deficiency-to-gh-excess---april-2017">Vitamin D across growth hormone (GH) disorders: From GH deficiency to GH excess - April 2017&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#people-with-acromegaly-should-be-tested-for-vitamin-d-deficiency---may-2018">People with acromegaly should be tested for Vitamin D deficiency - May 2018&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-in-children-with-growth-hormone-deficiency-due-to-pituitary-stalk-interruption-syndrome---jan-2018">Vitamin D in children with growth hormone deficiency due to pituitary stalk interruption syndrome - Jan 2018&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#investigation-of-the-vitamin-d-receptor-polymorphisms-in-acromegaly-patients---march-2015-50">Investigation of the Vitamin D Receptor Polymorphisms in Acromegaly Patients - March 2015 (50%)&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#igf-1-increases-if-take--1000-iu-of-vitamin-d-daily---meta-analysis-dec-2019">IGF-1 increases if take &amp;gt; 1,000 IU of vitamin D daily - meta-analysis Dec 2019&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-binding-protein-and-free-vitamin-d-concentrations-in-acromegaly---nov-2015">Vitamin D-binding protein and free vitamin D concentrations in acromegaly - Nov 2015&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="vitamin-d-across-growth-hormone-gh-disorders-from-gh-deficiency-to-gh-excess---april-2017">Vitamin D across growth hormone (GH) disorders: From GH deficiency to GH excess - April 2017&lt;/h4>
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/gh-chart.jpg" alt="image" width="800">
&lt;p>&lt;strong>&lt;i class="fas fa-file-pdf" style="margin-right: 0.3em;">&lt;/i>&lt;a href="https://d378j1rmrlek7x.cloudfront.net/attachments/pdf/gh-spectrum.pdf">Download the PDF from VitaminDWiki&lt;/a>&lt;/strong>&lt;/p></description></item><item><title>Blacks have lower vitamin D levels, but OK active vitamin D levels (VDBP)</title><link>/posts/blacks-have-lower-vitamin-d-levels-but-ok-active-vitamin-d-levels-vdbp.html</link><pubDate>Thu, 26 Feb 2015 00:00:00 +0000</pubDate><guid>/posts/blacks-have-lower-vitamin-d-levels-but-ok-active-vitamin-d-levels-vdbp.html</guid><description>&lt;h2 class="showhide_heading" id="See_also_VitaminDWiki">
&lt;p>See also VitaminDWiki&lt;/h2>&lt;/p>
&lt;ul>&lt;li>
&lt;p>&lt;a class="wiki wiki_page" href="Overview+Dark+Skin+and+Vitamin+D" title="Overview Dark Skin and Vitamin D">Overview Dark Skin and Vitamin D&lt;/a>&lt;/li>&lt;/p>
&lt;li>
&lt;p>&lt;a class="wiki wiki_page" href="Testing+misses+the+Vitamin+D+tied+up+with+VDBP+%E2%80%93+June+2014" title="Testing misses the Vitamin D tied up with VDBP – June 2014">Testing misses the Vitamin D tied up with VDBP – June 2014&lt;/a>&lt;/li>&lt;/p>
&lt;li>
&lt;p>&lt;a class="wiki wiki_page" href="Vitamin+D+can+be+somewhat+blocked+by+Vitamin+D+Binding+Protein+%E2%80%93+May+2014" title="Vitamin D can be somewhat blocked by Vitamin D Binding Protein – May 2014">Vitamin D can be somewhat blocked by Vitamin D Binding Protein – May 2014&lt;/a>&lt;/li>&lt;/p>
&lt;li>
&lt;p>&lt;a class="wiki wiki_page" href="Vitamin+D+tests+assume+constant+Binding+Protein+-+not+correct+across+races+and+clinical+situations+%E2%80%93+July+2014" title="Vitamin D tests assume constant Binding Protein - not correct across races and clinical situations – July 2014">Vitamin D tests assume constant Binding Protein - not correct across races and clinical situations – July 2014&lt;/a>&lt;/li>&lt;/p></description></item><item><title>Effects of low vitamin D on pregnancy and neonate – review</title><link>/posts/effects-of-low-vitamin-d-on-pregnancy-and-neonate-review.html</link><pubDate>Fri, 16 Jan 2015 00:00:00 +0000</pubDate><guid>/posts/effects-of-low-vitamin-d-on-pregnancy-and-neonate-review.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#maternalfetal-impact-of-vitamin-d-deficiency-a-critical-review">Maternal–Fetal Impact of Vitamin D Deficiency: A Critical Review&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamindwiki-observation-adding-vitamin-d-during-pregnancy-is-a-low-hanging-fruit">VitaminDWiki observation: Adding Vitamin D during pregnancy is a ‘’low hanging fruit’’&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="maternalfetal-impact-of-vitamin-d-deficiency-a-critical-review">Maternal–Fetal Impact of Vitamin D Deficiency: A Critical Review&lt;/h4>
&lt;p>Maternal and Child Health Journal, January 2015, Volume 19, Issue 1, pp 94-101&lt;/p>
&lt;p>Letícia Schwerz Weinert, Sandra Pinho Silveiro (Brazil)&lt;/p>
&lt;p>&lt;strong>Table of Contents&lt;/strong>&lt;/p>
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/toc-pregnancy.jpg" alt="image" width="500">
&lt;p>Research into the extra-skeletal functions of vitamin D has been expanding in recent years. During pregnancy, maternal vitamin D status may be of concern because of the key role of this vitamin in fetal skeletal development and due to the association between hypovitaminosis D and adverse maternal–fetal outcomes. Therefore, the objective of this manuscript was to review the maternal–fetal impact of gestational vitamin D deficiency and the benefits of vitamin D supplementation during pregnancy. A literature search was performed in PubMed and Embase employing the following keywords: vitamin D deficiency, pregnancy, 25-hydroxyvitamin D, and hypovitaminosis D. All relevant articles in English language published since 1980 were analysed by the two authors.&lt;/p></description></item><item><title>Vitamin D, immunity and microbiome</title><link>/posts/vitamin-d-immunity-and-microbiome.html</link><pubDate>Tue, 13 Jan 2015 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-immunity-and-microbiome.html</guid><description>&lt;p>&lt;strong>Vitamin D and immunity&lt;/strong>&lt;/p>
&lt;p>Special section of interest: &lt;span style="color:#F00;">Why doesn’t vitamin D supplementation decrease disease risks?&lt;/span>&lt;/p>
&lt;p> &lt;/p>
&lt;p>F1000Prime Rep2014, 6:118 (&lt;a href="https://doi.org/10.12703/P6-118">doi: 10.12703/P6-118)&lt;/a>),&lt;/p>
&lt;p>Published: 01 Dec 2014 © 2014 Faculty of 1000 Ltd&lt;/p>
&lt;p>Robyn M. Lucas1,2 &lt;a href="mailto:robyn.lucas@telethonkids.org.au">robyn.lucas@telethonkids.org.au&lt;/a>, Shelley Gorman1, Sian Geldenhuys1 and Prue H. Hart1&lt;/p>
&lt;ol>
&lt;li>
&lt;p>Telethon Kids Institute, University of Western Australia, 100 Roberts Road, Subiaco, Perth, Australia 6008&lt;/p>
&lt;/li>
&lt;li>
&lt;p>National Centre for Epidemiology and Population Health, The Australian National University, Canberra, Australia 0200&lt;/p>
&lt;/li>
&lt;/ol>
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/immunity-microbiome.jpg" alt="image" width="500">
&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#abstract">Abstract&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#introduction">Introduction&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#clues-from-epidemiology">Clues from epidemiology&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#mechanisms-by-which-l25oh2d-may-regulate-immune-cell-function">Mechanisms by which l,25(OH)2D may regulate immune cell function&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#multiple-sclerosis-a-case-study">Multiple sclerosis: a case study&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#an-indirect-pathway-vitamin-d-immunity-and-the-microbiome">An indirect pathway: vitamin D, immunity and the microbiome&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#span-stylecolorf00why-doesnt-vitamin-d-supplementation-decrease-disease-risksspan">&lt;span style="color:#F00;">Why doesn’t vitamin D supplementation decrease disease risks?&lt;/span>&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#conclusion">Conclusion&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#references-in-pdf">References in PDF&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;h4 id="abstract">Abstract&lt;/h4>
&lt;p>Vitamin D deficiency has been linked to an increased risk of a wide range of adverse health outcomes. The active form of vitamin D has an important role in calcium metabolism and in bone mineralisation, but the evidence for other health outcomes is mixed, with the strongest effects seen in the weakest epidemiological study designs. There are plausible pathways whereby vitamin D deficiency can impair immune function, resulting in both overactivity and increased risk of autoimmune disease, as well as immune suppression with poorer resistance to infection. Vitamin D status may influence the bacterial flora that constitute the microbiome and affect immune function through this route. Exposure of the skin to ultraviolet radiation causes the production of a range of chemicals, including vitamin D, and new research is exploring possible vitamin D-independent immunomodulatory pathways.&lt;/p></description></item><item><title>Genes are one of the reasons for low response to vitamin D</title><link>/posts/genes-are-one-of-the-reasons-for-low-response-to-vitamin-d.html</link><pubDate>Mon, 29 Dec 2014 00:00:00 +0000</pubDate><guid>/posts/genes-are-one-of-the-reasons-for-low-response-to-vitamin-d.html</guid><description>&lt;h4 id="dissecting-high-from-low-responders-in-a-vitamin-d3-intervention-study">Dissecting high from low responders in a vitamin D3 intervention study.&lt;/h4>
&lt;p>J Steroid Biochem Mol Biol. 2014 Nov 13. pii: S0960-0760(14)00267-2. &lt;a href="https://doi.org/10.1016/j.jsbmb.2014.11.012.">doi: 10.1016/j.jsbmb.2014.11.012.&lt;/a> &lt;span>[Epub ahead of print]&lt;/span>&lt;/p>
&lt;p>Saksa N1, Neme A1, Ryynänen J1, Uusitupa M2, de Mello VD2, Voutilainen S2, Nurmi T2, Virtanen JK2, Tuomainen T2, Carlberg C3.&lt;/p>
&lt;p>1 School of Medicine, Institute of Biomedicine, University of Eastern Finland, P.O. Box 1627, FIN-70211 Kuopio, Finland.&lt;/p>
&lt;p>2 Institute of Public Health and Clinical Nutrition, University of Eastern Finland, FIN-70211 Kuopio, Finland.&lt;/p></description></item><item><title>Gene makes COPD 2.6X more likely unless get more vitamin D – meta-analysis</title><link>/posts/gene-makes-copd-26x-more-likely-unless-get-more-vitamin-d-meta-analysis.html</link><pubDate>Wed, 10 Dec 2014 00:00:00 +0000</pubDate><guid>/posts/gene-makes-copd-26x-more-likely-unless-get-more-vitamin-d-meta-analysis.html</guid><description>&lt;h3 id="vitamin-d-binding-protein-genotype-variants-and-risk-of-chronic-obstructive-pulmonary-disease-a-meta-analysis">Vitamin D binding protein genotype variants and risk of chronic obstructive pulmonary disease: A meta-analysis.&lt;/h3>
&lt;p>Respirology. 2014 Dec 9. &lt;a href="https://doi.org/10.1111/resp.12448.">doi: 10.1111/resp.12448.&lt;/a> &lt;span>[Epub ahead of print]&lt;/span>&lt;/p>
&lt;p>Horita N1, Miyazawa N, Tomaru K, Inoue M, Ishigatsubo Y, Kaneko T.&lt;/p>
&lt;p>1Department of Respiratory Medicine, Saiseikai Yokohamashi Nanbu Hospital, Yokohama, Japan.&lt;/p>
&lt;p>BACKGROUND AND OBJECTIVE:&lt;/p>
&lt;p>Genetic susceptibility for development of chronic obstructive pulmonary disease (COPD) is under intensive investigation. Among the three alleles of vitamin D binding protein, or group-specific (GC) components, some have suggested that having GC-1F and GC-2 alleles was associated with a risk of COPD. Although previous studies have shown considerable variance, no meta-analysis has been conducted.&lt;/p></description></item><item><title>Tuberculosis risk decreased by 6 percent for each 1 ng increase in Vitamin D</title><link>/posts/tuberculosis-risk-decreased-by-6-percent-for-each-1-ng-increase-in-vitamin-d.html</link><pubDate>Sun, 12 Oct 2014 00:00:00 +0000</pubDate><guid>/posts/tuberculosis-risk-decreased-by-6-percent-for-each-1-ng-increase-in-vitamin-d.html</guid><description>&lt;h4 id="vitamin-d-status-and-incidence-of-tuberculosis-infection-conversion-in-contacts-of-pulmonary-tuberculosis-patients-a-prospective-cohort-study">Vitamin D status and incidence of tuberculosis infection conversion in contacts of pulmonary tuberculosis patients: a prospective cohort study.&lt;/h4>
&lt;p>Epidemiol Infect. 2014 Oct 2:1-11. &lt;span>[Epub ahead of print]&lt;/span>&lt;/p>
&lt;p>Arnedo-Pena A1, Juan-Cerdán JV2, Romeu-García MA1, García-Ferrer D2, Holguín-Gómez R3, Iborra-Millet J2, Pardo-Serrano F4.&lt;/p>
&lt;p>SUMMARY&lt;/p>
&lt;p>The objective of this study was to estimate the relationship between serum vitamin D (VitD) status and tuberculosis (TB) infection conversion (TBIC), measured by the tuberculin skin test (TST) and an interferon-gamma release assay, the QuantiFERON-TB Gold In-Tube (QFT-GIT) test, in the contacts of pulmonary TB patients in Castellon (Spain) in a prospective cohort study from 2010 to 2012. Initially, the participants were negative to latent TB infection after a screening that included TST and QFT-GIT tests, and other examinations. A baseline determination of 25-hydroxyvitamin D &lt;span>[25(OH)D]&lt;/span> was obtained by chemiluminescence immunoassay. After 8-10 weeks, participants were screened for a second time to determine TB infection conversion (TBIC). Poisson regression models were used in the statistical analysis. Of the 247 participants in the cohort, 198 (80·2%) were screened twice and 18 (9·1%) were TBIC cases. The means of VitD concentration in the TBIC cases and the non-cases were 20·7±11·9 and 27·2±11·4 ng/ml (P = 0·028), respectively. Adjusted for high exposure and TB sputum acid-fast bacilli (AFB)-positive index case, higher serum VitD concentration was associated with low incidence of TBIC (P trend = 0·005), and an increase of 1 ng/ml VitD concentration decreased the incidence of TBIC by 6% (relative risk 0·94, 95% confidence interval 0·90-0·99, P = 0·015). The results suggest that sufficient VitD level could be a protective factor of TBIC.&lt;/p></description></item><item><title>Cancer, Sunlight, and Vitamin D - Holick</title><link>/posts/cancer-sunlight-and-vitamin-d-holick.html</link><pubDate>Sun, 05 Oct 2014 00:00:00 +0000</pubDate><guid>/posts/cancer-sunlight-and-vitamin-d-holick.html</guid><description>&lt;p>Journal of Clinical &amp;amp; Translational Endocrinology (2014), &lt;a href="https://doi.org/10.1016/j.jcte.2014.10.001.">doi: 10.1016/j.jcte.2014.10.001.&lt;/a>&lt;/p>
&lt;p>Michael F. Holick,&lt;/p>
&lt;p>Section of Endocrinology, Diabetes, and Nutrition, Department of Medicine, Boston University Medical Center, 02118&lt;/p>
&lt;p>&lt;strong>&lt;i class="fas fa-file-pdf" style="margin-right: 0.3em;">&lt;/i>&lt;a href="https://d378j1rmrlek7x.cloudfront.net/attachments/pdf/sunlight-cancer-holick.pdf">Download the PDF from VitaminDWiki.&lt;/a>&lt;/strong>&lt;/p>
&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#abstract">Abstract&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#introduction">Introduction&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#physiology-and-metabolism-of-vitamin-d">Physiology and Metabolism of Vitamin D&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#association-studies-linking-sun-exposure-and-vitamin-d-status-with-cancer-risk">Association Studies Linking Sun Exposure and Vitamin D Status with Cancer Risk&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#the-vitamin-d-sunlight-and-cancer-conundrum">The Vitamin D, Sunlight and Cancer Conundrum&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#the-importance-of-maintaining-a-healthy-vitamin-d-status-to-reduce-risk-of-cancer">The Importance of Maintaining a Healthy Vitamin D Status to Reduce Risk of Cancer&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#approaches-for-raising-blood-levels-of-25-hydroxyvitamin-d">Approaches for Raising Blood Levels of 25-hydroxyvitamin D&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-toxicity">Vitamin D Toxicity&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#conclusion">Conclusion&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#references">References&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;h4 id="abstract">Abstract&lt;/h4>
&lt;p>The sunshine vitamin has been associated with reduced risk for many chronic illnesses including cancer and cancer mortality. Epidemiologic and ecological studies have suggested that living at higher latitudes and having lower blood levels of 25-hydroxyvitamin D are associated with increased risk for up to 15 cancers including breast, colon, lung, lymphoma, pancreatic, ovarian and prostate cancer. Most randomized controlled trials using appropriate doses of vitamin D have suggested that improvement in vitamin D status reduces risk for several cancers. Although the exact mechanism by which enhanced vitamin D status reduces risk for cancer is not completely understood, there is evidence that by raising blood levels of 25-hydroxyvitamin D this metabolite can enter a wide variety of cells in the body and then be converted to 1,25- dihydroxyvitamin D3. The vitamin D metabolite, 1,25-dihydroxyvitamin D3, has been demonstrated to markedly reduce cellular proliferation especially of malignant cells that have a vitamin D receptor. It also induces terminal differentiation. 1,25-dihydroxyvitamin D3 is also anti-angiogenic and pro-apoptotic which also plays a role in reducing the growth and spread of malignant cells. Thus improvement in vitamin D status with sensible sun exposure, vitamin D supplementation and ingesting foods containing vitamin D is a reasonable strategy to reduce risk of malignancy.&lt;/p></description></item><item><title>Antimicrobial peptides (which attack pathogens) are increased by Vitamin D</title><link>/posts/antimicrobial-peptides-which-attack-pathogens-are-increased-by-vitamin-d.html</link><pubDate>Tue, 30 Sep 2014 00:00:00 +0000</pubDate><guid>/posts/antimicrobial-peptides-which-attack-pathogens-are-increased-by-vitamin-d.html</guid><description>&lt;ul>
&lt;li>
&lt;p>&lt;strong>Cathelicidins&lt;/strong> are antimicrobial peptides found in vertebrates that kill pathogens directly and regulate immune responses. They contain a conserved cathelin domain and variable antimicrobial region, functioning in both pathogen defense and immune modulation.&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;strong>Antimicrobial particles, proteins, and peptides&lt;/strong> are natural defense molecules that fight pathogens. Particles are the largest, proteins are medium-sized complex molecules, and peptides are the smallest (12-100 amino acids). All three types kill microbes, but peptides are particularly effective due to their size and multiple mechanisms of action.&lt;/p></description></item><item><title>Inflammation, infection, active vitamin D, and Olmesartan</title><link>/posts/inflammation-infection-active-vitamin-d-and-olmesartan.html</link><pubDate>Fri, 26 Sep 2014 00:00:00 +0000</pubDate><guid>/posts/inflammation-infection-active-vitamin-d-and-olmesartan.html</guid><description>&lt;p>Author asked that their paper be removed from VitaminDWiki&lt;/p>
&lt;!-- ~tc~
__Inflammation and vitamin D: the infection connection__
Inflammation Research, October 2014, Volume 63, Issue 10, pp 803-819,
Meg Mangin info@chronicillnessrecovery.org, Rebecca Sinha, Kelly Fincher
Chronic Illness Recovery, Fort Worth, Texas, USA

__Figure 1 Metabolism__
{img fileId=2700}

__Figure 2__
{img attId="4410" width ="400"}

__Figure 3 Hypothesis __
{img attId="4411"}
__~~#00F: {ATTACH(inline="1" id="4409" icon="1")}Download the PDF from VitaminDWiki.{ATTACH}~~__

Introduction
Inflammation is believed to be a contributing factor to many chronic diseases. The influence of vitamin D deficiency on inflammation is being explored but studies have not demonstrated a causative effect.
Methods
Low serum 25(OH)D is also found in healthy persons exposed to adequate sunlight. Despite increased vitamin D supplementation inflammatory diseases are increasing. The current method of determining vitamin D status may be at fault. The level of 25(OH)D does not always reflect the level of 1,25(OH)2D. Assessment of both metabolites often reveals elevated 1,25(OH)2D, indicating abnormal vitamin D endocrine function.
Findings
This article reviews vitamin D's influence on the immune system, examines the myths regarding vitamin D photosynthesis, discusses ways to accurately assess vitamin D status, describes the risks of supplementation, explains the effect of persistent infection on vitamin D metabolism and presents a novel immunotherapy which provides evidence of an infection connection to inflammation.
Conclusion
Some authorities now believe that low 25(OH)D is a consequence of chronic inflammation rather than the cause. Research points to a bacterial etiology pathogenesis for an inflammatory disease process which results in high 1,25(OH)2D and low 25(OH)D. Immunotherapy, directed at eradicating persistent intracellular pathogens, corrects dysregulated vitamin D metabolism and resolves inflammatory symptoms.
{maketoc}
!!!!Introduction
Inflammation is involved in many chronic diseases and concern has been raised about the influence of vitamin D deficiency on inflammatory processes. When studies found an association between inflammatory diseases and low serum 25-hydroxyvitamin D (25(OH)D), further research found evidence of low vitamin D in a large segment of the general population. This led some authorities to declare a world-wide epidemic of vitamin D deficiency and to recommend vitamin D supplementation. Experts are debating the definition of vitamin D deficiency and the appropriate vitamin D doses, while further research is being done to determine if vitamin D supplementation has the intended effect.
According to some current definitions of vitamin D deficiency, even healthy persons, exposed to adequate sunlight, are unable to acquire enough vitamin D without supplementation. Often reiterated causes of vitamin D deficiency can be disputed in the light of more current research. In the absence of definitive studies, authorities are questioning the wisdom of supplementing the general population with vitamin D. The definition of Vitamin D deficiency needs re-evaluation in view of the fact that low 25(OH)D is found in both healthy and sick individuals. Concerns about vitamin D deficiency merit a closer look at the current method of determining vitamin D status because the level of 25(OH)D does not always reflect the level of 1,25-dihydroxyvitamin-D (1,25(OH)2D). Analysis of this active metabolite may reveal elevated 1,25(OH)2D) in the presence of low 25(OH)D and lead to a diagnosis of abnormal vitamin D endocrine system function.
An infectious pathogenesis posits that intracellular bacteria disrupt the vitamin D regulated immune system, resulting in persistent infection and chronic inflammation.
In the clinical setting, a novel immunotherapy is demonstrating the ability to resolve vitamin D metabolism dysfunction, restore immune function, and thus, eliminate infection and reduce inflammation. This review ponders the question, ‘‘Is low 25(OH)D a cause of, or a consequence of inflammation?” The answer is found in the evidence that adds persistent intracellular infection to the equation.
!!!!Vitamin D metabolism
The sequential metabolic processes that convert biologically inactive, parental vitamin D into active metabolites begin when vitamin D3 is photosynthesized in the skin or when vitamin D2 or D3 is ingested. Vitamin D is transported to the liver where it is hydroxylated by an enzyme (CYP2R1, also known as cytochrome P450 2R1) to produce 25(OH)D [1]. 25(OH)D is then transported to the kidneys where it is hydroxylated by another enzyme (CYP27B1, formerly 1a-hydroxylase) to produce 1,25(OH)2D. 1,25(OH)2D (also known as calcitriol), the active metabolite, is the most potent steroid hormone in the human body [2]. Feedback mechanisms regulate production of 1,25(OH)2D in the kidneys via serum levels of parathyroid hormone (PTH), fibroblast-like growth factor- 23 (FGF23) calcium, and phosphate [3]. 1,25(OH)2D is also produced in many other tissues (e.g., skin, macrophages, colon, pancreas, blood vessels, etc.) by enzymatic actions [4]. The vitamin D binding protein (VDBP) transports 1,25(OH)2D to the vitamin D receptor (VDR) in the cell nucleus [5]. The VDR is a member of the nuclear receptor family of ligand-regulated transcription factors. 1,25(OH)2D binds to the VDR and mediates the transcription of DNA, triggered by signaling proteins, like nuclear factor kappa-B (NFk-B) [6] (Fig. 1).
The influence of 1,25(OH)2D on the immune system is one of its most important roles. 1,25(OH)2D regulates the immune system via the VDR which is present in most immune cell types, particularly in antigen-presenting cells (APCs) such as monocytes, macrophages and dendritic cells [7]. 1,25(OH)2D activates the VDR to express antimicrobial peptides (AMPs) such as cathelicidin and beta defensins which attack pathogens [8, 9]. In general, the innate immune system is enhanced and the adaptive immune system is inhibited by 1,25(OH)2D [10, 11]. Thus, an effective immune response is heavily dependent on the vitamin D endocrine system which performs a balancing act of inflammation versus anti-inflammation.
!!!!Vitamin D deficiency
Concerns about vitamin D deficiency arose when studies showed patients with autoimmune diseases have lower levels of serum 25(OH)D and study subjects given vitamin D had lower rates of autoimmune diseases and fewer markers of inflammation [12, 13]. However, authorities have not agreed on the significance of low 25(OH)D and without a consistent normal range for serum 25(OH)D, the definitions of vitamin D insufficiency and deficiency from the Vitamin D Council, the Endocrine Society and the Institute of Medicine vary significantly.
__The Vitamin D Council definition [14]:__
Deficient: 0-40 ng/ml
Sufficient: 40-80 ng/ml
High normal: 80-100 ng/ml
__The Endocrine Society definition [15]:__
Deficiency &lt; 20 ng/ml
Insufficiency = 20-29 ng/ml
__The Institute of Medicine definition [16]:__
Risk/deficiency &lt;12 ng/ml
Risk/insufficiency = 12-20 ng/ml
Sufficient = 20 ng/ml
In 2006, the Merck Manual listed 25-40 ng/ml as the normal 25(OH)D range [17]. Recently, this range has skyrocketed to 30-74 ng/ml [18]. Quest Diagnostics now lists the upper limit of normal 25(OH)D as 100 ng/ml [19]. Laboratory reference ranges for serum 25(OH)D levels have long been based upon average values from populations of healthy individuals but many people are now supplementing with vitamin D. In the US, the leading authority regarding medical research is the prestigious Institute of Medicine (IOM). The 2010 IOM report on vitamin D emphasized that the current measurements, or cut-off points, of sufficiency and deficiency of 25(OH) D in use by laboratories have not been set using rigorous scientific studies. It suggests that since no central authority has determined which cut-off points to use, reports of deficiency and lab ranges may be skewed and numbers overestimated [16]. Therefore, it would be prudent to use the IOM vitamin D deficiency guideline in the clinical setting, for clinical studies and when evaluating research results.
!!!!Purported reasons for vitamin D deficiency
Is low 25(OH)D among the general population an accurate assessment of vitamin D deficiency? Many reasons are cited for the current ‘epidemic’ of vitamin D ‘deficiency’ but closer examination reveals these beliefs are based on outdated or limited studies and can be challenged with more recent research.
Melanin pigmentation is only one factor that determines the amount of vitamin D3 which is photosynthesized [20, 21]. Bogh et al. [22] measured the baseline serum 25(OH)D and total cholesterol levels of 182 fair-skinned and dark-skinned subjects; and studied the effect of UV radiation on their serum 25(OH)D levels. They found the amount of serum 25(OH)D produced was determined by the amount of cholesterol in the skin, not on skin pigmentation. Matsuoka et al. [23] investigated the effect of racial pigmentation on vitamin D3 formation, simulating the process with a fixed dose of UVB radiation and concluded that while racial pigmentation has a photoprotective effect, it does not prevent the generation of normal levels of active vitamin D metabolites. Persons with dark skin also compensate for low 25(OH)D by rapidly converting it to the active 1,25(OH)2D metabolite, thus allowing them to maintain adequate vitamin D status [24]. Skin pigmentation does not appear to negatively affect vitamin D status [25].
Clothing is a barrier to vitamin D photosynthesis but this is an issue only for people who cover themselves from head to toe [26]. It takes relatively little sunlight exposure to acquire adequate stores of vitamin D and few people wear enough clothes to prevent that from happening. Ten to 15 min of sunlight or daylight exposure to a small area of skin (e.g., the forearm or face, etc.) twice a week, without sunscreen, supplies all the vitamin D necessary for health [27]. The belief that sunscreen lotion blocks vitamin D production is based on a 1987 study done by Matsuoka et al. [28] that was funded by the ultraviolet foundation, which is supported by the tanning bed industry. Contradictory information was provided by Diehl and Chiu [29] which concluded that although sunscreens are effective, many may not actually be blocking UV-B because they are improperly or inadequately applied [30]. Thus, sunscreen use may not actually diminish vitamin D synthesis in real world use. However, prolonged unprotected sun exposure should be avoided to reduce the risk of developing skin cancer.
Although pollution can block some ultraviolet radiation, even in urban areas of high pollution 50 % of UV rays reach the ground [31]. A significant amount of UV radiation exposure can be obtained in dense metropolitan areas; tall buildings provide shade but shade gives up to 50 % of UV rays. Indoor workers receive 10-20 % of outdoor workers’ yearly UV exposure [31]; and for many, this may be adequate, especially if sunlight exposure is higher when they are not working. UV radiation is reflected or scattered to varying extents by different surfaces. The scattering and absorption of light by clouds may not significantly reduce natural light exposure because over 90 % of UV rays may penetrate clouds [31]. Environmental factors are rarely an impediment to photosynthesis of adequate vitamin D.
As the skin ages, there is a decline in the cutaneous levels of 7-dehydrocholesterol, resulting in a marked reduction of the skin’s capacity to produce vitamin D3 [32].
However, despite the up to fourfold reduction in vitamin D3 production in a 70-year-old compared to a 20-year-old, the skin has such a high capacity to make vitamin D3 that elders exposed to sunlight will produce an adequate amount of vitamin D3 to satisfy their vitamin D requirement [33, 34].
A 1988 study by Webb et al. [35] is often cited to support the conviction that latitude dramatically influences the amount of solar radiation available to synthesize vitamin D3. However, other researchers who conducted more recent studies refute this hypothesis. Kimlin et al. [36] report, ‘‘It may no longer be correct to assume that vitamin D levels in populations follow latitude gradients’’. And Lubin [37] states, ‘‘Geophysical surveys have shown that UV-B penetration over 24 h, during the summer months at Canadian north latitudes when there are many hours of sunlight, equals or exceeds UV-B penetration at the equator.’’ Ross et al. [16] report that ample opportunities exist to form vitamin D (and store it in the liver and fat for later use) from exposure to sunlight during the spring, summer, and fall months even in the far north latitudes.
Acceptance of these vitamin D myths regarding photosynthesis prevents consideration of the alternate hypothesis—low serum 25(OH)D, despite adequate photosynthesis of vitamin D3, is a result of an inflammatory process.
!!!!Low vitamin D is found in healthy subjects
Many studies of healthy subjects have found levels of 25(OH)D that, by some vitamin D definitions, are declared deficient (hypovitaminosis-D) [38, 39]. Vitamin D levels that are considered deficient have even been found in persons who are exposed to abundant sunlight [40]. Binkley et al. [41] showed a mean 25(OH)D level of 31.6 ng/ml among healthy young adult Hawaiian surfers. It is clear that low levels of 25(OH)D are found in both healthy persons and those with autoimmune or chronic inflammatory diseases. Opposing reasoning can be used to explain this contradiction. One explanation reasons that healthy persons with low 25(OH)D will become sick and sick people will develop lower 25(OH)D levels (Fig. 2); however, studies do not support this hypothesis. The correct explanation may be that, in the absence of disease, low 25(OH)D is normal.
!!!!Low vitamin D in the presence of diseases
Since low 25(OH)D is found in both healthy persons and those with autoimmune or chronic inflammatory diseases, assessing vitamin D status with the measurement of an additional clinical marker may be helpful. It is asserted that D status with measurement of 1,25(OH)2D may be helpful low levels of 25(OH)D accurately reflect vitamin D status; however, measurement of 1,25(OH)2D often demonstrates a positive correlation of elevated 1,25(OH)2D to inflammatory diseases (Fig. 2). This is illustrated by Blaney et al.

Fig. 2 Interpretation of vitamin D deficiency via calcitriol measurement. Since low 25(OH)D is found in both healthy persons and those with autoimmune or chronic inflammatory diseases, assessing vitamin D status with measurement of 1,25(OH)2D may be helpful

in a study of 100 patients with autoimmune and chronic disease which found that 85 % of subjects had levels of 1,25(OH)2D higher than 46.2 pg/ml without hypercalcemia. Although this serum level may be considered normal by some, lab ranges for 1,25(OH)2D may have been skewed high by the presence of patients with unrecognized persistent intracellular infection and thus, dysregulated vitamin D metabolism. The Danish 1,25(OH)2D population data (from a large and reliable study) found the mean value for 1,25(OH)2D in a normal population was 29 pg/ml with a standard deviation of 9.5
. More frequent measurement of both D-metabolites in the clinical and research settings, may shed light on the true meaning of low 25(OH)D.
Rickets is often cited as proof of the need for vitamin D supplementation. However, a review of the metabolic processes involved provides some prospective. Adequate vitamin D is essential to prevent rickets, but adequate calcium is equally important; if either calcium or vitamin D is deficient, bone health suffers. Hypophosphatemia is the common denominator of all rickets; low calcium intake leads to hyperparathyroidism, which leads to high phosphorus excretion and, thus, phosphorus deficiency [44]. Rickets is rare in the developed world; however, children in developing countries, who usually photosynthesize enough vitamin D from sunlight, develop rickets if poverty prevents them from eating enough calcium-rich food [45, 46]. Studies have found that rickets occurs in sunny countries due to poor calcium intake and is cured with increased calcium ingestion [47, 48].
Osteoporosis is another disease which is closely linked with vitamin D. Adequate vitamin D is an important factor in maintaining bone health to avoid osteoporosis but a study by Reid et al. [49] published in The Lancet found little evidence supporting the use of vitamin D supplements by seniors hoping to improve bone density and ward off potential fractures. 1,25(OH)2D maintains calcium homeostasis between blood, cells and bones by stimulating calcium absorption from the intestines, reabsorption in the kidneys, and resorption in bones [50]. 1,25(OH)2D up- regulates the VDR in the small intestine, which then transcribes genes that shuttle calcium and phosphorus through the intestinal epithelium. However, mucosal response and calcium/phosphorus absorption are dependent on a competent VDR and elevated 1,25(OH)2D reduces VDR competence [51]. Thus, calcium and phosphorus absorption may be inhibited if VDR function is impaired by elevated 1,25(OH)2D. This is illustrated by Abreu et al. [52] in a study of Crohn’s patients with elevated 1,25(OH)2D and low bone mineral density which concluded that treatment of the underlying inflammation would improve metabolic bone disease. In fact, there is ample evidence that elevated 1,25(OH)2D leads to bone loss. Brot et al. [53] found that elevated levels of 1,25(OH)2D were strongly associated with decreased bone mineral density and content, and increased bone turnover. When levels are above 42 pg/ml 1,25(OH)2D stimulates bone osteoclasts. This leads to osteoporosis, dental fractures and calcium deposition into the soft tissues [54]. Vanderschueren et al. [55] found that a combination of high 1,25(OH)2D and low 25(OH)D is associated with the poorest bone health.
!!!!Vitamin D supplementation
It is reasoned that if low 25(OH)D indicates a current or potential disease state, then increasing 25(OH)D by supplementing with vitamin D should provide some symptom relief and/or protection. So far, there is scant evidence for this hypothesis [56, 57]. According to Ross et al. [16] in the 2010 IOM report, ‘‘Outcomes related to autoimmune disorders, cancer, cardiovascular disease and hypertension, diabetes and metabolic syndrome, falls and physical performance, immune functioning, infections, neuropsychological functioning, and preeclampsia could not be linked reliably with calcium or vitamin D intake and were often conflicting.’’ Despite the recent increase in vitamin D supplementation, chronic diseases have increased and are expected to continue increasing [58, 59].
Consequently, more vitamin D experts are beginning to reconsider vitamin D supplementation among the general population [60]. Recommending higher vitamin D intake to large populations carries the potential risk of overdosing certain individuals [61]. It is difficult to ingest too much vitamin D from food, and natural mechanisms regulate the amount of vitamin D3 photosynthesized from sunlight [62].
However, elevated 25(OH)D and hypervitaminosis-D can occur due to vitamin D supplementation [63]. A study by Noordam et al. [65] cast doubt on the causal nature of previously reported associations between low levels of vitamin D and age-related diseases and mortality. A comprehensive review by Autier et al. [65] concluded that low concentrations of 25(OH)D are most likely an effect of health disorders and not a cause of illness. Commenting on the findings in a press statement, Autier et al. [64] advised against vitamin D supplementation and explained the observed discrepancy between observational and randomized trials:
Decreases in vitamin D levels are a marker of deteriorating health. Ageing and inflammatory processes involved in disease occurrence and clinical course reduce vitamin D concentrations, which would explain why vitamin D deficiency is reported in a wide range of disorders. We postulate that inflammation is the common factor between most nonskeletal health disorders and low 25(OH)D concentrations. Inflammatory processes involved in disease occurrence and clinical course would reduce 25(OH)D, which would explain why low vitamin D status is reported in a wide range of disorders. However, increases in 25(OH)D have no effect on inflammatory processes or on disorders at the origin of these processes.
A 2014 meta-analysis by Bolland et al. [66] on the effects of vitamin D supplementation on skeletal, vascular, or cancer outcomes concludes that vitamin D supplementation with or without calcium does not reduce skeletal or non-skeletal outcomes in unselected community-dwelling individuals by more than 15 %. The authors further state that future trials with similar designs are unlikely to alter these conclusions. Because of emerging concerns about elevated 25(OH)D, the IOM has shifted the paradigm from thinking about ‘more is better’ to a more risk-averse approach [67]. It has also challenged the notion that harm should be viewed in terms of vitamin D toxicity such as hypercalcemia, hypercalciuria, or metastatic calcification and has advanced the concept of ‘harm’ in terms of chronic disease outcomes and mortality [16]. Because adverse effects of vitamin D supplementation may take decades to be realized, clinicians (mindful of the medical ethics precept ‘‘First, do no harm’’) should err on the side of caution; follow the IOM guideline and wait for the results of longterm vitamin D studies.
!!!!Bacterial pathogenesis of low vitamin D hypothesis
If evidence indicates that most people get adequate vitamin D from sunlight exposure but healthy persons are found to be ‘deficient’ by recent standards, what is the explanation for this phenomenon? Vitamin D proponents use a disease deficiency model to explain low levels of 25(OH)D. Their hypothesis states low 25(OH)D causes chronic diseases; however, a pathogenesis has not been elucidated [68]. Low serum 25(OH)D in the presence of disease can also be explained with a dysregulated vitamin D metabolism model [69]. This hypothesis proposes that low vitamin D is the consequence of a chronic inflammatory process caused by persistent infection. The bacterial pathogenesis theorizes that intracellular (cell wall deficient) bacteria invade nucleated cells, use strategies to avoid destruction and cause abnormal vitamin D endocrine function, resulting in low vitamin D. Excess 1,25(OH)2D is produced in an effort to up-regulate the VDR to transcribe AMPs; and 25(OH)D is rapidly metabolized in the process, resulting in a low serum level. The resulting elevated 1,25(OH)2D causes chronic, systemic inflammation and its accompanying symptoms (Fig. 3).
The existence of bacteria which are capable of invading human cells has been known for over a century and are described by many authors [70, 71]. The lack of a cell wall enables them to enter human cells and proliferate because they fail to elicit an appropriate response when the immune system is compromised. In particular, they enter the macrophages—the very immune cells deployed to kill invading pathogens. The inability of most research labs to culture cell wall deficient (CWD) bacteria has been an obstacle to their acceptance, and reliance on Koch’s postulates has made it difficult to correlate CWD bacteria to specific diseases [72]. But some researchers believe Koch’s postulates may have to be redefined in terms of molecular data when dormant and non-culturable bacteria are implicated as causative agents of mysterious diseases [73]. OConnor et al. [74] (in their article entitled Emerging Infectious Determinants of Chronic Diseases) report, ‘‘microbes can now be irrefutably linked to pathology without meeting Koch’s postulates” and “...powerful tools of molecular biology have exposed new causal links by detecting diffi- cult-to-culture and novel agents in chronic illness settings.’’ Domingue [75] commented, ‘‘This might translate into an etiology for chronic inflammatory diseases, when the stressed bacteria increase in numbers and overwhelm the normal biological functions of the host.’’ Nunez [76] was quoted in the University of Michigan Health System newsletter, ‘‘In our study, the presence of bacterial microbes inside the cell is what triggers the immune response.’’ Rolhion and Darfeuille-Michaud [77] observed that the presence of pathogenic invasive bacteria could be the link between an innate immune response to invasive bacteria and the development of inflammation. A number of studies suggest disease associations with CWD bacteria [78-83]. Verway et al. [79] report ‘‘.data suggest that at least a subset of the genetic predisposition to Crohn’s disease results from defects in the detection and/or processing of intracellular pathogens by the innate immune system.’’ O’Connor et al. [74] state, ‘‘The epidemiologic, clinical, and pathologic features of many chronic inflammatory diseases are consistent with a microbial cause. Infectious agents likely determine more cancers, immune-mediated syndromes, neurodevelopmental disorders, and other chronic conditions than currently appreciated.”
CWD bacteria are considered communicable but not contagious; protective immunity depends on an effective cell-mediated immune response [80]. It is now well appreciated that pathologic processes caused by infectious agents may only emerge clinically after an incubation of decades [81]. Among the speculated causes of the increase in chronic infections are overuse of beta-lactam antibiotics [82, 83] and immunosuppression via excess 25(OH)D production [84] or immunosuppressive medications [85]. Many microbiologists now believe at least some, if not all, of the inflammation which drives the chronic disease process is caused by the presence of these stealthy intracellular pathogens [86]. A considerable body of experimental and clinical evidence supports the concept that difficult-to- culture and dormant bacteria are involved in latency of infection and that these persistent bacteria may be pathogenic [73, 87, 88]. McDougal [89] states, ‘‘Evidence now confirms that non-communicable chronic diseases can stem from infectious agents.’’
!!!!Effects of intracellular pathogens on the immune system
Pathogens gain many advantages by parasitizing immune cells and altering nuclear receptor activity. Tissue invasion provides a privileged niche with access to host protein and iron, sequestration from immune response, and a means for persistence [90]. In the arms race of host-microbe coevolution, successful microbial pathogens have evolved innovative strategies to evade host immune responses. For example, ‘crosstalk manipulation’ undermines host defenses and contributes to microbial adaptive fitness [91, 92]. Pathogenic microbes also induce stress responses which protect the cell from lethal factors, express proteases that degrade AMPs, use biofilms as a shield and modulate host cell motility to facilitate establishment of an infection [93, 94]. Genetic foreign and host protein interactions alter gene transcription and translation mechanisms, and many species survive by horizontal gene transfer [95, 96].
It is theorized that bacteria have developed some of these strategies in order to invade host cells and remain undetected within cellular cytoplasm. Many bacterial pathogens form antibiotic-tolerant persister cells which can replicate within macrophages. In this form they can cause subclinical infection and have been associated with chronic diseases [95, 97, 98]. Intracellular bacteria can modulate cytokine production [99]; and in monocytes and macrophages, cytokine activation markedly inhibits 1,25(OH)2D/ VDR gene transcription [100].
Macrophage microbicidal mechanisms are responsible for the control and elimination of pathogens. 1,25(OH)2D production and action in macrophages activates toll-like receptors to increase expression of the AMP cathelicidin which kills infectious invaders [101, 102]. When the immune system is fighting a persistent microbe, inflammatory molecules are continuously released in an effort to kill the pathogen [103]. Immune defenses stimulate Th17 cells and contribute to the development of chronic inflammatory conditions [104,	105]. An ineffective immunological response causes low-grade inflammation and hagocyte-inflicted tissue damage plays an important role in many chronic diseases [106]; autoimmune patients acquire a distinct pathogenic microbiota and multi-morbidity often results [107, 108]. Therefore, it is reasonable to infer that bacteria have evolved strategies which allow them to persist within host cells. The exact mechanisms are unknown and warrant further study.
!!!!The compromised immune system, infection and vitamin D
In an essay on the renin-angiotensin system (RAS) and immune response, Smith [109] postulated that unresolved cellular stress may be caused by infectious agents to avoid adaptive immune responses. The host immune response has developed many mechanisms to neutralize and remove pathogenic bacteria. In turn, pathogenic bacteria have developed mechanisms to alter and evade the host immune response [110, 111]. Regulation of the VDR is a common mechanism used in the host defense against pathogens but certain microbes have been shown to slow innate immune defenses by down-regulating the VDR:
*Mycobacterium tuberculosis down-regulates VDR activity [112].
*Mycobacterium leprae inhibits VDR activity through down-regulation of CYP27B1 in monocytes [113].
*Aspergillus fumigatus secretes a toxin capable of down-regulating the VDR in macrophages [114].
*Epstein-Barr virus lowers VDR activity [115].
*HIV completely shuts down VDR activity [116].
*In VDR knockout mice, a circumstance that closely mimics extreme VDR dysregulation, 1,25(OH)2D levels increase by a factor of ten [117].
Studies also point to immune system depression and elevated 1,25(OH)2D in chronic diseases [118]:
*Sarcoidosis patients are deficient in cathelicidin despite healthy vitamin D3 levels [119].
*1,25(OH)2D is high (>60 pg/ml) in 42 % of Crohn’s patients and the source of the active vitamin D may be the inflamed intestine [52].
*1,25(OH)2D is elevated in the synovial fluid of patients with RA (rheumatoid arthritis) [120].
*Crohn’s disease decreases expression of cathelicidin [121].
High levels of 1,25(OH)2D may result when down- regulation of the VDR by bacterial ligands prevents the receptor from expressing enzymes necessary to keep 1,25(OH)2D in a normal range [42]. Elevated 1,25(OH)2D further reduces VDR competence, suppresses macrophage function, and blocks the nuclear factor kappa-B pathway; thus inhibiting immune system function [116, 122, 123]. Reducing the ability of the VDR to express elements of innate immune function allows intracellular bacteria to persist in the cytoplasm of nucleated cells and may account for the increased susceptibility to non-bacterial co-infections that are commonly found in patients with chronic illnesses [124, 125]. Theoretically, immune system suppression allows parasitic microbes to persist and proliferate in host phagocytes, successfully compete for nutritional resources, and displace commensal organisms from their niche [126]. Elevated 1,25(OH)2D appears to be evidence of a disabled immune system’s attempt to activate the VDR to combat infection.
!!!!Autoimmune disease
Numerous examples can be found in which pathogens express antigens that cross-react with host antigens or induce local inflammatory responses that can lead to autoimmune responses through a very complex set of circumstances [127]. The prevailing theory regarding the etiology of autoimmune disease states that an overactive immune system produces auto-antibodies against self, but infection as an environmental factor in autoimmunity has long been recognized. An alternate hypothesis posits a bacterial etiology in which a persistent intracellular infection causes a cytokine release that induces signals to T cells and B cells, and the antibodies they produce (to the intracellular invader) include some that attack human proteins, as well as target the pathogens [128, 129]. Christen et al. [130] explored this hypothesis, ‘‘In theory, a structural similarity or identity between the host and an invading pathogen might cause the immune system of the host to react not only to the pathogen but also to self-components.’’ Infections can act as environmental triggers inducing or promoting autoimmune disease in genetically predisposed individuals [131]; researchers have shown how antinuclear antibodies (ANA) are created in response to infectious agents [132, 133].
Vitamin D appears to have a positive effect on autoimmune disease due to immune system suppression [122, 134, 135] and immune suppression is considered therapeutically beneficial for autoimmune diseases [136, 137]. However, vitamin D proponents have failed to recognize that positive effects are due to the immunosuppressive effect of elevated 25(OH)D or to understand that immunosuppression is contraindicated because of the probable presence of intracellular infection. When the immune system is suppressed clinical disease markers and symptoms are reduced but immunosuppression does not address an underlying cause of persistent bacteria, thus relapse is common [138]. Verway et al. [79] wonder, ‘‘Is a specific pathogen responsible for disease or rather is a dysregulated immune response generated against a complex microbial population? Why would immune-suppressive drugs be efficacious if the primary defect is an immune deficiency?” Much of current research focuses on finding drugs to suppress inflammation but, according to Collins [139], 95 % of these studies have failed It seems clear a better direction is needed. Immunotherapy which restores VDR competence corrects dysregulated vitamin D metabolism and eliminates intracellular bacteria could be the answer (as discussed in the section titled Restoring VDR Competence).
!!!!Dysregulated vitamin D metabolism
In a healthy individual, the complex interplay between innate and adaptive immunity cooperates to mount an appropriate response to infection through regulation of the vitamin D endocrine system [140]. The immune system detects and responds to the presence of intracellular bacteria by producing more 1,25(OH)2D to activate the VDR and express the crucial endogenous AMPs which enable the innate immune system to target intracellular pathogens [141]. Renal production of 1,25(OH)2D is tightly selfregulated, with the end product down-regulating its own further production. In contrast, extra-renal tissues (e.g., uterine decidua and placenta, colon, breast, prostate, spleen, bone, keratinocytes, melanoma and synovial cells, pulmonary monocytes and macrophages, etc.) which produce 1,25(OH)2D are regulated by cytokines (e.g., interferon-gamma), lipopolysaccharide, nitric oxide and intracellular VDBP, which activate the enzyme CYP27B1 to stimulate conversion of 25(OH)D to 1,25(OH)2D [142]. This extra-renal production of 1,25(OH)2D in tissues infected with intracellular bacteria can result in an excess in production of 1,25(OH)2D which may contribute to depletion and low levels of 25(OH)D [143] (Fig. 4).
Because extra-renal production of 1,25(OH)2D is primarily dependent on the availability of 25(OH)D [144], supplementation with vitamin D to increase 25(OH)D may promote the production of 1,25(OH)2D in non-renal tissues that are sites of intracellular infection and result in hypervitaminosis-D

{img attId="4412"}
Fig. 4 Proposed hypothesis for excess 1,25(OH)2D production in bacterially-stimulated extrarenal tissues. Extra-renal tissues, which produce 1,25(OH)2D, are regulated by cytokines, lipopolysaccharide, nitric oxide and intracellular VDBP, which activate the enzyme CYP27B1 to stimulate conversion of 25(OH)D to 1,25(OH)2D, resulting in low 25(OH)D

{img attId="4413"}
Fig. 5 Proposed hypothesis for dysregulated vitamin D metabolism caused by intracellular pathogens. Theoretically, when nucleated cells are parasitized by intracellular bacteria, extra-renal production of 1,25(OH)2D increases, the kidneys lose control of 1,25(OH)2D production, and pro-hormone 25(OH)D decreases due to rapid conversion to 1,25(OH)2D

Sunlight appears to play a part in this process and many patients with autoimmune disease report sun sensitivity. The skin (dermal fibroblasts and keratinocytes possess VDR) has the capacity to synthesize 1,25(OH)2D, and represents an important target tissue for 1,25(OH)2D [145]. If keratinocytes in the skin are infected, natural regulation of photosynthesis may be thwarted and solar energy may overstimulate cellular activity, resulting in an increase in cutaneous production of vitamin D3, 25(OH)D and 1,25(OH)2D following sun exposure.
We hypothesize that when nucleated cells are parasitized by intracellular bacteria, extra-renal production of 1,25(OH)2D increases, the kidneys lose control of 1,25(OH)2D production, and pro-hormone 25(OH)D decreases due to rapid conversion to 1,25(OH)2D. 
The following mechanisms are thought to be responsible (Fig. 5):
*Inflammatory cytokines activate CYP27B1, an enzyme that causes more 25(OH)D to be converted to 1,25(OH)2D [146].
*The microbial-repressed VDR cannot transcribe CYP24A1 (formerly 24-hydroxylase), an enzyme that breaks down excess 1,25(OH)2D [147].
*Excess 1,25(OH)2D binds the PXR (pregnane X receptor), to inhibit conversion of vitamin D3 to 25(OH)D so 25(OH)D is down-regulated [148].
*1,25(OH)2D inhibits the hepatic synthesis of 25(OH)D [149].
Thus, low 25(OH)D may be a consequence of the inflammatory process. More studies are concluding that suboptimal circulating levels of vitamin D appear to be caused by the disease process. Waldronn et al. [150] found serum 25(OH)D was decreased following an acute inflammatory insult (i.e., orthopedic surgery) and concluded that hypovitaminosis-D may be the consequence rather than cause of chronic inflammatory diseases. Ferder et al. [151] state, there may be a relationship between inflammatory processes induced by chronic overstimulation of the renin angiotensin system (RAS) and the worldwide vitamin D deficiency. In fact, the pandemic of vitamin D deficiency could be the other face of increased RAS activity, which could potentially cause a lower activity or lower levels of Vitamin D.’’
!!!!Diagnosis of dysregulated vitamin D metabolism
Assessing dysregulated vitamin D metabolism has the potential to guide clinical practice [152, 153]. Vitamin D status is currently determined by measuring the level of serum 25(OH)D which, presumably, reflects the serum levels of other vitamin D metabolites (e.g., vitamin D3, vitamin D2 and 1,25(OH)2D, etc.). This measurement may not, however, provide enough information to assess vitamin D endocrine function. The clinical utility of measuring 1,25(OH)D is not fully understood, but it is clear that associations are being made between this active metabolite of vitamin D and disease states [154]. 1,25(OH)2D is not being used as a measure associated with vitamin D nutritional status or as an intermediate marker related to health outcomes, or even routinely assessed in vitamin D research. In the context of solving the puzzle of low 25(OH)D, the reasons cited for this lapse fail to consider the possibility of abnormal levels in the presence of chronic inflammation:
*1,25(OH)2D has a short half-life (hours) and fluctuates rapidly.
+However, a high result may be discovered even at trough level.
*1,25(OH)2D levels are regulated by PTH, calcium, phosphate.
+This is not true if extra-renal production is prevalent [143].
*1,25(OH)2D does not decrease until 25(OH)D is very low.
+A low 25(OH)D may be a sign that 1,25(OH)2D is abnormally high [55].
*1,25(OH)2D is only over-produced in hypercalcemic disease states such as sarcoidosis.
+Studies show this is not true [42].
*1,25(OH)2D may be elevated as a result of up- regulation of the CYP27B1 enzyme.
+This begs the question, Why is this enzyme elevated [146]?
Measuring both 25(OH)D and 1,25(OH)2D (and PTH, calcium, phosphate when indicated) as clinical markers in
Table 1 D-metabolites tests
Serum 25(OH)D [157]
CPT code: 82306 [157]
Lowest mortality reported at 20 ng/ml [158] Immunosuppression reported when higher than 30 ng/ml [122] Serum 1,25(OH)2D [157]
CPT code: 82652 [157]
ICD-9 code:
275.40 Disorder of calcium metabolism, unspecified [157] Maximum normal = 45 pg/ml [17]
chronic disease is more likely to provide a true picture of vitamin D status, than measuring 25(OH)D alone [155, 156] (Table 1). Measuring 1,25(OH)2D should be considered in patients with low 25(OH)D, abnormal laboratory results (especially inflammatory markers), a diagnosis of autoimmune disease or other chronic inflammatory illness, or signs of chronic systemic inflammation. For example, elevated 1,25(OH)2D may serve as a marker of Crohn’s disease [52]. The 1,25(OH)2D test is a delicate assay which is only done in specialized laboratories. False low results have been observed due to apparent sample mishandling; freezing for transport is advised to prevent sample degradation due to agitation. A high result is always accurate.
!!!!Restoration of VDR competence
The ability to mount an appropriate immune system response to intracellular infection is highly dependent on a competent VDR [159]. When it appears that 1,25(OH)2D is unable to up-regulate the VDR due to microbial activity, VDR competence may be restored with another VDR ligand which acts as an agonist; an agonist increases the signal transduction activity of a cell when bound to a receptor on that cell. Over 3000 synthetic VDR ligands have been identified, but most of these 1,25(OH)2D analogues have no clinical use because of their undue disruption to calcium regulation [160]. A number of nonvitamin D VDR ligands have also been identified: curcu- min, omega-6 fatty acids (e.g., arachidonic acid, linoleic acid), and lithocolic acid (LCA) but are not being used for this purpose [161, 162].
Angiotensin receptor blockers (ARBs) have been shown, via in silico molecular modeling, to modulate VDR activation [163]. The most promising ARB, __olmesartan__ medoxomil (brand name Benicar®) was estimated to have a Ki value in the low nanomolar range, similar to the Ki values of the natural VDR ligands [163].

{img attId="4414"}
Fig. 6 Proposed hypothesis for restoring renal control of 1,25(OH)2D with __olmesartan__. __olmesartan__ is believed to decrease elevated 1,25(OH)2D by several mechanisms

__Olmesartan__ has been noted to cause a significant reduction in elevated 1,25(OH)2D within weeks of initiation, which provides
further evidence of its ability to up-regulate the VDR [164]. __olmesartan__ is believed to decrease elevated 1,25(OH)2D by several VDR-mediated effects (Fig. 6). The up-regulated VDR:
*transcribes CYP24A1 and CYP3A4 (enzymes which reduce 1,25(OH)2D production) [147].
*represses CYP27B1 (the enzyme that hydroxylates 25(OH)D to 1,25(OH)2D) so less 1,25(OH)2D is produced [146].
Consequently, renal control of 1,25(OH)2D production is restored and extra-renal production of 1,25(OH)2D is reduced. A decrease in elevated 1,25(OH)2D means less systemic inflammation, as these studies of __olmesartan__ indicate:
*Improvement of glycemic control and insulin resistance was only observed in the __olmesartan__ group and these effects of __olmesartan__ might be mediated by an antiinflammatory action [165].
*__Olmesartan__ treatment significantly reduced serum levels of inflammatory markers; h-CRP, h-TNFa, IL-6, MCP-1 after 6 weeks of therapy [166].
*Blocking angiotensin-converting enzyme induces potent regulatory T cells and modulates TH1- and TH17-mediated autoimmunity [167].
*Blocking angiotensin II receptor increases bone mass [168, 169].
__Olmesartan__ acts in a manner similar to 1,25(OH)2D to reduce inflammation and, by inference, improve immune system function. VDR and RAS receptors are distributed in almost the same tissues. The endogenous VDR ligand 1,25(OH)2D down-regulates the RAS by repressing renin gene expression to reduce inflammation via the nuclear factor-kappa B pathway [170]. __olmesartan__ has a similar effect in that it reduces angiotensin II (a peptide that is implicated in the inflammatory process) [171]. Inappropriate stimulation of the RAS has been associated with the pathogenesis of hypertension, heart attack and stroke [151]. Ferder et al. [151] state, ‘‘Changes in RAS activity and activation of the VDR seem to be inversely related, making it possible to speculate that both systems could have a feedback relationship. The combination of RAS blockade and VDR stimulation appears to be more effective than each one used individually.” Blocking angiotensin II and stimulating the VDR is what __olmesartan__ appears to accomplish and this function is consistent with a theory of VDR incompetence (Fig. 7).
In patients with autoimmune disorders and inflammatory symptoms, __olmesartan__ is noted to provoke an increase in inflammatory symptoms indicative of a Jarisch-Herxheimer reaction (JHR). JHR is a cascade of reactions including inflammation, cytokine release, and endotoxin release as part of the immune response to the disintegration of infected cells [172]. This immunopathology suggests transcription of AMPs by an activated VDR, points to the presence of occult infection and provides additional evidence that __olmesartan__ is a VDR agonist [167, 173, 174]. Theoretically, __olmesartan__ restores VDR competence and, thus, phagocytosis leads to bacterial death; consequently, inflammation is temporarily increased by cytokine reaction to microbial endotoxins and cellular debris from dead host cells and bacteria [175].
Hajishengallis and Lambris [92] conclude that a blockade of hijacked receptors of the innate immune system may offer promising options to control infection and associated immunopathology. Although this use of __olmesartan__ is off- label, its safety profile is well established [176]. The multiple, documented beneficial effects of __olmesartan__, including the ability to reduce cardiovascular and kidney disease, prevent migraines, and reduce oxidative stress, also suggest it could play a key role in the resolution of chronic systemic inflammation [177, 178].
!!!!Clinical use of __olmesartan__
__Olmesartan__ is being used as a novel VDR ligand in the clinical setting [179]. Immunotherapy with __olmesartan__ may also include pulsed administration of select MIC (minimum inhibitory concentration) oral antibiotics to weaken and help eradicate the intracellular pathogens. With each antibiotic dose, inflammatory symptoms (JHR) wax and wane, providing further evidence of persistent infection [180]. Changes in laboratory findings (e.g., BUN, creatinine, CRP, blood counts, liver enzymes) often point to areas of occult inflammation. A correlating treatment strategy is the avoidance of excessive sunlight exposure, foods high in vitamin D and vitamin D supplements to maintain serum 25(OH)D at a level (20-30 ng/ml) that is not likely to suppress the immune system and inhibit bacterial elimination [122, 135, 137].
Accumulating case reports now support the observation that a number of complex, chronic conditions can be improved by restoring VDR function using this type of immunotherapy [179, 181, 182]. It is becoming increasingly clear that microbes slow down immune reactivity by dysregulating the VDR, ultimately to increase their chance of survival. Immune modulatory therapies that enhance VDR expression and activity should, therefore, be considered in the clinical setting [183].
!!!!Discussion
Vitamin D is essential for many important biological processes and most people get an adequate supply from exposure to sunlight (Table 2). Long-term studies are needed to determine if low 25(OH)D in healthy individuals leads to disease. Evidence that vitamin D supplementation cures or prevents chronic disease is inconsistent. Despite increased supplementation chronic inflammatory diseases are on the rise. Attention to the alternate hypothesis—low 25(OH)D is a consequence of the chronic disease process, provoked by persistent intracellular infection—may be crucial to reversing this trend and needs further research.

!!!!Table 2 Key points
*Vitamin D is a steroid hormone which regulates immune system function
*Photosynthesis of vitamin D3 provides adequate vitamin D stores for most individuals
*Low levels of 25(OH)D are seen in healthy individuals, as well as those with chronic inflammatory conditions
*Studies are inconsistent regarding the health benefits of increasing vitamin D stores; vitamin D supplementation may have negative effects
*25(OH)D may not always reflect the level of 1,25(OH)D; accurate assessment of vitamin D status depends on measuring both metabolites
*Intracellular, cell wall deficient bacteria may cause dysregulated vitamin D metabolism and impaired immune system function
*A novel, non-vitamin D VDR ligand (an angiotensin receptor blocker) appears to 
+reactivate the immune system, 
+restore VDR competence, 
+correct dysregulated vitamin D metabolism and 
+reduce inflammatory symptoms
The prevailing dogma that the level of serum 25(OH)D provides an accurate assessment of vitamin D status needs closer examination. Circulating levels of 25(OH)D may not be an accurate reflection of vitamin D status. In those with an autoimmune disease or chronic inflammatory symptoms, 1,25(OH)2D may be elevated. This can lead to osteoporosis and cause inhibition of innate immunity, which is contraindicated in the presence of infection. The resulting immunosuppression may promote persistentinfection which has been implicated in chronic inflammatory diseases.
Human cells live in harmony with many types of microbes but some microbes may become pathogenic under commonly experienced conditions. The innate immune system is designed to kill pathogens via 1,25(OH)2D- mediated VDR transcription of anti-microbial peptides but microbes may use strategies which down-regulate the VDR in order to live and reproduce within nucleated host cells. Studies using more advanced cell culture and molecular techniques are confirming the presence of previously undetected intracellular bacteria. Defense mechanisms that intracellular bacteria use to persist and proliferate need to be investigated. Pathogen-induced VDR dysfunction which causes the release of pro-inflammatory cytokines appears to be at the root of chronic disease and low 25(OH)D. Improving VDR activation may be the key to reducing inflammatory diseases. Treatments that up-regulate the VDR to restore normal immune function, reduce inflammation and eradicate persistent bacterial infections require further research. An immunotherapy which has demonstrated efficacy in reversing vitamin D metabolism dysfunction and reducing inflammatory symptoms is currently being used by clinicians and warrants formal study.
In summary, elevated 1,25(OH)2D, often accompanied by reduced 25(OH)D, is a clinical sign of dysregulated vitamin D metabolism and evidence that the immune system is competing with parasitic microbes for VDR dominance. Failure of the immune system to mount an effective anti-microbial response results in persistent intracellular infection. This induces relentless inflammation (immunopathology) which causes tissue damage and disease symptoms.

Acknowledgments The authors wish to gratefully acknowledge the reviewers who commented on the original manuscript and provided helpful, expert advice. We thank the editor of Inflammation Research, Dr. Mauro Teixeira, for his kind consideration of our work. Special thanks to Tapen Sinha for sharing with us his expertise regarding manuscript formatting and submission. We thank Tom Mangin, Belinda Fenter, Terry Fenter, Debbie Yeager and John Yeager for their support. And we acknowledge with gratitude the generous donors to Chronic Illness Recovery who have enabled us to continue our research.

Open Access This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
!!!!References
#Cheng T, Chimeh C, Lu Z, et al. Factors that influence the cutaneous synthesis and dietary sources of vitamin D. Arch Bio Biophs. 2007;460(2):213-7.
#Jones G. Pharmacokinetics of vitamin D toxicity. Am J Clin Nutr. 2008;88(2):582-6.
#Holick M, Schnoes H, Deluca H, Suda T, Cousins R. Isolation and identification of 1,25-dihydroxycholecalciferol. A metabolite of vitamin D active in intestine. Biochem. 1971; 10(14):2799-804.
#Adams J, Hewison M. Extrarenal expression of the 25-hydrox- yvitamin D-1-hydroxylase. Arch Biochem Biophys. 2012; 523(1):95-102.
#Haddad J, Vitamin D. Binding protein (Gc-globulin): multiple tasks. J Steroid Biochem Mol Biol. 1996;53(1-6):579-82.
#Sutton A, MacDonald P. Vitamin D: more than a ‘‘bone-a-fide’’ hormone. Mol Endocrinol. 2003;17(5):777-91.
#White JH. Vitamin D signaling, infectious diseases, and regulation of innate immunity. Infect Immun. 2008;76(9):3837-43.
#Lai Y, Gallo RL. AMPed up immunity: how antimicrobial peptides have multiple roles in immune defense. Trends Immunol. 2009;30(3):131-41.
#Wang T, Nestel F, Bourdeau V, et al. Cutting edge: 1,25-di- hydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J Immunol. 2004;173(5):2909-12.
#Hayes C, Nashold F, Spach K, Pedersen L. The immunological functions of the vitamin D endocrine system. Cell Mol Biol (Noisy-le-grand). 2003;49(2):277-300.
#Topilski I, Flaishon L, Naveh Y, Harmelin A, Levo Y, Shachar I. The anti-inflammatory effects of 1,25-dihydroxyvitamin D3 on Th2 cells in vivo are due in part to the control of integrin-mediated T lymphocyte homing. Eur J Immunol. 2004;34(4):1068-76.
#Maxmen A. Nutrition advice: the vitamin D-lemma. Nature. 2011;475(7354):23-5.
#Autier P, Gandini S. Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. Arch Intern Med. 2007;167(16):1730-7.
#For health professionals: position statement on supplementation, blood levels and sun exposure Vitamin D Council. Vitamin D Council. Jan 12, 2010. Available at http://www.vitamindcouncil. org/further-topics/for-health-professionals-position-statement-on- supplementation-blood-levels-and-sun-exposure/. Accessed 28 Apr 2013.
#Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Guidelines for preventing and treating vitamin D deficiency and insufficiency revisited. J Clin Endocrinol Metab. 2012;97(4):1153-8.
#Ross AC, Taylor CL, Yaktine AL, Del Valle HB. Dietary reference intakes for calcium and vitamin D. Washington: National Academy of Sciences; 2010. 0-309-16394-3.
#Beers M. Vitamin D Deficiency and Dependency. Merck (Document). Oct 15, 2006. Available at http://web.archive.org/ web/20061015162329/www.merck.com/mrkshared/mmanual/ section1/chapter3/3d.jsp. Accessed 21 Apr 2013.
#Topiwala S. 25-hydroxy vitamin D test. MedlinePlus. Oct 7,
#Available at http://www.nlm.nih.gov/medlineplus/ency/ article/003569.htm. Accessed 21 Apr 2013.
#Vitamin D, 25-Hydroxy, LC/MS/MS. Quest diagnostics. 2013. Available at http://www.questdiagnostics.com/home/physicians/ testing-services/by-test-name/vitamind.html. Accessed 28 Apr 2013.
#Snellman G, Melhus H, Gedeborg R, et al. Seasonal genetic influence on serum 25-hydroxyvitamin D levels: a twin study. PLoS One. 2009;4(11):e7747.
#Bogh MK, Schmedes AV, Philipsen PA, Thieden E, Wulf HC. Vitamin D production depends on ultraviolet-B dose but not on dose rate: a randomized controlled trial. Exp Dermatol. 2011; 20(1):14-8.
#Bogh MK, Schmedes AV, Philipsen PA, Theiden E, Wulf HC. Vitamin D production after UVB exposure depends on baseline vitamin D and total cholesterol but not on skin pigmentation. J Invest Dermatol. 2010;130(2):546-53.
#Matsuoka LY, Worstman J, Haddad JG, Kolm P, Hollis BW. Racial pigmentation and the cutaneous synthesis of vitamin D. Arch Dermatol. 1991;127(4):536-8.
#Matsuoka LY, Wortsman J, Chen TC, Holick MF. Compensation for the interracial variance in the cutaneous synthesis of vitamin D. J Lab Clin Med. 1995;126(5):452-7.
#Villa M, Kelsey J, Chen J, Marcus R. Skin Pigmentation does not affect vitamin D status in community-dwelling Mexican- American women. J Bone Miner Res. 1994;9(Suppl 1):S418.
#Matsuoka LY, Wortsman J, Dannenberg MJ, Holis BW, Lu Z, Holick MF. Clothing prevents ultraviolet-B radiation-dependent photosynthesis of vitamin D3. J Clin Endocrinol Metab. 1992;75(4):1099-103.
#Dietary supplement fact sheet: vitamin D. National Institutes of Health. Jan 24, 2011. Available at http://ods.od.nih.gov/ factsheets/VitaminD-HealthProfessional/?print=1. Accessed 10 Mar 2013.
#Matsuoka LY, Ide L, MacLaughlin JA, Holick MF. Sunscreens suppress cutaneous vitamin D3 synthesis. J Clin Endocrinol Metab. 1987;64(6):1165-8.
#Diehl JW, Chiu MW. Effects of ambient sunlight and photoprotection on vitamin D status. Dermatol Ther. 2010;23(1): 48-60.
#Youl PH, Janda M, Kimlin M. Vitamin D and sun protection: the impact of mixed public health messages in Australia. Int J Cancer. 2009;124(8):1963-70.
#Global Solar UV Index: A Practical Guide. Geneva, Switzerland: World Health Organization; 2002. ISBN 9241590076.
#MacLaughlin J, Holick MF. Aging decreases the capacity of human skin to produce vitamin D3. J Clin Invest. 1985;76(4): 1536-8.
#Chuck A, Todd J, Diffey B. Subliminal ultraviolet-B irradiation for the prevention of vitamin D deficiency in the elderly: a feasibility study. Photodermatol Photoimmunol Photomed. 2001;17(4):168-71.
#Chel VG, Ooms ME, Popp-Snijders C, et al. Ultraviolet irradiation corrects vitamin D deficiency and suppresses secondary hyperparathyroidism in the elderly. J Bone Miner Res. 1998;13(8):1238-42.
#Webb AR, Kline L, Holick MF. Influence of season and latitude on the cutaneous synthesis of vitamin D3: exposure to winter sunlight in Boston and Edmonton will not promote vitamin D3 synthesis in human skin. Clin Endocrinol Metab. 1988;67(2): 373-8.
#Kimlin MG, Olds WJ, Moore MR. Location and vitamin D synthesis: is the hypothesis validated by geophysical data? J Photochem Photobiol B. 2007;86(3):234-9.
#Lubin D, Jensen EH, Gies HP. Global surface ultraviolet radiation climatology from TOMS and ERBE data. J Geo Res. 1998;103(D20):26061-91.
#Schoenmakers I, Goldberg GR, Prentice A. Abundant sunshine and vitamin D deficiency. Br J Nutr. 2008;99(6):1171-3.
#Al-Othman A, Al-Musharaf S, Al-Daghri NM, et al. Tea and coffee consumption in relation to vitamin D and calcium levels in Saudi adolescents. Nutr J. 2012;11:56.
#Willis KS, Smith DT, Broughton KS, Larson-Meyer DE. Vitamin D status and biomarkers of inflammation in runners. Open Access J Sports Med. 2012;2012(3):35-42.
#Binkley N, Novotny R, Krueger D, et al. Low vitamin D status despite abundant sun exposure. J Clin Endocrinol Metab. 2007;92(6):2130-5.
#Blaney GP, Albert PJ, Proal AD. Vitamin D metabolites as clinical markers in autoimmune and chronic disease. Ann NY Acad Sci. 2009;1173:384-90.
#Brot C, Jorgensen NR, Sorensen OH. The influence of smoking on vitamin D status and calcium metabolism. Eur J Clin Nutr. 1999;53(12):920-6.
#Tiosano D, Hochberg Z. Hypophosphatemia: the common denominator of all rickets. J Bone Miner Metab. 2009;27(4): 392-401.
#Rickets. MedlinePlus. Aug 1, 2012. Available at http://www. nlm.nih.gov/medlineplus/ency/article/000344.htm. Accessed 6 May 2013.
#Lerch C, Meissner T. Interventions for the prevention of nutritional rickets in term born children. Cochrane Database Syst Rev. 2007;4:CD006164.
#Pettifor JM, Ross P, Wang J, Moodley G, Couper-Smith J. Rickets in children of rural origin in South Africa: is low dietary calcium a factor? J Pediatr. 1978;92(2):320-4.
#Pettifor JM. Nutritional rickets: deficiency of vitamin D, calcium, or both? Am J Clin Nutr. 2004;80(6 Suppl):1725S-9S.
#Reid IR, Bolland MJ, Grey A. Effects of vitamin D supplements on bone mineral density: a systematic review and meta-analysis. Lancet. 2013;383:146-55.
#Boden SD, Kaplan FS. Calcium homeostasis. Orthop Clin North Am. 1990;21(1):31-42.
#Sun J. Vitamin D and mucosal immune function. Curr Opin Gastroenterol. 2010;26(6):591-5.
#Abreu MT, Kantorovich V, Vasiliauskas EA, et al. Measurement of vitamin D levels in inflammatory bowel disease patients reveals a subset of Crohn’s disease patients with elevated 1,25- dihydroxyvitamin D and low bone mineral density. Gut. 2004;53(8):1129-36.
#Brot C, J0rgensen N, Madsen OR, Jensen LB, S0rensen OH. Relationships between bone mineral density, serum vitamin D metabolites and calcium:phosphorus intake in healthy peri- menopausal women. J Intern Med. 1999;245(5):509-16.
#Ishizuka S, Kurihara N, Miura D, et al. Vitamin D antagonist, TEI-9647, inhibits osteoclast formation induced by 1alpha,25- dihydroxyvitamin D3 from pagetic bone marrow cells. J Steroid Biochem Mol Biol. 2004;89-90(1-5):331-4.
#Vanderschueren D, Pye SR, O’Neill TW, et al. Active vitamin D (1,25-dihydroxyvitamin D) and bone health in middle-aged and elderly men: the European Male Aging Study (EMAS). J Clin Endocrinol Metab. 2013;98(3):995-1005.
#Chung M, Lee J, Terasawa T, Lau J, Trikalinos TA. Vitamin D with or without calcium supplementation for prevention of cancer and fractures: an updated meta-analysis for the US. Preventive Services Task Force. Ann Intern Med. 2011;155(12): 827-38.
#Whayne TF Jr. Vitamin D: popular cardiovascular supplement but benefit must be evaluated. Int J Angiol. 2011;20(2):63-72.
#Shelby J. Needs great, evidence lacking for people with multiple chronic conditions. Scribd. Apr 2013. Accessed 7 May 2013.
#Mattke S, Klautzer L, Mengistu T, Hu J, Wu H. Health and wellbeing in the home: a global analysis of needs, expectations, and priorities for home health care technology. Rand Corporation. 2010. http://www.rand.org/pubs/occasional_papers/OP323.html. Accessed 7 May 2013.
#Tseng L. Controversies in vitamin D supplementation. eScholar- ship. 2003. http://www.escholarship.org/uc/item/4m84d4fn# page-1. Accessed 7 May 2013.
#Bjelakovic G, Gluud LL, Nikolova D, et al. Vitamin D supplementation for prevention of mortality in adults. Cochrane Database Syst Rev. 2011;(7):CD007470.
#Holick MF. Environmental factors that influence the cutaneous production of vitamin D. Am J Clin Nutr. 1995;61(3 Sup- pl):638S-45S.
#Vieth R. Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr. 1999;69(5):842-56.
#Noordam R, de Craen AJ, Pedram P, et al. Levels of 25-hy- droxyvitamin D in familial longevity: the Leiden Longevity Study. CMAJ. 2012;184(18):E963-8.
#Autier P, Boniol M, Pizot C, Mullie P. Vitamin D: chasing a myth? Vitamin D status and ill health: a systematic review. Lancet Diabetes Endocrinol. 2013.
#Bolland MJ, Grey A, Gamble GD, Reid IR. The effect of vitamin D supplementation on skeletal, vascular, or cancer outcomes: a trial sequential meta-analysis. Lancet Diabetes Endocrinol. 2014;4(2):307-20.
#Ross AC, Manson JE, Abrams SA, et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the institute of medicine: what clinicians need to know. J Clin Endocrinol Metab. 2011;96(1):53-8.
#Holick MF, Chen TC. Vitamin D deficiency: a worldwide problem with health consequences. Am J Clin Nutr. 2008;87:1080S-6S.
#Albert PJ, Proal AD, Marshall TG. Vitamin D the alternative hypothesis. Autoimmun Rev. 2009;8(8):639-44.
#Madoff S, editor. The Bacterial L-forms. 1st ed. USA: Marcel Dekker Inc; 1986.
#Allan EJ, Hoischen C, Gumpert J. Bacterial L-forms. Adv Appl Microbiol. 2009;68:1-39.
#Boya P. Lysosomal function and dysfunction: mechanism and disease. Antioxid Redox Signal. 2010;17(5):766-74.
#Domingue GJ, Woody HB. Bacterial persistence and expression of disease. Clin Microbiol Rev. 1997;10(2):320-44.
#O’Connor SM, Taylor CE, Hughes JM. Emerging infectious determinants of chronic diseases. Emerg Infect Dis. 2006;12(7): 1051-7.
#Domingue GJ. Demystifying pleomorphic forms in persistence and expression of disease: are they bacteria, and is peptidogly- can the solution? Discov Med. 2010;10(52):234-46.
#Rueter A. Microbes start immune response by sneaking inside cells. University of Michigan Health System. Apr 16, 2007. http://www2.med.umich.edu/prmc/media/newsroom/details.cfm? ID=577. Accessed 8 May 2013.
#Rolhion N, Darfeuille-Michaud A. Adherent-invasive Escherichia coli in inflammatory bowel disease. Inflamm Bowel Dis. 2007;13(10):1277-83.
#Onwuamaegbu ME, Belcher RA, Soare C. Cell wall-deficient bacteria as a cause of infections: a review of the clinical significance. J Int Med Res. 2005;33(1):1-20.
#Verway M, Behr MA, White JH. VitaminD NOD2, autophay and Crohn’s disease. Expert Rev Clin Immunol. 2010;6(4): 505-8.
#Pirofski L, Casadevall A. Q and A what is a pathogen? A question that begs the point. BMC Biol. 2012;12:6.
#Hof H. Opportunistic intracellular bacteria and immunity. Antibiotic treatment of infections with intracellular bacteria. USA: Springer; 2002.
#Fuller E, Elmer C, Nattress F, Horne G, Cook P, Fawcett T. Beta-lactam resistance in Staphylococcus aureus cells that do not require a cell wall for integrity. Antimicrob Agents Che- mother. 2005;49(12):5075-80.
#Wroblewska J, Janicka G, Gospodarek E, Szymankiewicz M. L-forms of Staphylococcus epidermidis induced by penicillin. Pol J Microbiol. 2006;55(3):243-4.
#Garssen J, Vandebriel RJ, De Gruijl FR, et al. UVB exposure- induced systemic modulation of Th1- and Th2-mediated immune responses. Immunology. 1999;97(3):506-14.
#Riminton DS, Hartung HP, Reddel SW. Managing the risks of immunosuppression. Curr Opin Neurol. 2011;24(3):217-23.
#Wall S, Kunze ZM, Saboor S, et al. Identification of spheroplast- like agents isolated from tissues of patients with Crohn’s disease and control tissues by polymerase chain reaction. J Clin Microbiol. 1993;31(5):1241-5.
#Negi M, Takemura T, Guzman J, et al. Localization of propi- onibacterium acnes in granulomas supports a possible etiologic link between sarcoidosis and the bacterium. Mod Pathol. 2012;25(9):1284-97.
#Astrauskiene D, Bernotiene E. New insights into bacterial persistence in reactive arthritis. Clin Exp Rheumatol. 2007;25(3): 470-9.
#McDougal JS. Emerging infectious diseases. Centers for Disease Control and Prevention. Mar 2006. http://wwwnc.cdc.gov/eid/ article/12/3/05-1409_article.htm#suggestedcitation. Accessed 8 May 2013.
#Kozarov E. Bacterial invasion of vascular cell types: vascular infectology and atherogenesis. Future Cardiol. 2012;8(1): 123-38.
#Khan N, Gowthaman U, Pahari S, Agrewala JN. Manipulation of costimulatory molecules by intracellular pathogens: veni, vidi, vici! PLoS Pathog. 2012;8(6):e1002676.
#Hajishengallis G, Lambris JD. Microbial manipulation of receptor crosstalk in innate immunity. Nat Rev Immunol. 2011;11(33):187-200.
#Dorr T, Vulic M, Lewis K. Ciprofloxacin causes persister formation by inducing the TisB toxin in Escherichia coli. PLoS Biol. 2010;8(2):e1000317.
#Fuks JM, Arrighi RB, Weidner JM, et al. GABAergic signaling is linked to a hypermigratory phenotype in dendritic cells infected by Toxoplasma gondii. PLoS Pathog. 2012;8(12): e1003051.
#Smillie CS, Smith MB, Friedman J, Cordero OX, David LA, Alm EJ. Ecology drives a global network of gene exchange connecting the human microbiome. Nature. 2011;480(7376): 241-4.
#Riley DR, Sieber KB, Robinson KM, et al. Bacteria-human somatic cell lateral gene transfer is enriched in cancer samples. PLOS Comput Biol. 2013;9(6):e1003107.
#Helaine S, Cheverton AM, Watson KG, Faure LM, Matthews SA, Holden DW. Internalization of Salmonella by macrophages induces formation of nonreplicating persisters. Science. 2014;343(6167):204-208. Available at http://www.sciencemag. org. Accessed 21 Jan 2014.
#Eishi Y. Etiologic aspect of sarcoidosis as an allergic endogenous infection caused by Propionibacterium acnes. Biomed Res Int. 2013;2013:935289.
#Wang KX, Chen L. Helicobacter pylori L-form and patients with chronic gastritis. World J Gastroenterol. 2004;10(9): 1306-9.
#Chen Y, Liu W, Sun T, et al. 1,25-Dihydroxyvitamin D promotes negative feedback regulation of TLR signaling via targeting MicroRNA-155-SOCS1 in macrophages. J Immunol. 2013; 190(7):3687-95.
#Nauciel C. Immune defenses against intracellular bacterial infection. In: Paradise LJ, Friedman H, Bendinelli M, editors. Opportunistic intracellular bacteria and immunity. New York: Kluwer Academic; 2002.
#Liu PT, Stenger S, Li H, et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science. 2006;311(5768):1770-3.
#Alexander C, Rietschel ET. Bacterial lipopolysaccharides and innate immunity. J Endotoxin Res. 2001;7(3):167-202.
#McGeachy MJ, McSorley SJ. Microbial-induced Th17: superhero or supervillain? J Immunol. 2012;189(7):3285-91.
#Oswald-Richter KA, Beachboard DC, Seeley EH, et al. Dual analysis for mycobacteria and propionibacteria in sarcoidosis BAL. J Clin Immunol. 2012;32(5):1129-40.
#Labro M. Interference of antibacterial agents with phagocyte functions: immunomodulation or ‘‘immuno-fairy tales’’? Clin Microbiol Rev. 2000;13(4):615-50.
#Giongo A, Gano KA, Crabb DB, et al. Toward defining the autoimmune microbiome for type 1 diabetes. ISME J. 2011; 5(1):82—91.
#Anderson G, Horvath J. The growing burden of chronic disease in America. Public Health Rep. 2004;119(3):263-70.
#Smith G. Angiotensin and systems thinking: wrapping your mind around the big picture. Ochsner J Spring. 2013;13(1): 11-25.
#Woolard MD, Frelinger JA. Outsmarting the host: bacteria modulating the immune response. Immunol Res. 2008;41(3): 188-202.
#Dermine JF, Desjardins M. Survival of intracellular pathogens within macrophages. Protoplasma. 1999;210(1-2):11-24.
#Xu Y, Xie J, Li Y, et al. Using a cDNA microarray to study cellular gene expression altered by Mycobacterium tuberculosis. Chin Med J (Engl). 2003;116(7):1070-3.
#Liu PT, Wheelwright M, Teles R, et al. MicroRNA-21 targets the vitamin D-dependent antimicrobial pathway in leprosy. Nat Med. 2012;18(2):267-73.
#Coughlan CA, Chotirmall SH, Renwick J, et al. The effect of Aspergillus fumigatus infection on vitamin D receptor expression in cystic fibrosis. Am J Respir Crit Care Med. 2012; 186(10):999-1007.
#Yenamandra SP, Lundin A, Arulampalam V, et al. Expression profile of nuclear receptors upon Epstein—Barr virus induced B cell transformation. Exp Oncol. 2009;31(2):92-6.
#Haug CJ, Aukrust P, Haug E, M0rkrid L, Muller F, Fr0land SS. Severe deficiency of 1,25-dihydroxyvitamin D3 in human immunodeficiency virus infection: association with immunological hyperactivity and only minor changes in calcium homeostasis. J Clin Endocrinol Metab. 1998;83(11):3832-8.
#Yoshizawa T, Handa Y, Uematsu Y, et al. Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning. Nat Genet. 1997;16(4):391-6.
#Sadeghi K, Wessner B, Laggner U, et al. Vitamin D3 down- regulates monocyte TLR expression and triggers. Eur J Immunol. 2006;36(2):361-70.
#Barna BP, Culver DA, Kanchwala A, et al. Alveolar macrophage cathelicidin deficiency in severe sarcoidosis. J Innate Immun. 2012;4(5-6):569-78.
#Mawer EB, Hayes ME, Still PE, et al. Evidence for nonrenal synthesis of 1,25-dihydroxyvitamin D in patients with inflammatory arthritis. J Bone Miner Res. 1991;6(7):733-9.
#Wang TT, Dabbas B, Laperriere EG, et al. Direct and indirect induction by 1,25-dihydroxyvitamin D3 of the NOD2/CARD15- defensin beta2 innate immune pathway defective in Crohn disease. J Biol Chem. 2010;285(4):2227-31.
#Lemire J. 1,25-Dihydroxyvitamin D3—a hormone with immunomodulatory properties. Z Rheumatol. 2000;59(Suppl 1): 24-7.
#Deb DK, Chen Y, Zhang Z, et al. 1,25-Dihydroxyvitamin D3 suppresses high glucose-induced angiotensinogen expression in kidney cells by blocking the NF-{kappa}B pathway. 296(5): F1212-8.
#Mouy R, Fischer A, Vilmer E, Seger R, Griscelli C. Incidence, severity, and prevention of infections in chronic granulomatous disease. J Pediatr. 1989;114(1):555-60.
#Wu S, Sun J. Vitamin D receptor, and macroautophagy in inflammation and infection. Discov Med. 2011;11(59):325-35.
#Domingue G, Turner B, Schlegel JU. Cell-wall deficient bacterial variants in kidney tissue. Detection by immunofluorescence. Urology. 1974;3(3):288-92.
#Pleister A, Eckels DD. Cryptic infection and autoimmunity. Autoimmun Rev. 2003;2(3):126-32.
#Chan TD, Wood K, Hermes JR, et al. Elimination of germinal- center-derived self-reactive B cells is governed by the location and concentration of self-antigen. Immunity. 2012;37(5): 893-904.
#Blander JM, Torchinsky MB, Campisi L. Revisiting the old link between infection and autoimmune disease with commensals and T helper 17 cells. Immunol Res. 2012;54(1-3):50-68.
#Christen U, Hintermann E, Holdener M, von Herrath MG. Viral triggers for autoimmunity: is the ‘glass of molecular mimicry’ half full or half empty? J Autoimmun. 2010;34(1):38-44.
#Proal AD, Albert PJ, Marshall TG. Autoimmune disease and the human metagenome. In: Nelson KE, editor. Metagenomics of the human body. 1st ed. USA: Springer; 2011.
#Berlin T, Zandman-Goddard G, Blank M, et al. Autoantibodies in nonautoimmune individuals during infections. Ann NY Acad Sci. 2007;1108:584-93.
#Molina V, Shoenfeld Y. Infection, vaccines and other environmental triggers of autoimmunity. Autoimmunity. 2005;38(3): 235-45.
#Griffin MD, Xing N, Kumar R. Vitamin D and its analogs as regulators of immune activation and antigen presentation. Annu Rev Nutr. 2003;23:117-45.
#Zhang Y, Leung DY, Richers BN, et al. Vitamin D inhibits monocyte/macrophage proinflammatory cytokine production by targeting MAPK phosphatase-1. J Immunol. 2012;188(5): 2127-35.
#Bohm M, Luger TA, Schneider M, Schwarz T, Kuhn A. New insight into immunosuppression and treatment of autoimmune diseases. Clin Exp Rheumatol. 2006;24(1 Suppl 40):S67-71.
#Arnson Y, Amital H, Shoenfeld Y. Vitamin D and autoimmunity: new aetiological and therapeutic considerations. Ann Rheum Dis. 2007;66(9):1137-42.
#Kim HM, Chung MJ, Chung JB. Remission and relapse of autoimmune pancreatitis: focusing on corticosteroid treatment. Pancreas. 2010;39(5):555-60.
#Collins FS. Reengineering translational science: the time is right. Sci Transl Med. 2011;3(90):9017.
#Norman A. From vitamin D to hormone D: fundamentals of the vitamin D endocrine system essential for good health. Am J Clin Nutr. 2008;88(2):491S-9S.
#Rasmussen SB, Reinert LS, Paludan SR. Innate recognition of intracellular pathogens: detection and activation of the first line of defense. APMIS. 2009;117(5-6):323-37.
#Dusso AS, Kamimura S, Gallieni M, et al. gamma-Interferon- induced resistance to 1,25-(OH)2D3 in human monocytes and macrophages: a mechanism for the hypercalcemia of various granulomatoses. J Clin Endocrinol Metab. 1997;82(7): 2222-32.
#Edfeldt K, Liu PT, Chun R, et al. T-cell cytokines differentially control human monocyte antimicrobial responses by regulating vitamin D metabolism. Proc Natl Acad Sci USA. 2010; 107(52):22593-8.
#Lambert PW, Stern PH, Avioli RC, et al. Evidence for extrarenal production of 1 alpha,25-dihydroxyvitamin D in man. J Clin Invest. 1982;69(3):722-5.
#Reichrath J. Vitamin D and the skin: an ancient friend, revisited. Exp Dermatol. 2007;16(7):618-25.
#Bikle DD. Vitamin D and immune function: understanding common pathways. Curr Osteoporos Rep. 2009;7(2):58-63.
#Jones G, Prosser DE, Kaufman M. 25-Hydroxyvitamin D-24- hydroxylase (CYP24A1): Its important role in the degradation of vitamin D. Arch Biochem Biophys. 2012;523(1):9-18.
#Xu Y, Hashizume T, Shuhart MC, et al. Intestinal and hepatic CYP3A4 catalyze hydroxylation of 1alpha,25-dihydroxyvitamin
#D(3): implications for drug-induced osteomalacia. Mol Pharmacol. 2006;69(1):56-65.
#Bell NH, Shaw S, Turner RT. Evidence that 1,25-dihydroxyvi- tamin D3 inhibits the hepatic production of 25-hydroxyvitamin D in man. J Clin Invest. 1984;74(4):1540-4.
#Waldron JL, Ashby HL, Cornes MP, et al. Vitamin D: a negative acute phase reactant. J Clin Pathol. 2013 (Epub ahead of print).
#Ferder M, Inserra F, Manucha W, Ferder L. The world pandemic of Vitamin D deficit could possibly be explained by cellular inflammatory response activity induced by the renin angiotensin system. Am J Physiol Cell Physiol. 2013 (Epub ahead of print).
#Akbaraly TN, Hamer M, Ferrie JE, et al. Chronic inflammation as a determinant of future aging phenotypes. CMAJ. 2013 (Epub ahead of print).
#Phillips CM, Perry IJ. Does inflammation determine metabolic health status in obese and nonobese adults? J Clin Endocrinol Metab. 2013;98(10):E1610-9.
#Strathmann FG, Laha TJ, Hoofnagle AN. Quantification of 1a,25 dihydroxy vitamin D by immunoextraction and liquid chromatography-tandem mass spectrometry. Clin Chem. 2011;57(9):1279-85.
#Hollis B. Detection of vitamin D and its major metabolites. In: Feldman D, Pike JW, Glorieux F, editors. vitamin D. San Diego: Elsevier Academic; 2005.
#Perez T. Bacteria induced vitamin D receptor dysfunction in autoimmune disease; theoretical and practical implication for interpretation of serum vitamin D metabolite levels. Paper presented at: 6th International Congress on Autoimmunity, 2006; Porto, Portugal.
#Vitamin D Assay Testing. Medicare Limited Coverage Tests— Covered Diagnosis Codes. Nov 14, 2011. Available at http:// www.sonoraquest.com/uploads/docs/Vitamin_D_Assay_ Testing.pdf?AspxAutoDetectCookieSupport=1. Accessed 31 Jan 2014.
#Durup DJHCJSPHALB. A reverse J-shaped association of allcause mortality with serum 25-hydroxyvitamin D in general practice: the CopD study. J Clin Endocrinol Metab. 2012;97(8): 2644-52.
#Liu PT, Schenk M, Walker VP, et al. Convergence of IL-1beta and VDR activation pathways in human TLR2/1-induced antimicrobial responses. PLoS One. 2009;4(6):e5810.
#Carlberg C, Molnar F. Detailed molecular understanding of agonistic and antagonistic vitamin D receptor ligands. Curr Top Med Chem. 2006;6(12):1243-53.
#Haussler M, Haussler C, Bartik L, et al. Vitamin D receptor: molecular signaling and actions of nutritional ligands in disease prevention. Nutr Rev. 2008;66(10 Suppl 2):98-112.
#Ishizawa M, Matsunawa M, Adachi R, et al. Lithocholic acid derivatives act as selective vitamin D receptor modulators without inducing hypercalcemia. J Lipid Res. 2008;49(4): 763-72.
#Marshall TG, Lee RE, Marshall FE. Common angiotensin receptor blockers may directly modulate the immune system via VDR, PPAR and CCR2b. Theor Biol Med Model. 2006;3:1.
#Waterhouse JC, Marshall TG, Fenter B, Mangin M, Blaney G. High levels of active 1,25-dihydroxyvitamin D despite low levels of the 25-hydroxyvitamin D precursor-implications of dysregulated vitamin D for diagnosis and treatment of chronic disease. In: Stolzt VD, editor. Vitamin D: New Research. New York: Nova Science Publishers; 2006.
#Arao T, Okada Y, Mori H, Nishida K, Tanaka Y. Antihypertensive and metabolic effects of high-dose __olmesartan__ and telmisartan in type 2 diabetes patients with hypertension. Endocr J. 2013; (Epub ahead of print).
#Fliser D, Buchholz K, Haller H. Antiinflammatory effects of angiotensin II subtype 1 receptor blockade in hypertensive patients with microinflammation. Circulation. 2004;110(9): 1103-7.
#Platten M, Youssef S, Hur EM, et al. Blocking angiotensinconverting enzyme induces potent regulatory T cells and modulates TH1- and TH17-mediated autoimmunity. Proc Natl Acad Sci USA. 2009;106(35):14948-53.
#Izu Y, Mizoguchi F, Kawamata A, et al. Angiotensin II type 2 receptor blockade increases bone mass. J Biol Chem. 2009;284(8):4857-64.
#Shimuru H, Nakagami H, Osako MK, et al. Angiotensin II accelerates osteoporosis by activating osteoclasts. FASEB J. 2008;22(7):2465-75.
#Li YC, Kong J, Wei M, Chen ZF, Liu SQ, Cao LP. 1,25-Di- hydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest. 2002;110(2):229-38.
#Suzuki Y, Ruiz-Ortega M, Lorenzo O, Ruperez M, Esteban V, Egido J. Inflammation and angiotensin II. Int J Biochem Cell Biol. 2003;35(6):881-900.
#Herxheimer K, Martin H. So-called Herxheimer reaction. Arch Derm Syphilol. 1926;13(1):115-7.
#Sonawane A, Santos JC, Mishra BB, et al. Cathelicidin is involved in the intracellular killing of mycobacteria in macrophages. Cell Microbiol. 2011;13(10):1601-17.
#Nickel D, Busch M, Mayer D, Hagemann B, Knoll V, Stenger S. Hypoxia triggers the expression of human beta defensin 2 and antimicrobial activity against Mycobacterium tuberculosis in human macrophages. J Immunol. 2012;188(8):4001-7.
#Hurley JC. Antibiotic-induced release of endotoxin. A therapeutic paradox. Drug Saf. Mar 1995;12(3):183-95.
#Schwocho LR, Masonson HN. Pharmacokinetics of CS-866, a new angiotensin II receptor blocker, in healthy subjects. J Clin Pharmacol. 2001;41(5):515-27.
#Ferrario C. Effect of angiotensin receptor blockade on endothelial function: focus on __olmesartan__ medoxomil. Vasc Health Risk Manag. 2009;5(1):301-14.
#Takizawa S, Dan T, Uesugi T, et al. A sartan derivative with a very low angiotensin II receptor affinity ameliorates ischemic cerebral damage. J Cereb Blood Flow Metab. 2009;29(10): 1665-72.
#Proal AD, Albert PJ, Marshall TG, Blaney GP, Lindseth LA. Immunostimulation in the treatment for chronic fatigue syn- drome/myalgic encephalomyelitis. Immunol Res. 2013;56: 398-412.
#Hof H. Antibiotic treatment of infections with intracellular bacteria. In: Paradise LJ, Friedman H, Bendinelli M, editors. Opportunistic intracellular bacteria and immunity. New York: Kluwer Academic; 2002.
#Waterhouse JC, Perez TH, Albert PJ. Reversing bacteria- induced vitamin D receptor dysfunction is key to autoimmune disease. Ann NY Acad Sci. 2009;1173:757-65.
#Mangin M. Monitoring recovery from autoimmune disease with an interactive, internet-based clinical trial based on a molecular model of chronic disease. Paper presented at: 6th International Congress on Autoimmunity, 2008; Porto, Portugal.
#Kongsbak M, Levring TB, Geisler C, von Essen MR. The vitamin D receptor and T cell function. Front Immunol. 2013; 4:148.</description></item><item><title>Vitamin D-binding protein controls T cell responses to vitamin D in the lab</title><link>/posts/vitamin-d-binding-protein-controls-t-cell-responses-to-vitamin-d-in-the-lab.html</link><pubDate>Fri, 19 Sep 2014 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-binding-protein-controls-t-cell-responses-to-vitamin-d-in-the-lab.html</guid><description>&lt;h4 id="vitamin-d-binding-protein-controls-t-cell-responses-to-vitamin-d">Vitamin D-binding protein controls T cell responses to vitamin D&lt;/h4>
&lt;p>BMC Immunology 2014, 15:35 doi:10.1186/s12865-014-0035-2&lt;/p>
&lt;p>Martin Kongsbak1, Marina Rode von Essen1, Trine Bøegh Levring1, Peter Schjerling23, Anders Woetmann1, Niels Ødum1, Charlotte Menné Bonefeld1 and Carsten Geisler1 &lt;a href="mailto:cg@sund.ku.dk">cg@sund.ku.dk&lt;/a>&lt;/p>
&lt;p>1 Department of International Health, Immunology and Microbiology, Faculty of Health and Medical Sciences, U. of Copenhagen, Copenhagen, Denmark&lt;/p>
&lt;p>2 Department of Orthopedic Surgery M, Institute of Sports Medicine, Bispebjerg Hospital, Copenhagen, Denmark&lt;/p>
&lt;p>3 Center for Healthy Aging, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark&lt;/p></description></item><item><title>Changes during pregnancy of vitamin D (decrease), DBP (2X) and albumin (0.8X)</title><link>/posts/changes-during-pregnancy-of-vitamin-d-decrease-dbp-2x-and-albumin-08x.html</link><pubDate>Thu, 28 Aug 2014 00:00:00 +0000</pubDate><guid>/posts/changes-during-pregnancy-of-vitamin-d-decrease-dbp-2x-and-albumin-08x.html</guid><description>&lt;h3 id="impact-of-pregnancy-on-vitamin-d-status-a-longitudinal-study">Impact of pregnancy on vitamin D status: a longitudinal study.&lt;/h3>
&lt;p>Br J Nutr. 2014 Oct 14;112(7):1081-7. &lt;a href="https://doi.org/10.1017/S0007114514001883.">doi: 10.1017/S0007114514001883.&lt;/a> Epub 2014 Aug 27.&lt;/p>
&lt;p>Zhang JY 1, Lucey AJ 1, Horgan R 2, Kenny LC 2, Kiely M 1.&lt;/p>
&lt;p>1 Vitamin D Research Group, School of Food and Nutritional Sciences, University College Cork,Cork,Republic of Ireland.&lt;/p>
&lt;p>2 The Irish Centre for Fetal and Neonatal Translational Research (INFANT), Department of Obstetrics and Gynaecology, University College Cork,Cork,Republic of Ireland.&lt;/p></description></item><item><title>Restless Legs Syndrome - Vitamin D, Iron, etc. - many studies</title><link>/posts/restless-legs-syndrome-vitamin-d-iron-etc-many-studies.html</link><pubDate>Tue, 26 Aug 2014 00:00:00 +0000</pubDate><guid>/posts/restless-legs-syndrome-vitamin-d-iron-etc-many-studies.html</guid><description>&lt;p>&lt;strong>RLS has been separately treated by Iron, Magnesium. and Vitamins&lt;/strong>&lt;/p>
&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#rls-review-by-perplexity-ai-jan-2025httpswwwperplexityaisearchrestless-legs-syndrome-appears-6eckwsmnqho2qdmwpckqg">RLS review by &lt;a href="https://www.perplexity.ai/search/restless-legs-syndrome-appears-6EckWsmNQHO2qDMW.Pckqg">Perplexity AI Jan 2025&lt;/a>&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#rls-genes-and-glutamate---meta-analysis-june-2024">RLS: genes and glutamate - meta-analysis June 2024&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-and-restless-legs-syndrome-a-review-of-current-literature---april-2023">Vitamin D and Restless Legs Syndrome: A Review of Current Literature - April 2023&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#rls-associated-with-low-vitamin-d-the-more-severe-the-rls-the-lower-the-d---dec2021">RLS associated with low vitamin D, The more severe the RLS, the lower the D - Dec 2021&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#rls-treated-by-weekly-50000-iu-of-vitamin-d---feb2020">RLS treated by weekly 50,000 IU of vitamin D - Feb 2020&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#rls-3-x-more-likely-if--20-ngml-of-vitamin-d-8x-if-a-teacher--march2018">RLS 3 X more likely if &amp;lt; 20 ng/mL of Vitamin D (8X if a teacher) – March 2018&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#rls-associated-with-many-other-vitamin-d-deficiency-diseases---july2017">RLS associated with many other Vitamin D Deficiency diseases - July 2017&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#restless-legs-syndrome-associated-with-a-few-major-diseases--a-systematic-review-and-new-concept---april2016">Restless legs syndrome associated with (a few) major diseases -A systematic review and new concept - April 2016&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#rls-score-dropped-from-26-to-10-after-vitamin-d-levels-were-raised-to-just-25-ng---aug2014">RLS score dropped from 26 to 10 after Vitamin D levels were raised to just 25 ng - Aug 2014&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#restless-legs-syndrome-5x-more-likely-if-vitamin-d-deficient---may2014">Restless Legs Syndrome 5X more likely if vitamin D deficient - May 2014&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#sleep-apnea-solutions-may-apply-also-to-rls-vitamins-d-and-b-good-gut">Sleep Apnea solutions may apply also to RLS (Vitamins D and B, good gut)&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#rls-triggers---oct2018">RLS triggers - Oct 2018&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#rls-not-treated-by-weekly-50000-iu-of-vitamin-d-but-was-treated-by-placebo---rct-nov2018">RLS not treated by weekly 50,000 IU of vitamin D, but was treated by placebo - RCT Nov 2018&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#rls-increased-risk-of-vascular-dementia-18x-suspect-low-d-or-mg---march2023">RLS increased risk of Vascular Dementia 1.8X (suspect low D or Mg) - March 2023&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="rls-review-by-perplexity-ai-jan-2025httpswwwperplexityaisearchrestless-legs-syndrome-appears-6eckwsmnqho2qdmwpckqg">RLS review by &lt;a href="https://www.perplexity.ai/search/restless-legs-syndrome-appears-6EckWsmNQHO2qDMW.Pckqg">Perplexity AI Jan 2025&lt;/a>&lt;/h4>
&lt;p>&lt;strong>Restless Legs Syndrome appears to be treated by at least Vitamin D, Vitamin K, Iron and Magnesium.&lt;br>
Are there others? Which is best? Is there some combination which is best?&lt;/strong>&lt;/p></description></item><item><title>Tuberculosis is controlled by Interleukin-32 when it has enough Vitamin D – patent applied for</title><link>/posts/tuberculosis-is-controlled-by-interleukin-32-when-it-has-enough-vitamin-d-patent-applied-for.html</link><pubDate>Fri, 22 Aug 2014 00:00:00 +0000</pubDate><guid>/posts/tuberculosis-is-controlled-by-interleukin-32-when-it-has-enough-vitamin-d-patent-applied-for.html</guid><description>&lt;h3 id="new-interaction-discovered-between-vitamin-d-and-certain-protein-in-tuberculosishttpwwwvitamindcouncilorgvitamin-d-newsnew-interaction-discovered-between-vitamin-d-and-certain-protein-in-tuberculosis-vitamin-d-council-describes-the-study">&lt;a href="http://www.vitamindcouncil.org/vitamin-d-news/new-interaction-discovered-between-vitamin-d-and-certain-protein-in-tuberculosis/#">New interaction discovered between vitamin D and certain protein in tuberculosis&lt;/a> Vitamin D Council describes the study&lt;/h3>
&lt;h3 id="study-identifies-protein-that-helps-prevent-active-tuberculosis-in-infected-patientshttpnewsroomuclaedureleasesstudy-identifies-protein-that-helps-prevent-active-tuberculosis-in-infected-patients-ucla-newsroom">&lt;a href="http://newsroom.ucla.edu/releases/study-identifies-protein-that-helps-prevent-active-tuberculosis-in-infected-patients">Study identifies protein that helps prevent active tuberculosis in infected patients&lt;/a> UCLA Newsroom&lt;/h3>
&lt;ul>
&lt;li>
&lt;p>“When vitamin D levels were low, IL-32 was not able to kill the bacteria,”&lt;/p>
&lt;/li>
&lt;li>
&lt;p>. . applied for a patent application for further development of IL-32 as a potential diagnostic marker to see which patients with latent TB are at risk for activation of the disease, as well as for use as a possible therapeutic to treat tuberculosis by stimulating antimicrobial activity.&lt;/p></description></item><item><title>Vitamin D Binding Protein special Issue</title><link>/posts/vitamin-d-binding-protein-special-issue.html</link><pubDate>Thu, 07 Aug 2014 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-binding-protein-special-issue.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#editorial-vitamin-d-binding-protein-and-vitamin-d-levels">Editorial: Vitamin D Binding Protein and Vitamin D Levels&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#testing">Testing&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#different-conditions">Different Conditions&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-binding-protein-and-bone-health">Vitamin D Binding Protein and Bone Health&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#other-special-issue-articles-full-free-text-on-linehttpwwwhindawicomjournalsijesi643760">Other Special Issue articles (&lt;a href="http://www.hindawi.com/journals/ije/si/643760/">full free text on-line&lt;/a>)&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#see-also-vitamindwiki">See also VitaminDWiki&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;h3 id="editorial-vitamin-d-binding-protein-and-vitamin-d-levels">Editorial: Vitamin D Binding Protein and Vitamin D Levels&lt;/h3>
&lt;p>&lt;strong>International Journal of Endocrinology&lt;/strong> . Volume 2014 (2014), Article ID 638263, 2 pages&lt;/p>
&lt;p>&lt;a href="http://dx.doi.org/10.1155/2014/638263">http://dx.doi.org/10.1155/2014/638263&lt;/a>&lt;/p>
&lt;p>Zhongjian Xie,1 Arthur C. Santora,2 Sue A. Shapses,3 and Xiangbing Wang4&lt;/p>
&lt;p>1Institute of Metabolism and Endocrinology, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, China&lt;/p></description></item><item><title>Vitamin D tests assume constant Binding Protein - not correct across races and clinical situations</title><link>/posts/vitamin-d-tests-assume-constant-binding-protein-not-correct-across-races-and-clinical-situations.html</link><pubDate>Sat, 12 Jul 2014 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-tests-assume-constant-binding-protein-not-correct-across-races-and-clinical-situations.html</guid><description>&lt;h3 id="a-comparison-of-measured-and-calculated-free-25oh-vitamin-d-levels-in-clinical-populations">A comparison of measured and calculated free 25(OH) vitamin D levels in clinical populations.&lt;/h3>
&lt;p>J Clin Endocrinol Metab. 2014 May;99(5):1631-7. &lt;a href="https://doi.org/10.1210/jc.2013-3874.">doi: 10.1210/jc.2013-3874.&lt;/a> Epub 2014 Jan 31.&lt;/p>
&lt;p>Schwartz JB1, Lai J, Lizaola B, Kane L, Markova S, Weyland P, Terrault NA, Stotland N, Bikle D.&lt;/p>
&lt;p>1Departments of Medicine (J.B.S., J.L., B.L., N.A.T., D.B.), Bioengineering and Therapeutic Sciences (J.B.S., S.M.), Physiological Nursing (P.W.), Obstetrics and Gynecology (N.S.), and Dermatology (D.B.), University of California San Francisco, San Francisco, California 94143; and Jewish Home of San Francisco (J.B.S., L.K.), San Francisco, California 94112.&lt;/p></description></item><item><title>4700 IU of vitamin D needed by most seniors – an equation</title><link>/posts/4700-iu-of-vitamin-d-needed-by-most-seniors-an-equation.html</link><pubDate>Tue, 08 Jul 2014 00:00:00 +0000</pubDate><guid>/posts/4700-iu-of-vitamin-d-needed-by-most-seniors-an-equation.html</guid><description>&lt;h3 id="abstract">Abstract&lt;/h3>
&lt;p>Background: Vitamin D is essential for bone health and probably the health of most nonskeletal tissues. Vitamin D deficiency is widespread, and recommended doses are usually inadequate to maintain healthy levels. We conducted a retrospective observational study to determine whether the recommended doses of vitamin D are adequate to correct deficiency and maintain normal levels in a population seeking health care. We also sought to develop a predictive equation for replacement doses of vitamin D.&lt;/p></description></item><item><title>Vitamin D levels around the world - DSM review</title><link>/posts/vitamin-d-levels-around-the-world-dsm-review.html</link><pubDate>Mon, 16 Jun 2014 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-levels-around-the-world-dsm-review.html</guid><description>&lt;h3 id="31-vitamin-d-a-critical-and-essential-micronutrient-for-human-health">3.1 Vitamin D: a critical and essential micronutrient for human health&lt;/h3>
&lt;p>Frontiers in Physiology, 1664-042X, Provisional PDF published on: &lt;a href="https://www.frontiersin.org">www.frontiersin.org&lt;/a>:&lt;/p>
&lt;p>Igor Bendik, Angelika Friedel, Franz F. Roos, Peter Weber &amp;amp; Manfred Eggersdorfer&lt;/p>
&lt;p>DSM Nutritional Products Ltd, Kaiseraugst, Switzerland&lt;/p>
&lt;p>Correspondence: Dr. Igor Bendik, DSM Nutritional Products Ltd,&lt;/p>
&lt;p>Department of Human Nutrition and Health, Bldg 201/219A, P.O. Box 2676, CH-4002 Basel, Switzerland, E-mail: &lt;a href="mailto:Igor.bendik@dsm.com">Igor.bendik@dsm.com&lt;/a>&lt;/p>
&lt;p>Conflict of Interest Statement: All authors are employees of DSM Nutritional Products Ltd. They declare no conflict of interest.&lt;/p></description></item><item><title>Autistic teens have lower levels of vitamin D than siblings or parents</title><link>/posts/autistic-teens-have-lower-levels-of-vitamin-d-than-siblings-or-parents.html</link><pubDate>Sun, 15 Jun 2014 00:00:00 +0000</pubDate><guid>/posts/autistic-teens-have-lower-levels-of-vitamin-d-than-siblings-or-parents.html</guid><description>&lt;h3 id="vitamin-d-in-the-general-population-of-young-adults-with-autism-in-the-faroe-islands">Vitamin D in the General Population of Young Adults with Autism in the Faroe Islands.&lt;/h3>
&lt;p>J Autism Dev Disord. 2014 Jun 14. &lt;span>[Epub ahead of print]&lt;/span>&lt;/p>
&lt;p>Kočovská E1, Andorsdóttir G, Weihe P, Halling J, Fernell E, Stóra T, Biskupstø R, Gillberg IC, Shea R, Billstedt E, Bourgeron T, Minnis H, Gillberg C.&lt;/p>
&lt;p>1Gillberg Neuropsychiatry Centre, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Kungsgatan 12, 411 19, Göteborg, Sweden, &lt;a href="mailto:eva.kocovska@gnc.gu.se">eva.kocovska@gnc.gu.se&lt;/a>.&lt;/p></description></item><item><title>Essential nutrient requirements of the elderly (vitamin D, etc.)</title><link>/posts/essential-nutrient-requirements-of-the-elderly-vitamin-d-etc.html</link><pubDate>Sat, 14 Jun 2014 00:00:00 +0000</pubDate><guid>/posts/essential-nutrient-requirements-of-the-elderly-vitamin-d-etc.html</guid><description>&lt;p>Published Date June 2014 Volume 2014:6	 Pages 59 - 68; DOI: &lt;a href="http://dx.doi.org/10.2147/NDS.S35381">http://dx.doi.org/10.2147/NDS.S35381&lt;/a>&lt;/p>
&lt;p>Skully R&lt;/p>
&lt;p>Department of Family Medicine, Grant Medical Center, OhioHealth, Columbus, OH, USA&lt;/p>
&lt;p>Abstract: Government-sponsored medical organizations in developed countries have established guidelines for daily nutritional requirements. For most nutrients there is general agreement surrounding these requirements, which are based on exhaustive scientific literature review. Differences in these recommendations exist because of genetic and environmental factors that result in differences in disease susceptibility, but also due to incomplete understanding of the roles of nutrients in disease prevention. This review briefly summarizes nutrient recommendations for older adults such as where those recommendations differ from those of younger adults; and includes areas of developing understanding such as the possible role of thiamine deficiency in patients with congestive heart failure, the need for some older adults to ingest absorbable forms of vitamin B12, the high prevalence of vitamin D deficiency, the potential role of vitamin K in bone health, the need for higher levels of protein intake in order to stimulate muscle protein synthesis as one ages, the role of calcium in osteoporosis, and the possible need for zinc supplementation in hospitalized patients.&lt;/p></description></item><item><title>Blood tests can be a poor measure of actual vitamin D due to D Binding Protein (DBP)</title><link>/posts/blood-tests-can-be-a-poor-measure-of-actual-vitamin-d-due-to-d-binding-protein-dbp.html</link><pubDate>Thu, 29 May 2014 00:00:00 +0000</pubDate><guid>/posts/blood-tests-can-be-a-poor-measure-of-actual-vitamin-d-due-to-d-binding-protein-dbp.html</guid><description>&lt;p>&lt;strong>Vitamin D Binding Protein Impact on 25-Hydroxyvitamin D Levels under Different Physiologic and Pathologic Conditions&lt;/strong>&lt;/p>
&lt;p>Hindawi Publishing Corporation International Journal of Endocrinology Volume 2014, Article ID 981581, 6 pages &lt;a href="http://dx.doi.org/10.1155/2014/981581">http://dx.doi.org/10.1155/2014/981581&lt;/a>&lt;/p>
&lt;p>Pegah Yousefzadeh,1 Sue A. Shapses,2 and Xiangbing Wang1&lt;/p>
&lt;p>1 Division of Endocrinology, Metabolism &amp;amp; Nutrition, Department of Medicine, Rutgers University-Robert Wood Johnson Medical School, New Brunswick, NJ 08903, USA&lt;/p>
&lt;p>2 Department of Nutritional Sciences, Rutgers University, New Brunswick, NJ 08901, USA&lt;/p></description></item><item><title>Endocrine problems and low vitamin D – review</title><link>/posts/endocrine-problems-and-low-vitamin-d-review.html</link><pubDate>Thu, 29 May 2014 00:00:00 +0000</pubDate><guid>/posts/endocrine-problems-and-low-vitamin-d-review.html</guid><description>&lt;p>&lt;strong>Vitamin D as a potential contributor in endocrine health and disease&lt;/strong>&lt;/p>
&lt;p>Eur J Endocrinol May 28, 2014 EJE-14-0158&lt;/p>
&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#introduction">Introduction&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-homeostasis">Vitamin D homeostasis&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#classification-of-vitamin-d-status-and-vitamin-d-intake-requirements">Classification of vitamin D status and vitamin D intake requirements&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-and-primary-hyperparathyroidism">Vitamin D and Primary Hyperparathyroidism&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-and-type-1-diabetes-t1dm">Vitamin D and type 1 diabetes (T1DM)&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-and-type-2-diabetes-t2dm">Vitamin D and Type 2 Diabetes (T2DM)&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-and-addisons-disease">Vitamin D and Addison&amp;rsquo;s disease&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-and-hashimotos-thyroiditis">Vitamin D and Hashimoto&amp;rsquo;s thyroiditis&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-and-graves-disease">Vitamin D and Graves&amp;rsquo; Disease&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-and-polycystic-ovary-syndrome-pcos">Vitamin D and polycystic ovary syndrome (PCOS)&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#limitations-in-the-study-of-vitamin-d">Limitations in the study of vitamin D&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#conclusions">Conclusions&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#summary-tables-are-in-pdf">Summary tables are in PDF&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;p>&lt;strong>&lt;span style="color:#00F;">PDF is attached at the bottom of this page&lt;/span>&lt;/strong>&lt;/p></description></item><item><title>Testing misses the Vitamin D tied up with VDBP</title><link>/posts/testing-misses-the-vitamin-d-tied-up-with-vdbp.html</link><pubDate>Thu, 29 May 2014 00:00:00 +0000</pubDate><guid>/posts/testing-misses-the-vitamin-d-tied-up-with-vdbp.html</guid><description>&lt;h2 id="assessing-vitamin-d-status-time-for-a-rethink">Assessing Vitamin D Status: Time for a Rethink?&lt;/h2>
&lt;p>Clinical Chemistry, June 2014 vol. 60 no. 6 809-811&lt;/p>
&lt;p>Graham D. Carter1,* and Karen W. Phinney2&lt;/p>
&lt;p>1 Imperial College Healthcare NHS Trust, Oncology/Endocrine Laboratory, Charing Cross Hospital, London, UK;&lt;/p>
&lt;p>2 Biomolecular Measurement Division, NIST, Gaithersburg, MD&lt;/p>
&lt;p>↵* Address correspondence to this author at: Imperial College Healthcare NHS Trust, Oncology/Endocrine Laboratory Charing Cross Hospital, Fulham Palace Rd., London W6 8RF, UK. Fax +44-(0)20-8846-7007; e-mail &lt;a href="mailto:b.carter1@which.net">b.carter1@which.net&lt;/a>.&lt;/p></description></item><item><title>Vitamin D-binding protein and vitamin D status of black Americans and white Americans</title><link>/posts/vitamin-d-binding-protein-and-vitamin-d-status-of-black-americans-and-white-americans.html</link><pubDate>Thu, 29 May 2014 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-binding-protein-and-vitamin-d-status-of-black-americans-and-white-americans.html</guid><description>&lt;p>N Engl J Med. 2013 Nov 21;369(21):1991-2000. &lt;a href="https://doi.org/10.1056/NEJMoa1306357.">doi: 10.1056/NEJMoa1306357.&lt;/a>&lt;/p>
&lt;p>Powe CE1, Evans MK, Wenger J, Zonderman AB, Berg AH, Nalls M, Tamez H, Zhang D, Bhan I, Karumanchi SA, Powe NR, Thadhani R.&lt;/p>
&lt;p>1From the Department of Medicine, Brigham and Women&amp;rsquo;s Hospital (C.E.P.), Division of Nephrology, Massachusetts General Hospital (J.W., H.T., I.B., R.T.), Department of Pathology, Beth Israel Deaconess Medical Center and Harvard Medical School (A.H.B.), Division of Nephrology, Beth Israel Deaconess Medical Center (D.Z., S.A.K.), and Howard Hughes Medical Institute (D.Z., S.A.K.) - all in Boston; the Laboratory of Epidemiology and Population Sciences, National Institute on Aging, National Institutes of Health, Baltimore (M.K.E., A.B.Z.); the Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD (M.N.); and the Department of Medicine, San Francisco General Hospital and University of California, San Francisco, San Francisco (N.R.P.).&lt;/p></description></item><item><title>Vitamin D and bone health: Epidemiologic studies</title><link>/posts/vitamin-d-and-bone-health-epidemiologic-studies.html</link><pubDate>Wed, 14 May 2014 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-and-bone-health-epidemiologic-studies.html</guid><description>&lt;p>BoneKEy Reports (2014) 3, Article number: 511 (2014) doi:10.1038/bonekey.2014.6&lt;/p>
&lt;p>Received 04 September 2013 Accepted 11 November 2013 Published online 05 March 2014&lt;/p>
&lt;p>Peter R Ebeling&lt;/p>
&lt;p>Department of Endocrinology, NorthWest Academic Centre, The University of Melbourne, Western Health, St. Albans, Victoria, Australia&lt;/p>
&lt;img src="/attachments/d3.mock.jpg" alt="image">
&lt;p>Allelic variation in the vitamin D receptor was the first non-structural gene to be associated with osteoporosis, and together with the effects of the vitamin D system on bone homeostasis, suggested that this vitamin might have a strong role in bone health. However, controversy exists regarding what level of serum 25-hydroxyvitamin D (25(OH)D) is optimal. Current data from biochemical, observational and randomized controlled trials (RCTs), indicate serum 25(OH)D levels of at least 50 nmol l−1 are required for normalization of parathyroid hormone (PTH) levels, to minimize the risk of osteomalacia and for optimal bone cell function. The skeletal consequences of 25(OH)D insufficiency include secondary hyperparathyroidism, increased bone turnover and bone loss and an increased risk of minimal trauma fractures. In large scale epidemiological studies, serum 25(OH)D levels are associated with bone mineral density in both men and women. However, there is mixed evidence on the effectiveness of optimizing serum 25(OH)D levels for the prevention of bone loss and minimal trauma fractures in postmenopausal women and older men. There may be some benefit on primary fracture prevention for those who have inadequate serum levels of 25(OH)D, particularly in institutionalised elderly patients, but only when combined with calcium supplements. For optimal bone health, evidence from RCTs suggests vitamin D may be considered a threshold nutrient with few further bone benefits observed at levels of 25(OH)D above which PTH is normalized. An adequate calcium intake is also imperative to gain optimum benefit from an improved vitamin D status in those with insufficient 25(OH)D levels, with an increased calcium intake being associated with suppression of PTH levels.&lt;/p></description></item><item><title>Vitamin D can be somewhat blocked by Vitamin D Binding Protein</title><link>/posts/vitamin-d-can-be-somewhat-blocked-by-vitamin-d-binding-protein.html</link><pubDate>Wed, 14 May 2014 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-can-be-somewhat-blocked-by-vitamin-d-binding-protein.html</guid><description>&lt;h4 id="vitamin-d-binding-protein-affects-the-correlation-of-25ohd-and-frailty-in-the-older-men">Vitamin D Binding Protein Affects the Correlation of 25(OH)D and Frailty in the Older Men.&lt;/h4>
&lt;p>Int J Endocrinol. 2014;2014:543783. &lt;a href="https://doi.org/10.1155/2014/543783.">doi: 10.1155/2014/543783.&lt;/a> Epub 2014 Apr 13.&lt;/p>
&lt;p>Wang Y, Wang YJ, Zhan JK, Tang ZY, Huang W, Tan P, Gao S, Ma CL, Jian ZJ, Liu YS.&lt;/p>
&lt;p>Geriatric Department of the Second Xiang-Ya Hospital, Institute of Aging and Geriatric, Central South University, Changsha, Hunan 410011, China.&lt;/p>
&lt;p>Vitamin D binding protein (DBP) may alter the biologic activity of 25-hydroxyvitamin D &lt;span>[25(OH)D]&lt;/span>. The objective of our present study was to determine the joint effect of serum 25(OH)D and DBP on the risk of frailty. Five hundred sixteen male participants aged 70 years or older were recruited in Changsha city and its surrounding area in Hunan province of China. Frailty was defined as the presence of at least three of the five following criteria: weakness, low physical activity, slow walking speed, exhaustion, and weight loss. Multivariate linear regression analysis was performed to assess the relationship between 25(OH)D and DBP levels. Odds ratios (ORs) for frailty were evaluated across quartiles of 25(OH)D and DBP levels, adjusted age, education, and body mass index. The results showed that participants in the&lt;/p></description></item><item><title>Vitamin D binding protein: a multifunctional protein of clinical importance – book chapter</title><link>/posts/vitamin-d-binding-protein-a-multifunctional-protein-of-clinical-importance-book-chapter.html</link><pubDate>Sat, 03 May 2014 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-binding-protein-a-multifunctional-protein-of-clinical-importance-book-chapter.html</guid><description>&lt;p>Adv Clin Chem. 2014;63:1-57.&lt;/p>
&lt;p>Speeckaert MM, Speeckaert R, van Geel N, Delanghe JR.&lt;/p>
&lt;p>Since the discovery of group-specific component and its polymorphism by Hirschfeld in 1959, research has put spotlight on this multifunctional transport protein (vitamin D binding protein, DBP).&lt;/p>
&lt;p>Besides the transport of vitamin D metabolites, DBP is a plasma glycoprotein with many important functions, including&lt;/p>
&lt;ul>
&lt;li>
&lt;p>sequestration of actin,&lt;/p>
&lt;/li>
&lt;li>
&lt;p>modulation of immune and inflammatory responses,&lt;/p>
&lt;/li>
&lt;li>
&lt;p>binding of fatty acids, and&lt;/p></description></item><item><title>Is too much vitamin D bad – possible causes and cures</title><link>/posts/is-too-much-vitamin-d-bad-possible-causes-and-cures.html</link><pubDate>Thu, 24 Apr 2014 00:00:00 +0000</pubDate><guid>/posts/is-too-much-vitamin-d-bad-possible-causes-and-cures.html</guid><description>&lt;p>&lt;strong>It is well known that TOO LITTLE vitamin D is associated with health problems&lt;/strong>&lt;/p>
&lt;p>&lt;strong>TOO MUCH vitamin D may also be associated with health problems&lt;/strong>&lt;/p>
&lt;h4 id="possible-reasons-include">Possible reasons include:&lt;/h4>
&lt;ol>
&lt;li>&lt;strong>Body is out of balance with too much vitamin D – consider adjusting &lt;a href="/posts/low-cost-cofactors-for-vitamin-d" style="color: red; text-decoration: underline;" title="This post/category does not exist yet: Low cost cofactors for vitamin D">cofactors&lt;/a>&lt;/strong>&lt;/li>
&lt;/ol>
&lt;blockquote>
&lt;p>&lt;strong>&lt;span style="color:#06F;">CURE:&lt;/span>&lt;/strong> Increase &lt;a href="/posts/overview-vitamin-k-and-vitamin-d" style="color: red; text-decoration: underline;" title="This post/category does not exist yet: Overview Vitamin K and Vitamin D">Vitamin K2&lt;/a>&lt;/p></description></item><item><title>Vitamin D Conference papers and poster abstracts – London</title><link>/posts/vitamin-d-conference-papers-and-poster-abstracts-london.html</link><pubDate>Thu, 24 Apr 2014 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-conference-papers-and-poster-abstracts-london.html</guid><description>&lt;p>&lt;strong>&lt;span style="color:#F00;">188 abstracts&lt;/span>&lt;/strong>&lt;/p>
&lt;p>Browser (cntrl F usually) can FIND words, phrases, authors, etc.&lt;/p>
&lt;p>Note: due to extraction and formatting problems all &lt;span>[ became ( &lt;del>hs&lt;/del> &lt;del>hs&lt;/del> and all ]&lt;/span> became )&lt;/p>
&lt;p>Conference is described at: &lt;a href="/posts/vitamin-d-conference-in-england-april-23-25-2014">Vitamin D conference in England - April 23-25 2014&lt;/a>&lt;/p>
&lt;p>These absracts of presentations and posters were published in the &lt;a href="http://www.ncbi.nlm.nih.gov/pubmed/25054551?dopt=Abstract">Journal Nutrients&lt;/a> July 2014&lt;/p>
&lt;p>    Note: Clicking on Hide Health Problems above will make it easier to read the Table of Contents&lt;/p></description></item><item><title>Vitamin D and neurocognitive function – Holick</title><link>/posts/vitamin-d-and-neurocognitive-function-holick.html</link><pubDate>Tue, 08 Apr 2014 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-and-neurocognitive-function-holick.html</guid><description>&lt;p>&lt;strong>Note: &lt;a href="/posts/vitamin-d-and-neurocognitive-function-holick">Update by same authors with same title 8 years later&lt;/a>&lt;/strong>&lt;/p>
&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#vitamin-d-and-neurocognitive-function">Vitamin D and neurocognitive function&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#introduction">Introduction&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#background">Background&lt;/a>
 &lt;ul>
 &lt;li>&lt;a href="#vitamin-d-metabolism">Vitamin D metabolism&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-receptor-in-the-brain">Vitamin D receptor in the brain&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-and-aging">Vitamin D and aging&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#malnutrition-in-the-elderly">Malnutrition in the elderly&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#prevalence-of-vitamin-d-deficiency">Prevalence of vitamin D deficiency&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-and-neurocognitive-functioning">Vitamin D and neurocognitive functioning&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-and-mild-cognitive-impairment">Vitamin D and mild cognitive impairment&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-alzheimers-disease-and-vascular-dementia">Vitamin D, Alzheimer&amp;rsquo;s disease, and vascular dementia&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;li>&lt;a href="#conclusion">Conclusion&lt;/a>
 &lt;ul>
 &lt;li>&lt;a href="#span-stylecolor00freferences-in-pdf-attached-at-the-bottom-of-this-pagespan">&lt;strong>&lt;span style="color:#00F;">References in PDF attached at the bottom of this page&lt;/span>&lt;/strong>&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#see-also-vitamindwiki">See also VitaminDWiki&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h3 id="vitamin-d-and-neurocognitive-function">Vitamin D and neurocognitive function&lt;/h3>
&lt;p>Clinical Interventions in Aging 2 April 2014&lt;/p></description></item><item><title>Central Nervous System helped by Vitamin D – Review – 2013</title><link>/posts/central-nervous-system-helped-by-vitamin-d-review-2013.html</link><pubDate>Sat, 08 Feb 2014 00:00:00 +0000</pubDate><guid>/posts/central-nervous-system-helped-by-vitamin-d-review-2013.html</guid><description>&lt;h2 id="vitamin-d-and-the-central-nervous-system">Vitamin D and the central nervous system&lt;/h2>
&lt;p>Pharmacological Reports 2013, 65, 271-278 ISSN 1734-1140&lt;/p>
&lt;p>Matgorzata Wrzosek1, Jacek tukaszkiewicz2, Michat Wrzosek3, Andrzej Jakubczyk4, Halina Matsumoto4, Pawet Piatkiewicz3, Maria Radziwoh-Zaleska4, Marcin Wojnar4,5, Grazyna Nowicka1&lt;/p>
&lt;p>department of Pharmacogenomics, department of Biochemistry and Clinical Chemistry,&lt;/p>
&lt;p>department of Internal Medicine and Diabetology, department of Psychiatry, Medical University of Warsaw,&lt;/p>
&lt;p>Zwirki i Wigury 61, PL 02-091 Warszawa, Poland&lt;/p>
&lt;p>department of Psychiatry, University of Michigan, 4250 Plymouth Rd., Ann Arbor, MI 48109, USA Correspondence: Grazyna Nowicka, e-mail: &lt;a href="mailto:grazyna.nowicka@wum.edu.p">grazyna.nowicka@wum.edu.p&lt;/a>&lt;/p></description></item><item><title>Roles of Vitamin D in 11 diseases</title><link>/posts/roles-of-vitamin-d-in-11-diseases.html</link><pubDate>Mon, 03 Feb 2014 00:00:00 +0000</pubDate><guid>/posts/roles-of-vitamin-d-in-11-diseases.html</guid><description>&lt;h3 id="summary-of-studies-of-vitamin-d-and-the-following-concerns">Summary of studies of Vitamin D and the following concerns&lt;/h3>
&lt;p>Sorry that we do not have hyperlinks (yet). You will have to scroll down or FIND table #&lt;/p>
&lt;ul>
&lt;li>
&lt;p>Table 1 Diabetes Mellitus&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Table 2 Tuberculosis&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Table 3 Hypertension&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Table 4 Cardiovascular Diseases&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Table 5 Osteoporosis&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Table 6 Multiple Sclerosis&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Table 7 Cognition&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Table 8 Chronic Pain&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Table 9 Colon Cancer&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Table 10 Breast cancer&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Table 11 Prostate cancer&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Table 12 Vitamin D levels recommended&lt;/p></description></item><item><title>Bone density correlates better with free D (calculated) rather than measured vitamin D</title><link>/posts/bone-density-correlates-better-with-free-d-calculated-rather-than-measured-vitamin-d.html</link><pubDate>Sun, 05 Jan 2014 00:00:00 +0000</pubDate><guid>/posts/bone-density-correlates-better-with-free-d-calculated-rather-than-measured-vitamin-d.html</guid><description>&lt;h3 id="serum-free-and-bio-available-25-hydroxyvitamin-d-correlate-better-with-bone-density-than-serum-total-25-hydroxyvitamin-d">Serum free and bio-available 25-hydroxyvitamin D correlate better with bone density than serum total 25-hydroxyvitamin D.&lt;/h3>
&lt;p>Scand J Clin Lab Invest. 2014 Jan 2.&lt;/p>
&lt;p>Martin S. Johnsen 1, Guri Grimnes 1,2, Yngve Figenschau 3, Peter A. Torjesen 4, Bjørg Almås 5 &amp;amp; Rolf Jorde 1,2&lt;/p>
&lt;p>1 Tromsø Endocrine Research Group, Department of Clinical Medicine, University of Tromsø,&lt;/p>
&lt;p>Tromsø&lt;/p>
&lt;p>2 Division of Internal Medicine, University Hospital of North Norway, Tromsø&lt;/p>
&lt;p>3 Institute of Medical Biochemistry, University of Tromsø and Department of Laboratory Medicine, University Hospital of North Norway, Tromsø&lt;/p></description></item><item><title>Parkinson’s Disease and the “Sunshine” Vitamin (vitamin D)</title><link>/posts/parkinsons-disease-and-the-sunshine-vitamin-vitamin-d.html</link><pubDate>Thu, 26 Dec 2013 00:00:00 +0000</pubDate><guid>/posts/parkinsons-disease-and-the-sunshine-vitamin-vitamin-d.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>&lt;a href="#introduction">Introduction&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#biology-of-the-sunshine-vitamin">Biology of the &amp;ldquo;Sunshine&amp;rdquo; Vitamin&lt;/a>
 &lt;ul>
 &lt;li>&lt;a href="#prevalence-of-hypovitaminosis-d">Prevalence of Hypovitaminosis D&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#pd-and-the-sunshine-vitamin-the-relationship">PD and the &amp;ldquo;Sunshine&amp;rdquo; Vitamin: The Relationship&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#pd-and-vitamin-d-biological-evidence-for-a-relationship">PD and Vitamin D: Biological Evidence for a Relationship&lt;/a>
 &lt;ul>
 &lt;li>&lt;a href="#vitamin-d-inducible-nitric-oxide-synthase--peroxynitrite--and-glutathione">Vitamin D, Inducible Nitric Oxide Synthase, &lt;strong>peroxynitrite&lt;/strong> and Glutathione&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-the-vitamin-d-receptor-and-glial-derived-neurotrophic-factor">Vitamin D, the Vitamin D Receptor, and Glial-Derived Neurotrophic Factor&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-and-the-nurrl-gene">Vitamin D and the Nurrl Gene&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;li>&lt;a href="#pd-and-vitamin-d-evidence-against-a-relationship-less-pd-with-darker-skin">PD and Vitamin D: Evidence Against a Relationship (less PD with darker skin)&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#discussion">Discussion&lt;/a>
 &lt;ul>
 &lt;li>&lt;a href="#meta-analysis">Meta-analysis&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;li>&lt;a href="#vitamin-d-and-pd-biological-evidence-for-and-against">Vitamin D and PD: Biological Evidence for and Against&lt;/a>
 &lt;ul>
 &lt;li>&lt;a href="#clinical-trials">Clinical Trials&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;li>&lt;a href="#conclusions">Conclusions&lt;/a>
 &lt;ul>
 &lt;li>&lt;a href="#epidemiological-studies-present">Epidemiological Studies Present&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#proposed-novel-experimental-paradigms">Proposed Novel Experimental Paradigms&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#clinical-trials-1">Clinical Trials&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;li>&lt;a href="#references">References&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h1 id="parkinsons-disease-and-the-sunshine-vitamin---july-2013">Parkinson’s Disease and the “Sunshine” Vitamin - July 2013&lt;/h1>
&lt;p>Alzheimers Dis Parkinsonism 3:120. &lt;a href="https://doi.org/10.4172/2161-0460.1000120">doi: 10.4172/2161-0460.1000120&lt;/a>&lt;/p></description></item><item><title>Variety of non-skeletal vitamin D studies in special issue of Nutrients</title><link>/posts/variety-of-non-skeletal-vitamin-d-studies-in-special-issue-of-nutrients.html</link><pubDate>Thu, 26 Dec 2013 00:00:00 +0000</pubDate><guid>/posts/variety-of-non-skeletal-vitamin-d-studies-in-special-issue-of-nutrients.html</guid><description>&lt;h2 id="vitamin-d-and-human-health-celebrating-diversity">Vitamin D and Human Health: Celebrating Diversity&lt;/h2>
&lt;p>Nutrients 2014, 6, 11-14; doi:10.3390/nu6010011&lt;/p>
&lt;p>Simon Spedding &lt;strong>Editorial&lt;/strong>&lt;/p>
&lt;p>Nutritional Physiology Research Centre, University of South Australia, Adelaide,&lt;/p>
&lt;p>South Australia 5000, Australia; E-Mail: &lt;a href="mailto:spedding@adam.com.au">spedding@adam.com.au&lt;/a>; Tel.: +61-439-687-886&lt;/p>
&lt;p>Received: 17 December 2013 /Accepted: 17 December 2013 /Published: 19 December 2013&lt;/p>
&lt;p>This Special Issue of Nutrients: Vitamin D and Human Health celebrates diversity in vitamin D research with articles from bench-to-bedside, examining mechanisms, epidemiology, and clinical issues in the management of non-skeletal disease following themes set by an earlier review in Nutrients &lt;sup>[1]&lt;/sup>. Vitamin D became synonymous with calcium and bone metabolism originating from Casimir Funk&amp;rsquo;s concept of &amp;ldquo;Vitamines&amp;rdquo;. This suggests that vitamin D is an amine found in food with a single mode of action affecting calcium and bone metabolism &lt;sup>[2]&lt;/sup>, whereas vitamin D is a secosteroid hormone derived from sunshine with a plethora of physiological functions (autocrine, paracrine, endocrine &lt;sup>[3]&lt;/sup>, and epigenetic &lt;sup>[4]&lt;/sup>) associating vitamin D deficiency with many illnesses &lt;sup>[1]&lt;/sup>. Deficiency is pandemic and most prevalent where sun exposure is limited by culture climate and skin colour &lt;sup>[5]&lt;/sup>. Whilst reports have focused on diet and bone metabolism &lt;sup>[6]&lt;/sup>, this Special Issue of Nutrients about Vitamin D and Human Health focuses on non-skeletal disease, and research driven by industry and community health concerns.&lt;/p></description></item><item><title>Vitamin D update for Nurse Practitioners</title><link>/posts/vitamin-d-update-for-nurse-practitioners.html</link><pubDate>Sun, 22 Dec 2013 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-update-for-nurse-practitioners.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>&lt;a href="#an-update-on-vitamin-d-the-role-in-chronic-disease-clinical-practice-implications-and-the-current-status-of-nurse-practitioner-knowledge">An Update on Vitamin D: The Role in Chronic Disease, Clinical Practice Implications, and the Current Status of Nurse Practitioner Knowledge&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#table-of-contents">Table of Contents&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#list-of-tables">List of Tables&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#introduction-to-the-final-dnp-capstone-report-sara-robertson-university-of-kentucky">Introduction to the Final DNP Capstone Report Sara Robertson University of Kentucky&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#the-association-between-vitamin-d-deficiency-and-type-2-diabetes-mellitus-a-systematic-review">The Association between Vitamin D Deficiency and Type 2 Diabetes Mellitus: A Systematic Review&lt;/a>
 &lt;ul>
 &lt;li>&lt;a href="#background">Background&lt;/a>
 &lt;ul>
 &lt;li>&lt;a href="#methods">Methods&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#inclusionexclusion-criteria">Inclusion/Exclusion Criteria&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#results">Results&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;li>&lt;a href="#optimal-intake-of-vitamin-d-in-relation-to-type-2-diabetes">Optimal Intake of Vitamin D in Relation to Type 2 Diabetes&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#gaps-and-future-research">Gaps and Future Research&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#conclusion">Conclusion&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#references">References&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;li>&lt;a href="#update-on-vitamin-d-deficiency-clearing-up-the-confusion-for-nurse-practitioners-sara-e-robertson-university-of-kentucky">Update on Vitamin D Deficiency: Clearing Up the Confusion for Nurse Practitioners Sara E. Robertson University of Kentucky&lt;/a>
 &lt;ul>
 &lt;li>&lt;a href="#abstract">Abstract&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#what-is-vitamin-d">What is Vitamin D?&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#what-is-vitamin-d-deficiency">What is Vitamin D Deficiency?&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#what-about-vitamin-d-and-other-diseases-besides-bone-health">What About Vitamin D and Other Diseases Besides Bone Health?&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#what-are-the-risk-factors-for-vitamin-d-deficiency">What Are the Risk Factors for Vitamin D Deficiency?&lt;/a>
 &lt;ul>
 &lt;li>&lt;a href="#nutrition">Nutrition&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#uv-light-exposure">UV Light Exposure&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#use-of-sunscreen">Use of Sunscreen&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#genetics">Genetics&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#obesity">Obesity&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;li>&lt;a href="#what-is-the-epidemiology-of-vitamin-d-deficiency">What is the Epidemiology of Vitamin D Deficiency?&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#what-is-the-current-dietary-allowance-of-vitamin-d">What is the Current Dietary Allowance of Vitamin D?&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#who-should-be-screened-for-vitamin-d-deficiency">Who Should be Screened for Vitamin D Deficiency?&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#what-is-the-best-way-to-treat-vitamin-d-deficiency">What is the Best Way to Treat Vitamin D Deficiency?&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#conclusion-1">Conclusion&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#references-1">References&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;li>&lt;a href="#vitamin-d-knowledge-among-nurse-practitioners-sara-e-robertson-university-of-kentucky">Vitamin D Knowledge among Nurse Practitioners Sara E. Robertson University of Kentucky&lt;/a>
 &lt;ul>
 &lt;li>&lt;a href="#background-1">Background&lt;/a>
 &lt;ul>
 &lt;li>&lt;a href="#purpose">Purpose&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#instrument">Instrument&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#human-subjects-and-research-approval-procedures">Human Subjects and Research Approval Procedures&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#data-analysis">Data Analysis&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#results-1">Results&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#discussion">Discussion&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#limitations">Limitations&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#implications-for-practice">Implications for Practice&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#references-2">References&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#table-3---demographics-of-the-study-sample-n100-characteristic_n_">Table 3 Demographics of the study sample (N=100) Characteristic_N_%&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#table-5-knowledge-score-components_">Table 5 Knowledge score components_&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#table-6-knowledge-score-components-eliminated-from-final-instrument">Table 6 Knowledge score components eliminated from final Instrument&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#table-7-treatment-preference-for-vitamin-d-deficiency">Table 7 Treatment preference for vitamin D deficiency&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;li>&lt;a href="#bibliography">Bibliography&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;p>Sara E. Robertson, University of Kentucky Follow&lt;/p></description></item><item><title>Handbook of Vitamin D – 700 pages – 2013</title><link>/posts/handbook-of-vitamin-d-700-pages-2013.html</link><pubDate>Fri, 20 Dec 2013 00:00:00 +0000</pubDate><guid>/posts/handbook-of-vitamin-d-700-pages-2013.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#handbook-of-vitamin-d-in-human-health-vitamin-d-in-human-health-prevention-treatment-and-toxicity">Handbook of vitamin D in human health: vitamin D in human health, Prevention, treatment and toxicity&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#see-also-vitamindwiki">See also VitaminDWiki&lt;/a>
 &lt;ul>
 &lt;li>&lt;a href="#overview-of-key-vitamin-d-modified-conditions">Overview of key vitamin D modified conditions&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-and-musculoskeletal-health">Vitamin D and musculoskeletal health&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-and-chronic-disease">Vitamin D and chronic disease&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-and-infectious-disease">Vitamin D and infectious disease&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-and-cancer">Vitamin D and cancer&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#women-and-children">Women and children&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#index">Index&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;h3 id="handbook-of-vitamin-d-in-human-health-vitamin-d-in-human-health-prevention-treatment-and-toxicity">Handbook of vitamin D in human health: vitamin D in human health, Prevention, treatment and toxicity&lt;/h3>
&lt;p>Edited by: Ronald Ross Watson&lt;/p></description></item><item><title>Being on “the pill” increases low vitamin D levels by about 20 percent</title><link>/posts/being-on-the-pill-increases-low-vitamin-d-levels-by-about-20-percent.html</link><pubDate>Thu, 19 Dec 2013 00:00:00 +0000</pubDate><guid>/posts/being-on-the-pill-increases-low-vitamin-d-levels-by-about-20-percent.html</guid><description>&lt;h3 id="increased-plasma-concentrations-of-vitamin-d-metabolites-and-vitamin-d-binding-protein-in-women-using-hormonal-contraceptives-a-cross-sectional-study">Increased Plasma Concentrations of Vitamin D Metabolites and Vitamin D Binding Protein in Women Using Hormonal Contraceptives: A Cross-Sectional Study&lt;/h3>
&lt;p>Nutrients 2013, 5(9), 3470-3480; doi:10.3390/nu5093470&lt;/p>
&lt;p>Ulla K. Møller 1, &lt;a href="mailto:kristine.moller@ki.au.dk">kristine.moller@ki.au.dk&lt;/a>, Susanna við Streym 1, Lars T. Jensen 2, Leif Mosekilde 1, Inez Schoenmakers 3, Shailja Nigdikar 3 and Lars Rejnmark 1&lt;/p>
&lt;p>1 Department of Endocrinology and Internal Medicine, THG, Aarhus University Hospital, Tage Hansens Gade&lt;/p>
&lt;p>2, DK, Aarhus 8000, Denmark 2 Department of Clinical Physiology, Glostrup University Hospital, Copenhagen DK-2900, Denmark&lt;/p></description></item><item><title>Great Vitamin D webinar for doctors - Plotnikoff</title><link>/posts/great-vitamin-d-webinar-for-doctors-plotnikoff.html</link><pubDate>Sun, 24 Nov 2013 00:00:00 +0000</pubDate><guid>/posts/great-vitamin-d-webinar-for-doctors-plotnikoff.html</guid><description>&lt;h4 id="update---new-webinar-vitamin-d-webinar---plotnikoff---feb-29-2016postsvitamin-d-webinar-plotnikoff">Update - new webinar &lt;a href="/posts/vitamin-d-webinar-plotnikoff">Vitamin D Webinar - Plotnikoff - Feb 29 2016&lt;/a>&lt;/h4>
&lt;h3 id="the-shocking-truth-about-vitamin-d-status">The Shocking Truth About Vitamin D Status&lt;/h3>
&lt;p>Some notes of excellent 90 minute Vitamin D webinar for doctors with CME credit&lt;/p>
&lt;p>Webinar by Dr. Greg Plotnikoff, &lt;a href="/posts/vitamin-d-webinars-by-diasorin-2013-2014">Vitamin D Webinars by DiaSorin 2013-2014&lt;/a>&lt;/p>
&lt;ul>
&lt;li>
&lt;p>Vitamin D is a Nature Deficient Disorder&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Safe sunning, no burning&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Rickets making a comeback – Plotnikoff asked viewer to guess which year&lt;/p>
&lt;/li>
&lt;li>
&lt;p>IoM in 2010 lowered 30ng ==&amp;gt; 20 ng, but tripled recommend amount for elderly&lt;/p></description></item><item><title>5X less risk of Kidney cancer if good ratio of Vitamin D binding protein to circulating vitamin D</title><link>/posts/5x-less-risk-of-kidney-cancer-if-good-ratio-of-vitamin-d-binding-protein-to-circulating-vitamin-d.html</link><pubDate>Mon, 11 Nov 2013 00:00:00 +0000</pubDate><guid>/posts/5x-less-risk-of-kidney-cancer-if-good-ratio-of-vitamin-d-binding-protein-to-circulating-vitamin-d.html</guid><description>&lt;h3 id="vitamin-d-binding-protein-circulating-vitamin-d-and-risk-of-renal-cell-carcinoma">Vitamin D binding protein, circulating vitamin D, and risk of renal cell carcinoma&lt;/h3>
&lt;p>International Journal of Cancer, DOI: 10.1002/ijc.28596&lt;/p>
&lt;p>Alison M. Mondul 1, &lt;a href="mailto:mondulam@mail.nih.gov">mondulam@mail.nih.gov&lt;/a>&lt;/p>
&lt;p>Stephanie J. Weinstein 1,&lt;/p>
&lt;p>Kristin A. Moy 1,&lt;/p>
&lt;p>Satu Männistö 2,&lt;/p>
&lt;p>Demetrius Albanes 1&lt;/p>
&lt;p>1 Nutritional Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Rockville, MD&lt;/p>
&lt;p>2 Department of Chronic Disease Prevention, National Institute for Health and Welfare, Helsinki, Finland&lt;/p>
&lt;p>Cell culture experiments suggest that vitamin D may inhibit renal carcinogenesis, but human studies of circulating 25-hydroxyvitamin D (25(OH)D), the accepted measure of vitamin D status, and kidney cancer have been null. Limited research has examined the role of circulating vitamin D binding protein (DBP) in the association between 25(OH)D and disease risk, and it is unclear whether free 25(OH)D in circulation is a better measure of effective exposure, or if DBP may independently impact outcomes.&lt;/p></description></item><item><title>Vitamin D test statistics: recent increase, esp. middle age, most under 30ng</title><link>/posts/vitamin-d-test-statistics-recent-increase-esp-middle-age-most-under-30ng.html</link><pubDate>Wed, 06 Nov 2013 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-test-statistics-recent-increase-esp-middle-age-most-under-30ng.html</guid><description>&lt;h4 id="analysis-of-vitamin-d-status-at-two-academic-medical-centers-and-a-national-reference-laboratory">Analysis of vitamin D status at two academic medical centers and a national reference laboratory:&lt;/h4>
&lt;p>Result patterns vary by age, gender, season, and patient location&lt;/p>
&lt;p>BMC Endocrine Disorders 2013, 13:52 doi:10.1186/1472-6823-13-52&lt;/p>
&lt;p>Jonathan R Genzen (&lt;a href="mailto:jonathan.genzen@path.utah.edu">jonathan.genzen@path.utah.edu&lt;/a>) Jennifer T Gosselin (&lt;a href="mailto:gosselinj@sacredheart.edu">gosselinj@sacredheart.edu&lt;/a>) Thomas C Wilson (&lt;a href="mailto:thomas-wilson@uiowa.edu">thomas-wilson@uiowa.edu&lt;/a>) Emilian Racila (&lt;a href="mailto:emil-racila@uiowa.edu">emil-racila@uiowa.edu&lt;/a>)&lt;/p>
&lt;p>Matthew D Krasowski (&lt;a href="mailto:matthew-krasowski@uiowa.edu">matthew-krasowski@uiowa.edu&lt;/a>)&lt;/p>
&lt;p>1 Department of Pathology, University of Utah; ARUP Laboratories / ARUP Institute for Clinical and Experimental Pathology, Salt Lake City, UT, USA&lt;/p></description></item><item><title>60,000 IU vitamin D weekly with daily Calcium was safe but not enough in the winter – 2012</title><link>/posts/60000-iu-vitamin-d-weekly-with-daily-calcium-was-safe-but-not-enough-in-the-winter-2012.html</link><pubDate>Sat, 02 Nov 2013 00:00:00 +0000</pubDate><guid>/posts/60000-iu-vitamin-d-weekly-with-daily-calcium-was-safe-but-not-enough-in-the-winter-2012.html</guid><description>&lt;p>&lt;strong>Efficacy and Safety of Cholecalciferol Supplementation in Vitamin D Deficient Subjects Based on Endocrine Society Clinical Practice Guidelines&lt;/strong>&lt;/p>
&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#introduction">Introduction&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#materials-andmethods">Materials and Methods&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#follow-up-compliance-and-subjectsanalyzed">Follow-up, compliance, and subjects analyzed&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#biochemical-estimations">Biochemical estimations&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#statistical-analysis">Statistical analysis&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#results">Results&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#discussion">Discussion&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#references">References&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;p>Endocrinol Metabol Syndrome 2012, S:4 &lt;a href="http://dx.doi.org/10.4172/2161-1017.S4-004">http://dx.doi.org/10.4172/2161-1017.S4-004&lt;/a>&lt;/p>
&lt;p>Chittari Venkata Harinarayan1*, Leena Appicatlaa2, Bangalore Arunachalam Nalini3 and Shalini Joshi3&lt;/p>
&lt;p>1Chief Consultant Endocrinologist, Fortis Hospitals (opp IIM-B), Bannerughatta Road, Bangalore - 560 076, India 2Chief Biochemistry Services, Fortis Hospitals (opp IIM-B), Bannerughatta Road, Bangalore - 560 076, India &amp;lsquo;Consultant Internal Medicine, Fortis Hospitals (opp IIM-B), Bannerughatta Road, Bangalore - 560 076, India&lt;/p></description></item><item><title>Inflammation and Vitamin D in Chronic Kidney Disease</title><link>/posts/inflammation-and-vitamin-d-in-chronic-kidney-disease.html</link><pubDate>Sat, 02 Nov 2013 00:00:00 +0000</pubDate><guid>/posts/inflammation-and-vitamin-d-in-chronic-kidney-disease.html</guid><description>&lt;h3 id="infection-inflammation-and-vitamin-d">Infection Inflammation and Vitamin D&lt;/h3>
&lt;p>Clin Microbial 2013, 2:4 &lt;a href="http://dx.doi.org/10.4172/2327-5073.1000116">http://dx.doi.org/10.4172/2327-5073.1000116&lt;/a>&lt;/p>
&lt;p>Yildirim I, Magden K and Hur E &lt;a href="mailto:hurender@hotmail.com">hurender@hotmail.com&lt;/a>&lt;/p>
&lt;p>Bulent Ecevit University Medical School, Division of Nephrology, Department of Internal Medicine, Zonguldak, Turkey&lt;/p>
&lt;p>&lt;strong>&lt;span style="color:#00F;">PDF is attached at the bottom of this page&lt;/span>&lt;/strong>&lt;/p>
&lt;p>&lt;strong>See also &lt;a href="/posts/kidney-inflammation-not-reduced-by-30-ng-vitamin-d-many-health-problems-need-50-ng" style="color: red; text-decoration: underline;" title="This post/category does not exist yet: Kidney Inflammation not reduced by 30 ng Vitamin D (many health problems need 50 ng) – Nov 2022">Kidney Inflammation not reduced by 30 ng Vitamin D (many health problems need 50 ng) – Nov 2022&lt;/a>&lt;/strong>&lt;/p></description></item><item><title>Parkinson's Disease perhaps prevented and treated by Vitamin D</title><link>/posts/parkinsons-disease-perhaps-prevented-and-treated-by-vitamin-d.html</link><pubDate>Sat, 02 Nov 2013 00:00:00 +0000</pubDate><guid>/posts/parkinsons-disease-perhaps-prevented-and-treated-by-vitamin-d.html</guid><description>&lt;h2 id="parkinsons-disease-and-the-sunshine-vitamin">Parkinson&amp;rsquo;s Disease and the &amp;ldquo;Sunshine&amp;rdquo; Vitamin&lt;/h2>
&lt;p>Alzheimers Dis Parkinsonism 2013, 3:2 &lt;a href="http://dx.doi.org/10.4172/2161-0460.1000120">http://dx.doi.org/10.4172/2161-0460.1000120&lt;/a>&lt;/p>
&lt;p>Lucy Elisabeth James1 and Ayodeji A Asuni2 &lt;a href="mailto:a.a.asuni@soton.ac.uk">a.a.asuni@soton.ac.uk&lt;/a>&lt;/p>
&lt;p>1 Biomedical Sciences Undergraduate Program, Centre for Biological Sciences, Institute for Life Sciences, University of Southampton, Southampton, United Kingdom&lt;/p>
&lt;p>2 Centre for Biological Sciences, Institute for Life Sciences, University of Southampton, Southampton, United Kingdom&lt;/p>
&lt;p>Accrued evidence suggesting that hypovitaminosis D acts as a risk factor for developing Parkinson&amp;rsquo;s disease (PD) remains controversial. Herein we evaluated existing results, and outline several biological mechanisms by which the hypovitaminosis D-PD relationship may occur. We performed a meta-analysis, using data obtained from a search of PubMed from July 2002 to July 2012, for studies reporting serum vitamin D levels in PD and control patients.We found that in comparison to healthy individuals, those with PD had lower levels of serum vitamin D. Furthermore, we explore a number of potential associated biological mechanisms, including the actions of reactive nitrogen species (RNS), glutathione (GSH), and glial-derived neurotrophic factor (GDNF) in the brain. We also examine the roles of Nurrl and VDR genes in PD. Although a unifying hypothesis remains challenging, there is evidence to demonstrate that supplementation with the vitamin can to have a positive effect on PD pathobiology. We surmise that hypovitaminosis D does act as a risk factor in the development of PD. However, the need for new epidemiological studies and further research around vitamin D metabolism is highlighted. Urgent efforts to correct vitamin D deficiency through supplementation are warranted as they may improve either motor and/or non-motor symptoms in PD.&lt;/p></description></item><item><title>One test to estimate Vitamin D, A, Cu, Se, etc : measure proteins in blood</title><link>/posts/one-test-to-estimate-vitamin-d-a-cu-se-etc-measure-proteins-in-blood.html</link><pubDate>Fri, 25 Oct 2013 00:00:00 +0000</pubDate><guid>/posts/one-test-to-estimate-vitamin-d-a-cu-se-etc-measure-proteins-in-blood.html</guid><description>&lt;h3 id="the-plasma-proteome-identifies-expected-and-novel-proteins-correlated-with-micronutrient-status-in-undernourished-nepalese-children">The plasma proteome identifies expected and novel proteins correlated with micronutrient status in undernourished nepalese children.&lt;/h3>
&lt;p>J Nutr. 2013 Oct;143(10):1540-8. &lt;a href="https://doi.org/10.3945/jn.113.175018.">doi: 10.3945/jn.113.175018.&lt;/a> Epub 2013 Aug 21.&lt;/p>
&lt;p>Cole RN, Ruczinski I, Schulze K, Christian P, Herbrich S, Wu L, Devine LR, O&amp;rsquo;Meally RN, Shrestha S, Boronina TN, Yager JD, Groopman J, West KP Jr.&lt;/p>
&lt;p>Mass Spectrometry and Proteomics Core Facility.&lt;/p>
&lt;p>Micronutrient deficiencies are common in undernourished societies yet remain inadequately assessed due to the complexity and costs of existing assays. A plasma proteomics-based approach holds promise in quantifying multiple nutrient:protein associations that reflect biological function and nutritional status. To validate this concept, in plasma samples of a cohort of 500 6- to 8-y-old Nepalese children, we estimated cross-sectional correlations between vitamins A (retinol), D (25-hydroxyvitamin D), and E (α-tocopherol), copper, and selenium, measured by conventional assays, and relative abundance of their major plasma-bound proteins, measured by quantitative proteomics using 8-plex iTRAQ mass tags.&lt;/p></description></item><item><title>Endometriosis treated, and perhaps prevented, by vitamin D - many studies</title><link>/posts/endometriosis-treated-and-perhaps-prevented-by-vitamin-d-many-studies.html</link><pubDate>Thu, 17 Oct 2013 00:00:00 +0000</pubDate><guid>/posts/endometriosis-treated-and-perhaps-prevented-by-vitamin-d-many-studies.html</guid><description>&lt;p>&lt;strong>Introduction:&lt;br>
Endometrial tissue inside the uterus expands and then is shed during menstruation.&lt;br>
Sometimes the tissue attaches itself on the outside of the uterus or elsewhere in the body.&lt;br>
It continues to cycle in size with each menstrual cycle.&lt;br>
Normally the autoimmune system destroys these attachments.&lt;br>
There is some effort to call Endo an autoimmune disorder&lt;br>
Note: High-Dose Vitamin D + Magnesium + Omega-3 is claimed to &lt;a href="/posts/video-by-dr-coimbra-95-percent-of-auto-immune-cured-with-vitamin-d-in-high-doses">treat 95% of all autoimmune disorders&lt;/a>.&lt;/strong>&lt;/p></description></item><item><title>1 month after plasma exchange vitamin D levels reduced by 40 percent</title><link>/posts/1-month-after-plasma-exchange-vitamin-d-levels-reduced-by-40-percent.html</link><pubDate>Wed, 16 Oct 2013 00:00:00 +0000</pubDate><guid>/posts/1-month-after-plasma-exchange-vitamin-d-levels-reduced-by-40-percent.html</guid><description>&lt;h3 id="plasma-exchange-induces-vitamin-d-deficiency">Plasma Exchange Induces Vitamin D Deficiency&lt;/h3>
&lt;p>QJM (2013) &lt;a href="https://doi.org/10.1093/qjmed/hct208">doi: 10.1093/qjmed/hct208&lt;/a>&lt;/p>
&lt;p>Thomas F Hiemstra 1,2,&lt;/p>
&lt;p>Alina Casian 2,&lt;/p>
&lt;p>Paul Boraks 3,&lt;/p>
&lt;p>David R Jayne 2 and&lt;/p>
&lt;p>Inez Schoenmakers 4&lt;/p>
&lt;p>1 Divisions of Clinical Pharmacology and Nephrology, Department of Medicine, University of Cambridge; 2 Lupus and Vasculitis and 3 Apheresis units, Addenbrooke&amp;rsquo;s Hospital, Cambridge; 4MRC Human Nutrition Research, Elsie Widdowson Laboratory, Cambridge.&lt;/p>
&lt;p>To whom correspondence should be addressed: Thomas F Hiemstra, Divisions of Nephrology and Clinical Pharmacology, Department of Medicine, University of Cambridge, Box 118 Addenbrooke&amp;rsquo;s Hospital, Hills Road, Cambridge, CB2 0QQ, &lt;a href="mailto:tfh24@cam.ac.uk">tfh24@cam.ac.uk&lt;/a>, Phone: +44 1223 349844&lt;/p></description></item><item><title>Hypothesis: Vitamin D Binding Protein limits vitamin D benefits outside of kidney too</title><link>/posts/hypothesis-vitamin-d-binding-protein-limits-vitamin-d-benefits-outside-of-kidney-too.html</link><pubDate>Tue, 08 Oct 2013 00:00:00 +0000</pubDate><guid>/posts/hypothesis-vitamin-d-binding-protein-limits-vitamin-d-benefits-outside-of-kidney-too.html</guid><description>&lt;p>&lt;strong>&lt;span style="color:#00F;">There are several items on this page&lt;/span>&lt;/strong>&lt;/p>
&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#vitamin-d-and-dbp-the-free-hormone-hypothesis-revisited">Vitamin D and DBP: The free hormone hypothesis revisited.&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#variations-in-the-vitamin-d-binding-protein-dbp-gene-are-related-to-lower-25-hydroxyvitamin-d-levels-in-healthy-girls-a-cross-sectional-study">Variations in the vitamin D-binding protein (DBP) gene are related to lower 25-hydroxyvitamin D levels in healthy girls: a cross-sectional study.&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;h4 id="vitamin-d-and-dbp-the-free-hormone-hypothesis-revisited">Vitamin D and DBP: The free hormone hypothesis revisited.&lt;/h4>
&lt;p>J Steroid Biochem Mol Biol. 2013 Oct 3. pii: S0960-0760(13)00186-6. doi:0.1016/j.jsbmb.2013.09.012.&lt;/p>
&lt;p>Chun RF, Peercy BE, Orwoll ES, Nielson CM, Adams JS, Hewison M.&lt;/p>
&lt;p>Orthopaedic Hospital Research Center, University of California Los Angeles, Los Angeles, CA 90095, USA.&lt;/p></description></item><item><title>ICU reduces Vitamin D levels, deregulates PTH</title><link>/posts/icu-reduces-vitamin-d-levels-deregulates-pth.html</link><pubDate>Sat, 28 Sep 2013 00:00:00 +0000</pubDate><guid>/posts/icu-reduces-vitamin-d-levels-deregulates-pth.html</guid><description>&lt;h3 id="changes-in-the-calcium-parathyroid-hormone-vitamin-d-axis-and-prognosis-for-critically-ill-patients-a-prospective-observational-study">Changes in the Calcium-Parathyroid Hormone-Vitamin D Axis and Prognosis for Critically Ill Patients: A Prospective Observational Study&lt;/h3>
&lt;p>PLoS One. 2013 Sep 20;8(9):e75441. &lt;a href="https://doi.org/10.1371/journal.pone.0075441.">doi: 10.1371/journal.pone.0075441.&lt;/a>&lt;/p>
&lt;p>Jieyu Hu equal contributor,&lt;/p>
&lt;p>Zuojie Luo equal contributor mail,&lt;/p>
&lt;p>Xiaoqin Zhao,&lt;/p>
&lt;p>Qiang Chen,&lt;/p>
&lt;p>Zhaoyan Chen,&lt;/p>
&lt;p>Hua Qin,&lt;/p>
&lt;p>Yingfen Qin,&lt;/p>
&lt;p>Xinghuan Liang,&lt;/p>
&lt;p>Yingjun Suo&lt;/p>
&lt;p>Objective: Vitamin D deficiency is prevalent in critically ill patients and may contribute to suboptimal clinical outcomes, but little is known about alterations of the calcium-parathyroid hormone (PTH)-vitamin D axis and prognosis in these individuals.&lt;/p></description></item><item><title>Evidence that vitamin D is also stored in muscle cells</title><link>/posts/evidence-that-vitamin-d-is-also-stored-in-muscle-cells.html</link><pubDate>Wed, 25 Sep 2013 00:00:00 +0000</pubDate><guid>/posts/evidence-that-vitamin-d-is-also-stored-in-muscle-cells.html</guid><description>&lt;h3 id="evidence-for-a-specific-uptake-and-retention-mechanism-for-25-hydroxyvitamin-d-25ohd-in-skeletal-muscle-cells">Evidence for a Specific Uptake and Retention Mechanism for 25-Hydroxyvitamin D (25OHD) in Skeletal Muscle Cells&lt;/h3>
&lt;p>Endocrinology September 1, 2013 vol. 154 no. 9 3022-3030&lt;/p>
&lt;p>M. Abboud*, D. A. Puglisi*, B. N. Davies*, M. Rybchyn, N. P. Whitehead, K. E. Brock, L. Cole, C. Gordon-Thomson, D. R. Fraser and R. S. Mason&lt;/p>
&lt;p>Department of Physiology and Bosch Institute (M.A., D.A.P., B.N.D., M.R., N.P.W., C.G.-T., R.S.M.), Faculty of Medicine, Faculty of Health Sciences (K.E.B.), Bosch Institute (L.C.), and Faculty of Veterinary Science (D.R.F.), University of Sydney, Sydney, New South Wales 2006, Australia&lt;/p></description></item><item><title>If at high risk of vitamin D deficiency, get a higher response if take more Magnesium</title><link>/posts/if-at-high-risk-of-vitamin-d-deficiency-get-a-higher-response-if-take-more-magnesium.html</link><pubDate>Wed, 25 Sep 2013 00:00:00 +0000</pubDate><guid>/posts/if-at-high-risk-of-vitamin-d-deficiency-get-a-higher-response-if-take-more-magnesium.html</guid><description>&lt;h4 id="magnesium-vitamin-d-status-and-mortality">Magnesium, vitamin D status and mortality:&lt;/h4>
&lt;p>results from US National Health and Nutrition Examination Survey (NHANES) 2001 to 2006 and NHANES III&lt;/p>
&lt;p>BMC Medicine 2013, 11:187 &lt;a href="http://www.biomedcentral.eom/1741-7015/11/187">http://www.biomedcentral.eom/1741-7015/11/187&lt;/a>&lt;/p>
&lt;p>Xinqing Deng1, Yiqing Song2, JoAnn E Manson2,3, Lisa B Signorello3, Shumin M Zhang2, Martha J Shrubsole1, Reid M Ness4, Douglas L Seidner4 and Qi Dai1,5&lt;/p>
&lt;p>Background: Magnesium plays an essential role in the synthesis and metabolism of vitamin D and magnesium supplementation substantially reversed the resistance to vitamin D treatment in patients with magnesium-dependent vitamin-D-resistant rickets. We hypothesized that dietary magnesium alone, particularly its interaction with vitamin D intake, contributes to serum 25-hydroxyvitamin D (25(OH)D) levels, and the associations between serum 25(OH)D and risk of mortality may be modified by magnesium intake level.&lt;/p></description></item><item><title>3X more likely to die within 3 months of being in ICU for 2 days if less than 20 ng vitamin D</title><link>/posts/3x-more-likely-to-die-within-3-months-of-being-in-icu-for-2-days-if-less-than-20-ng-vitamin-d.html</link><pubDate>Sat, 21 Sep 2013 00:00:00 +0000</pubDate><guid>/posts/3x-more-likely-to-die-within-3-months-of-being-in-icu-for-2-days-if-less-than-20-ng-vitamin-d.html</guid><description>&lt;h4 id="changes-in-the-calcium-parathyroid-hormone-vitamin-d-axis-and-prognosis-for-critically-ill-patients-a-prospective-observational-study">Changes in the Calcium-Parathyroid Hormone-Vitamin D Axis and Prognosis for Critically Ill Patients: A Prospective Observational Study&lt;/h4>
&lt;p>PLoS ONE 8(9): e75441. doi:10.1371/journal.pone.0075441&lt;/p>
&lt;p>Jieyu Hu equal contributor, Zuojie Luo equal contributor mail, Xiaoqin Zhao, Qiang Chen, Zhaoyan Chen, Hua Qin, Yingfen Qin, Xinghuan Liang, Yingjun Suo&lt;/p>
&lt;p>Objective: Vitamin D deficiency is prevalent in critically ill patients and may contribute to suboptimal clinical outcomes, but little is known about alterations of the calcium-parathyroid hormone (PTH)-vitamin D axis and prognosis in these individuals.&lt;/p></description></item><item><title>Review of Vitamin D (including free, frequency, injection, how much.)</title><link>/posts/review-of-vitamin-d-including-free-frequency-injection-how-much.html</link><pubDate>Fri, 13 Sep 2013 00:00:00 +0000</pubDate><guid>/posts/review-of-vitamin-d-including-free-frequency-injection-how-much.html</guid><description>&lt;div class="border" style="background-color:#FF9;padding:15px;margin:10px 0;border-radius:5px;width:600px">
&lt;ul>
&lt;li>
&lt;p>&lt;a href="/posts/bone-density-correlates-better-with-free-d-calculated-rather-than-measured-vitamin-d">Bone density correlates better with free D (calculated) rather than measured vitamin D – Jan 2014&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/vitamin-d-supplementation-protocols-loading-injection-etc-rct">Vitamin D supplementation protocols: loading, injection, etc – RCT June 2014&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/600000-vitamin-d-loading-doses-good-response-to-both-oral-and-muscular">600,000 vitamin D loading doses – good response to both oral and muscular – Oct 2015&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="https://www.VitaminDWiki.com/Search+Results?hl=en&amp;amp;oe=UTF-8&amp;amp;ie=UTF-8&amp;amp;btnG=Google+Search&amp;amp;googles.x=0&amp;amp;googles.y=0&amp;amp;q=injection&amp;amp;domains=VitaminDWiki.com&amp;amp;sitesearch=VitaminDWiki.com">Search VitaminDWiki for INJECTION&lt;/a> 629 items as of Jan 2015&lt;/p>
&lt;/li>
&lt;/ul>
&lt;p>&lt;strong>&lt;i class="fas fa-file-pdf" style="margin-right: 0.3em;">&lt;/i>&lt;a href="https://d378j1rmrlek7x.cloudfront.net/attachments/pdf/endocine-disease.pdf">Download the PDF from VitaminDWiki.&lt;/a>&lt;/strong>&lt;/p>
&lt;/div>
&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>&lt;a href="#value-and-limitations-of-assessing-vitamin-d-nutritional-status-and-advised-levels-of-vitamin-d-supplementation">Value and limitations of assessing vitamin D nutritional status and advised levels of vitamin D supplementation&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#introduction">Introduction&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#measurement-of-25ohd">Measurement of 25(OH)D&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-binding-protein">Vitamin D binding protein&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-and-the-search-for-a-threshold">Vitamin D and the search for a threshold&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-and-supplementation-general-considerations">Vitamin D and supplementation: general considerations&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-and-the-supplementation-the-discussion">Vitamin D and the supplementation: the discussion&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#achieving-and-maintaining-vitamin-d-sufficiency">Achieving and maintaining vitamin D sufficiency&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-supplementation-which-type">Vitamin D supplementation: which type?&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-supplementation-im-or-oral-route-of-administration">Vitamin D supplementation: i.m. or oral route of administration?&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-supplementation-and-safety">Vitamin D supplementation and safety&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-supplementation-and-the-real-world">Vitamin D supplementation and the real world&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#conclusions-and-perspectives">Conclusions and perspectives&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#references">References&lt;/a>&lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;h2 id="value-and-limitations-of-assessing-vitamin-d-nutritional-status-and-advised-levels-of-vitamin-d-supplementation">Value and limitations of assessing vitamin D nutritional status and advised levels of vitamin D supplementation&lt;/h2>
&lt;p>European Journal of Endocrinology (2013) 169 R59-R69&lt;/p></description></item><item><title>Huntington disease patients also have low levels of vitamin D</title><link>/posts/huntington-disease-patients-also-have-low-levels-of-vitamin-d.html</link><pubDate>Wed, 04 Sep 2013 00:00:00 +0000</pubDate><guid>/posts/huntington-disease-patients-also-have-low-levels-of-vitamin-d.html</guid><description>&lt;h3 id="high-prevalence-of-vitamin-d-deficiency-and-insufficiency-in-patients-with-manifest-huntington-disease-an-explorative-study">High prevalence of vitamin D deficiency and insufficiency in patients with manifest Huntington disease: An explorative study&lt;/h3>
&lt;p>Dermato-Endocrinology 5:3, ; July 1, 2013; © 2013 Landes Bioscience.&lt;/p>
&lt;p>Victor GM Chel, 1, 2, * Marcel E Ooms, 2 Jessie van der Bent, 1 Fleur Veldkamp, 1 Raymund AC Roos, 3 Wilco P Achterberg, 1, 4 Paul Lips 5&lt;/p>
&lt;p>Vitamin D deficiency and insufficiency are common in older institutionalized people and known to be associated with muscle weakness, impaired balance and increased fall risk. Falls and balance problems are common in people with Huntington disease (HD). Despite this, the prevalence of vitamin D deficiency in patients with manifest HD has never been investigated.&lt;/p></description></item><item><title>Magnesium and Vitamin D very synergistic</title><link>/posts/magnesium-and-vitamin-d-very-synergistic.html</link><pubDate>Tue, 27 Aug 2013 00:00:00 +0000</pubDate><guid>/posts/magnesium-and-vitamin-d-very-synergistic.html</guid><description>&lt;h4 id="magnesium-vitamin-d-status-and-mortality-results-from-us-national-health-and-nutrition-examination-survey-nhanes-2001-to-2006-and-nhanes-iii">Magnesium, vitamin D status and mortality: results from US National Health and Nutrition Examination Survey (NHANES) 2001 to 2006 and NHANES III&lt;/h4>
&lt;p>BMC Medicine 2013,11:187 doi:10.1186/1741-7015-11-187&lt;/p>
&lt;p>Xinqing Deng (&lt;a href="mailto:xinqing.deng@vanderbilt.edu">xinqing.deng@vanderbilt.edu&lt;/a>) Yiqing Song (&lt;a href="mailto:ysong3@rics.bwh.harvard.edu">ysong3@rics.bwh.harvard.edu&lt;/a>) JoAnn E Manson (&lt;a href="mailto:jmanson@rics.bwh.harvard.edu">jmanson@rics.bwh.harvard.edu&lt;/a>) Lisa B Signorello (&lt;a href="mailto:signorello@hsph.harvard.edu">signorello@hsph.harvard.edu&lt;/a>) Shumin M Zhang (&lt;a href="mailto:szhang@rics.bwh.harvard.edu">szhang@rics.bwh.harvard.edu&lt;/a>) Martha J Shrubsole (&lt;a href="mailto:martha.shrubsole@vanderbilt.edu">martha.shrubsole@vanderbilt.edu&lt;/a>) Reid M Ness (&lt;a href="mailto:reid.ness@vanderbilt.edu">reid.ness@vanderbilt.edu&lt;/a>) Douglas L Seidner (&lt;a href="mailto:douglas.seidner@vanderbilt.edu">douglas.seidner@vanderbilt.edu&lt;/a>) Qi Dai (&lt;a href="mailto:qi.dai@vanderbilt.edu">qi.dai@vanderbilt.edu&lt;/a>)&lt;/p>
&lt;div class="border" style="background-color:#FF9;padding:15px;margin:10px 0;border-radius:5px;width:700px">
&lt;ul>
&lt;li>
&lt;p>&lt;a href="/posts/overview-magnesium-and-vitamin-d" style="color: red; text-decoration: underline;" title="This post/category does not exist yet: Overview Magnesium and vitamin D">Overview Magnesium and vitamin D&lt;/a>&lt;/p></description></item><item><title>Response to vitamin D related to DBP and CYP2RI genes</title><link>/posts/response-to-vitamin-d-related-to-dbp-and-cyp2ri-genes.html</link><pubDate>Sat, 10 Aug 2013 00:00:00 +0000</pubDate><guid>/posts/response-to-vitamin-d-related-to-dbp-and-cyp2ri-genes.html</guid><description>&lt;h3 id="the-serum-25-hydroxyvitamin-d-response-to-vitamin-d-supplementation-is-related-to-genetic-factors-body-mass-index-and-baseline-levels">The serum 25-hydroxyvitamin D response to vitamin D supplementation is related to genetic factors, body mass index and baseline levels&lt;/h3>
&lt;p>Eur J Endocrinol August 9, 2013 EJE-13-0233&lt;/p>
&lt;p>Allan Didriksen &lt;a href="mailto:allan.didriksen@unn.no">allan.didriksen@unn.no&lt;/a>.&lt;/p>
&lt;p>Guri Grimnes,&lt;/p>
&lt;p>Moira Strand Hutchinson,&lt;/p>
&lt;p>Marie Kjærgaard,&lt;/p>
&lt;p>Johan Svartberg,&lt;/p>
&lt;p>Ragnar Martin Joakimsen and&lt;/p>
&lt;p>Rolf Jorde&lt;/p>
&lt;p>A Didriksen, Insitute of Clinical Medicine, University of Tromsø, Tromsø, Norway&lt;/p>
&lt;p>G Grimnes, Division of Internal Medicine, University Hospital of North Norway, Tromsø, Norway&lt;/p>
&lt;p>M Hutchinson, Insitute of Clinical Medicine, University of Tromsø, Tromsø, Norway&lt;/p></description></item><item><title>Migraine more common with high vitamin D, perhaps because of low Magnesium</title><link>/posts/migraine-more-common-with-high-vitamin-d-perhaps-because-of-low-magnesium.html</link><pubDate>Sun, 04 Aug 2013 00:00:00 +0000</pubDate><guid>/posts/migraine-more-common-with-high-vitamin-d-perhaps-because-of-low-magnesium.html</guid><description>&lt;h2 id="the-relationship-between-serum-levels-of-vitamin-d-and-migraine">The relationship between serum levels of vitamin D and migraine&lt;/h2>
&lt;p>Journal of Research in Medical Sciences, Supplement 1 March 2013&lt;/p>
&lt;p>Tayebeh Mottaghi 1, Fariborz Khorvash 2, Gholamreza Askari 3 Askari@ mui.ac.ir, Mohammad Reza Maracy 4, Reza Ghiasvand 1,3, Zahra Maghsoudi 1, Bijan Iraj 5&lt;/p>
&lt;p>1Food Security Research Center, Isfahan University of Medical Sciences, 2Neurology Research Center, School of Medicine, Isfahan University of Medical Sciences, 3Department of Community Nutrition, School of Nutrition and Food Sciences, Isfahan University of Medical Sciences, &amp;ldquo;Department of Epidemiology and Biostatistics, School of Health, Isfahan University of Medical Sciences, 5Isfahan Endocrine and Metabolism Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.&lt;/p></description></item><item><title>50,000 IU vitamin D 1-3 times per week helped obese patients in rehab.</title><link>/posts/50000-iu-vitamin-d-1-3-times-per-week-helped-obese-patients-in-rehab.html</link><pubDate>Wed, 31 Jul 2013 00:00:00 +0000</pubDate><guid>/posts/50000-iu-vitamin-d-1-3-times-per-week-helped-obese-patients-in-rehab.html</guid><description>&lt;h3 id="improving-protein-and-vitamin-d-status-of-obese-patients-participating-in-physical-rehabilitation">Improving protein and vitamin D status of obese patients participating in physical rehabilitation.&lt;/h3>
&lt;p>Baer JT.&lt;/p>
&lt;p>Rehabil Nurs. 2013 May-Jun;38(3):115-9. &lt;a href="https://doi.org/10.1002/rnj.100.">doi: 10.1002/rnj.100.&lt;/a>&lt;/p>
&lt;p>College of Nursing, University of Cincinnati, OH, USA. &lt;a href="mailto:jbear7777@gmail.com">jbear7777@gmail.com&lt;/a>&lt;/p>
&lt;p>PURPOSE: Sarcopenia and vitamin D deficiency increase risk of disability outcomes associated with a million hip and knee replacements annually.&lt;/p>
&lt;p>The purpose of the present study was to identify protein and vitamin D inadequacy in arthroplasty patients, and observe the effect of supplementation on metabolic markers on protein and vitamin D status.&lt;/p></description></item><item><title>Global Map of vitamin D deficiency</title><link>/posts/global-map-of-vitamin-d-deficiency.html</link><pubDate>Thu, 25 Jul 2013 00:00:00 +0000</pubDate><guid>/posts/global-map-of-vitamin-d-deficiency.html</guid><description>&lt;h2 id="a-global-representation-of-vitamin-d-status-in-healthy-populations">A global representation of vitamin D status in healthy populations.&lt;/h2>
&lt;p>Arch Osteoporos. 2012 Dec;7(1-2):155-72. &lt;a href="https://doi.org/10.1007/s11657-012-0093-0.">doi: 10.1007/s11657-012-0093-0.&lt;/a> Epub 2012 Aug 29.&lt;/p>
&lt;p>D. A. Wahl (2); C. Cooper (3); P. R. Ebeling (4); M. Eggersdorfer (5); J. Hilger (6); K. Hoffmann (6)&lt;/p>
&lt;p>R. Josse (7); J. A. Kanis (9); A. Mithal (8); D. D. Pierroz (2); J. Stenmark (2); E. Stöcklin (5); B. Dawson-Hughes &lt;a href="mailto:bess.dawson-hughes@tufts.edu">bess.dawson-hughes@tufts.edu&lt;/a> (1)&lt;/p>
&lt;ol>
&lt;li>
&lt;p>U.S. Department of Agriculture Human Nutrition Research Center on Aging, Tufts University, 711 Washington Street, Boston, MA, 02111, USA&lt;/p></description></item><item><title>Fatty liver disease (NAFLD) and the importance of vitamin D</title><link>/posts/fatty-liver-disease-nafld-and-the-importance-of-vitamin-d.html</link><pubDate>Wed, 24 Jul 2013 00:00:00 +0000</pubDate><guid>/posts/fatty-liver-disease-nafld-and-the-importance-of-vitamin-d.html</guid><description>&lt;h1 class="svTitle">
&lt;p>&lt;span style="font-size:18px;">&lt;em>D-livering&lt;/em> the message: The importance of vitamin D status in chronic liver disease&lt;/span>&lt;/h1>&lt;/p>
&lt;div class="sponsored">
&lt;div class="publicationHead">
&lt;div class="title">
&lt;p>&lt;a class="cLink" href="http://www.sciencedirect.com/science/journal/01688278" title="Go to Journal of Hepatology on SciVerse ScienceDirect">&lt;span>Journal of Hepatology;&lt;/span>&lt;/a>&lt;a href="http://www.sciencedirect.com/science/journal/01688278/57/4" title="Go to table of contents for this volume/issue">Volume 57, Issue 4&lt;/a>, October 2012, Pages 897–909&lt;/div>&lt;/p>
&lt;/div>
&lt;p>&lt;span class="refText" title="Sponsored free access to all users">Universally Available &lt;/span>&lt;/div>&lt;/p>
&lt;ul class="authorGroup noCollab">&lt;li>
&lt;p>&lt;a class="authorName" href="http://www.sciencedirect.com/science/article/pii/S0168827812003601#" id="authname_N2c43e728N3a17d138">Matthew T. Kitson&lt;/a>,&lt;/li>&lt;/p>
&lt;li>
&lt;p>&lt;a class="authorName" href="http://www.sciencedirect.com/science/article/pii/S0168827812003601#" id="authname_N2c43e728N3a17d1c8">Stuart K. Roberts&lt;/a>&lt;a class="intra_ref auth_corr" href="http://www.sciencedirect.com/science/article/pii/S0168827812003601#cor1" id="bcor1" title="Corresponding author contact information">&lt;img alt="Corresponding author contact information" class="imgLazyJSB" src="http://cdn.els-cdn.com/sd/entities/REcor.gif" />&lt;/a>&lt;sup>, &lt;/sup>&lt;a href="mailto:S.Roberts@alfred.org.au">S.Roberts@alfred.org.au&lt;/a>&lt;/li>&lt;/p>
&lt;/ul>&lt;ul class="affiliation">&lt;li>
&lt;p>&lt;span>Department of Gastroenterology, The Alfred, Melbourne, Australia&lt;/span>&lt;/li>&lt;/p></description></item><item><title>Tuberculosis, UV and perhaps vitamin D</title><link>/posts/tuberculosis-uv-and-perhaps-vitamin-d.html</link><pubDate>Mon, 22 Jul 2013 00:00:00 +0000</pubDate><guid>/posts/tuberculosis-uv-and-perhaps-vitamin-d.html</guid><description>&lt;h1 class="svTitle">
&lt;p>&lt;span style="font-size:22px;">Vitamin D and solar ultraviolet radiation in the risk and treatment of tuberculosis&lt;/span>&lt;/h1>&lt;/p>
&lt;div class="publicationHead titleBanner">
&lt;div class="cover">
&lt;div class="title">
&lt;p>&lt;a class="cLink" href="http://www.sciencedirect.com/science/journal/14733099" title="Go to The Lancet Infectious Diseases on SciVerse ScienceDirect">&lt;img alt="The Lancet Infectious Diseases" class="imgLazyJSB" height="25" src="http://ars.els-cdn.com/content/image/B14733099.gif" width="310" />&lt;/a>&lt;a href="http://www.sciencedirect.com/science/journal/14733099/13/1" title="Go to table of contents for this volume/issue">Volume 13, Issue 1&lt;/a>, January 2013, Pages 77–88&lt;/div>&lt;/p>
&lt;/div>
&lt;/div>
&lt;ul class="authorGroup noCollab">&lt;li>
&lt;p>&lt;span class="authorDegrees">Dr &lt;/span>&lt;a class="authorName" href="http://www.sciencedirect.com/science/article/pii/S147330991270275X#" id="authname_N5d0e3940N5d020df8">Anna P Ralph&lt;/a>, &lt;span class="authorDegrees">PhD&lt;/span>&lt;a class="intra_ref auth_aff" href="http://www.sciencedirect.com/science/article/pii/S147330991270275X#aff1" id="baff1" title="Affiliation: a">&lt;sup>a&lt;/sup>&lt;/a>&lt;sup>, &lt;/sup>&lt;a class="intra_ref auth_aff" href="http://www.sciencedirect.com/science/article/pii/S147330991270275X#aff2" id="baff2" title="Affiliation: b">&lt;sup>b&lt;/sup>&lt;/a>&lt;sup>, &lt;/sup>&lt;a class="intra_ref auth_aff" href="http://www.sciencedirect.com/science/article/pii/S147330991270275X#aff3" id="baff3" title="Affiliation: c">&lt;sup>c&lt;/sup>&lt;/a>&lt;sup>, &lt;/sup>&lt;a class="intra_ref auth_corr" href="http://www.sciencedirect.com/science/article/pii/S147330991270275X#cor1" id="bcor1" title="Corresponding author contact information">&lt;img alt="Corresponding author contact information" class="imgLazyJSB" src="http://cdn.els-cdn.com/sd/entities/REcor.gif" />&lt;/a>&lt;sup>, &lt;/sup>&lt;a href="mailto:anna.ralph@menzies.edu.au">anna.ralph@menzies.edu.au&lt;/a>&lt;/li>&lt;/p>
&lt;li>
&lt;p>&lt;a class="authorName" href="http://www.sciencedirect.com/science/article/pii/S147330991270275X#" id="authname_N5d0e3940N5d020ee8">Robyn M Lucas&lt;/a>, &lt;span class="authorDegrees">PhD&lt;/span>&lt;a class="intra_ref auth_aff" href="http://www.sciencedirect.com/science/article/pii/S147330991270275X#aff4" id="baff4" title="Affiliation: d">&lt;sup>d&lt;/sup>&lt;/a>,&lt;/li>&lt;/p></description></item><item><title>Rickets in Mongolia</title><link>/posts/rickets-in-mongolia.html</link><pubDate>Sun, 21 Jul 2013 00:00:00 +0000</pubDate><guid>/posts/rickets-in-mongolia.html</guid><description>&lt;h1 class="svTitle">
&lt;p>&lt;span style="font-size:18px;">Prevalence of classic signs and symptoms of rickets and vitamin D deficiency in Mongolian children and women&lt;/span>&lt;/h1>&lt;/p>
&lt;ul class="authorGroup noCollab">&lt;li>
&lt;p>&lt;a class="authorName" href="http://www.sciencedirect.com/science/article/pii/S0960076012002154#" id="authname_N301d7e20N3024a390">Tserendolgor Uush&lt;/a>&lt;a class="intra_ref auth_corr" href="http://www.sciencedirect.com/science/article/pii/S0960076012002154#cor0005" id="bcor0005" title="Corresponding author contact information">&lt;img alt="Corresponding author contact information" class="imgLazyJSB" src="http://cdn.els-cdn.com/sd/entities/REcor.gif" />&lt;/a>&lt;sup>, &lt;/sup>&lt;a href="mailto:utserendolgor@yahoo.com">&lt;img alt="E-mail the corresponding author" class="imgLazyJSB" src="http://cdn.els-cdn.com/sd/entities/REemail.gif" />&lt;/a>&lt;/li>&lt;/p>
&lt;/ul>&lt;ul class="affiliation">&lt;li>
&lt;p>&lt;span>Nutrition Research Center, Public Health Institute, MOH, Mongolia&lt;/span>&lt;/li>&lt;/p>
&lt;/ul>&lt;ul class="articleDoi">&lt;li>
&lt;p>&lt;a href="http://dx.doi.org/10.1016/j.jsbmb.2012.10.014" id="ddDoi">&lt;a href="http://dx.doi.org/10.1016/j.jsbmb.2012.10.014">http://dx.doi.org/10.1016/j.jsbmb.2012.10.014&lt;/a>&lt;/a>, &lt;a href="http://www.sciencedirect.com/science/help/doi.htm">How to Cite or Link Using DOI&lt;/a>&lt;/li>&lt;/p>
&lt;li>
&lt;div class="title">
&lt;p>&lt;a class="cLink" href="http://www.sciencedirect.com/science/journal/09600760" title="Go to The Journal of Steroid Biochemistry and Molecular Biology on SciVerse ScienceDirect">&lt;span>The Journal of Steroid Biochemistry and Molecular Biology,&lt;/span>&lt;/a>&lt;a href="http://www.sciencedirect.com/science/journal/09600760/136/supp/C" title="Go to table of contents for this volume/issue">Volume 136&lt;/a>, July 2013, Pages 207–210&lt;/div>&lt;/p></description></item><item><title>Response to Vitamin D3 varied with rs4588, D2 less response than D3 and did not change</title><link>/posts/response-to-vitamin-d3-varied-with-rs4588-d2-less-response-than-d3-and-did-not-change.html</link><pubDate>Sat, 13 Jul 2013 00:00:00 +0000</pubDate><guid>/posts/response-to-vitamin-d3-varied-with-rs4588-d2-less-response-than-d3-and-did-not-change.html</guid><description>&lt;h3 id="changes-in-circulating-25-hydroxyvitamin-d-according-to-vitamin-d-binding-protein-genotypes-after-vitamin-d-or-d-supplementation">Changes in circulating 25-hydroxyvitamin D according to vitamin D binding protein genotypes after vitamin D₃ or D₂ supplementation.&lt;/h3>
&lt;p>Nutr J. 2013 Apr 4;12:39. &lt;a href="https://doi.org/10.1186/1475-2891-12-39.">doi: 10.1186/1475-2891-12-39.&lt;/a>&lt;/p>
&lt;p>Nimitphong H, Saetung S, Chanprasertyotin S, Chailurkit LO, Ongphiphadhanakul B.&lt;/p>
&lt;p>Division of Endocrinology and Metabolism, Department of Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Rama 6 Rd, Rajthevi, Bangkok 10400, Thailand. &lt;a href="mailto:hataikarnn@hotmail.com">hataikarnn@hotmail.com&lt;/a>&lt;/p>
&lt;p>BACKGROUND: It is not known whether genetic variation in the vitamin D binding protein (DBP) influences 25-hydroxyvitamin D levels &lt;span>[25(OH)D]&lt;/span> after vitamin D supplementation. We aimed to investigate the changes of total 25(OH)D, 25(OH)D₃ and 25(OH)D₂ in a Thai cohort, according to type of vitamin D supplement (vitamin D₃ or D₂) and DBP genotype, after receiving vitamin D₃ or D₂ for 3 months.&lt;/p></description></item><item><title>Overview of vitamin D issues: IoM, Endocrine Society etc.</title><link>/posts/overview-of-vitamin-d-issues-iom-endocrine-society-etc.html</link><pubDate>Fri, 12 Jul 2013 00:00:00 +0000</pubDate><guid>/posts/overview-of-vitamin-d-issues-iom-endocrine-society-etc.html</guid><description>&lt;p>&lt;strong>Value and limitations of assessing vitamin D nutritional status and advised levels of vitamin D supplementations&lt;/strong>&lt;/p>
&lt;p>Eur J Endocrinol July 11, 2013 EJE-13-0435&lt;/p>
&lt;p>Elisabetta Romagnoli, Jessica Pepe, Sara Piemonte, Cristiana Cipriani, Salvatore Minisola &lt;a href="mailto:salvatore.minisola@fastwebnet.it">salvatore.minisola@fastwebnet.it&lt;/a> ; &lt;a href="mailto:salvatore.minisola@uniroma1.it">salvatore.minisola@uniroma1.it&lt;/a>&lt;/p>
&lt;p>Department of Internal Medicine and Medical Disciplines, University of Rome &amp;ldquo;Sapienza&amp;rdquo;, Rome, Italy&lt;/p>
&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#abstract">Abstract&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#introduction">Introduction&lt;/a>
 &lt;ul>
 &lt;li>&lt;a href="#figure-1">Figure 1&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#figure-2">Figure 2&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;li>&lt;a href="#measurement-of-25ohd">Measurement of 25(OH)D&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-binding-protein">Vitamin D binding protein&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#the-vitamin-d-and-the-search-for-a-threshold">The vitamin D and the search for a threshold&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#the-vitamin-d-and-the-supplementation-general-considerations">The vitamin D and the supplementation: general considerations&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#the-vitamin-d-and-the-supplementation-the-discussion">The vitamin D and the supplementation: the discussion&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#achieving-and-maintaining-vitamin-d-sufficiency">Achieving and maintaining vitamin D sufficiency&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-supplementation-which-type">Vitamin D supplementation: which type?&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-supplementation-intramuscular-or-oral-route-of-administration">Vitamin D supplementation: intramuscular or oral route of administration?&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-supplementation-and-the-safety">Vitamin D supplementation and the safety&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-supplementation-and-real-world">Vitamin D supplementation and real world&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#conclusions-and-perspectives">Conclusions and perspectives&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#references-are-in-pdf">References are in PDF&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;h3 id="abstract">Abstract&lt;/h3>
&lt;p>The growing attention to the role of vitamin D in skeletal and extra-skeletal diseases over the last decade, induced an increased demand for Vitamin D determination as well as a dramatic rise of sales of vitamin D supplement. However, several critical points in this field remain to be clarified. We lack a clear consensus about the definition of vitamin D deficiency, insufficiency and sufficiency. The identification of different thresholds defining vitamin D status have relevant implications in clinical practice. In fact, the worldwide prevalence of low vitamin D status is highly varying according to the level of 25(OH)D utilized to define sufficiency. Therefore, the assessment of 25-hydroxyvitamin D levels may have a critical role, but a number of different technical problems associated with its determination may interfere in interpreting the results. The hydrophobic nature of the vitamin D and the tight binding to its carrier (vitamin D binding protein, DBP), the different forms circulating in blood and the issue of standardisation are among the most important factors influencing the measurement of this metabolite. Another controversial point relies on the conflicting guidance on prevention and treatment of vitamin D deficiency endorsed by different medical and scientific communities. In particular, uncertainty exists about how to replete vitamin D stores, how to maintain normal 25(OH)D levels after repletion, which form of vitamin D is preferable for supplementation, which route of administration and dosing regimens are advisable. Finally, concerns have been raised regarding vitamin D toxicity and its adverse effects.&lt;/p></description></item><item><title>Tuberculosis, ethnic differences, and vitamin D</title><link>/posts/tuberculosis-ethnic-differences-and-vitamin-d.html</link><pubDate>Fri, 05 Jul 2013 00:00:00 +0000</pubDate><guid>/posts/tuberculosis-ethnic-differences-and-vitamin-d.html</guid><description>&lt;h2 id="ethnic-differences-affect-immune-response-to-tuberculosis-infection">Ethnic Differences Affect Immune Response To Tuberculosis Infection&lt;/h2>
&lt;p>^Comment by VitaminDWiki&lt;/p>
&lt;p>Does not appear to mention the lower vitamin D levels in those with dark skins^&lt;/p>
&lt;p>&lt;strong>&lt;a href="http://trap.it/#!traps/id/907cd246-0855-49f4-97b4-04aaff5e62f3/articles/6HsUm3uJq0064crtMTSu%20">AsianScientist (Jul. 5, 2013) – Health &amp;amp; Medicine&lt;/a>&lt;/strong>&lt;/p>
&lt;p>The immune response to the bacterium that causes tuberculosis (TB) varies between patients of different ethnic origin, according to a new UK study.&lt;/p>
&lt;p>The study, published in the journal PLOS Pathogens and led by researchers at Queen Mary, University of London, analyzed the immune response of 128 newly-diagnosed TB patients in London who were divided by ethnicity into those of African (45), European (27), Asian (55) or mixed European/Asian (1) ancestry.&lt;/p></description></item><item><title>Muscles and Vitamin D - many studies</title><link>/posts/muscles-and-vitamin-d-many-studies.html</link><pubDate>Wed, 03 Jul 2013 00:00:00 +0000</pubDate><guid>/posts/muscles-and-vitamin-d-many-studies.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#max-strength-not-improved-by-resistance-training-plus-daily-8000-iu-of-vitamin-d-and-whey-protien--rct-oct-2024">Max strength not improved by resistance training plus daily 8,000 IU of vitamin D and whey protien – RCT Oct 2024&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#surplus-calories-not-put-into-fat-if-good-level-of-vitamin-d-mice-may-2024">Surplus calories not put into fat if good level of Vitamin D (mice) May 2024&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#do-fast-twitch-muscles-respond-more-quickly-if-there-is-a-higher-level-of-vitamin-d-in-the-blood">Do fast twitch muscles respond more quickly if there is a higher level of vitamin D in the blood?&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#the-role-of-vitamin-d-in-skeletal-muscle-repair-and-regeneration-in-animal-models-and-humans-a-systematic-review---oct-2023">The Role of Vitamin D in Skeletal Muscle Repair and Regeneration in Animal Models and Humans: A Systematic Review - Oct 2023&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#muscle-health-and-vitamin-d---meta-analysis-sept-2021-not-help-much---ignored-dose-size">Muscle Health and Vitamin D - Meta-analysis Sept 2021 (not help much - ignored dose size)&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-promotes-skeletal-muscle-regeneration-and-mitochondrial-health--april-2021">Vitamin D Promotes Skeletal Muscle Regeneration and Mitochondrial Health – April 2021&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-helps-muscles-in-many-ways--sept-2021">Vitamin D helps muscles in many ways – Sept 2021&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#the-roles-of-vitamin-d-in-skeletal-muscle-feb-2013">The Roles of Vitamin D in Skeletal Muscle Feb 2013&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#small-vitamin-d-doses-given-for-a-few-months-do-not-improve-muscles---meta-analysis-oct-2023">Small Vitamin D doses given for a few months do not improve muscles - meta-analysis Oct 2023&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#48000-iu-monthly-for-a-year-did-not-help-elderly-muscles--june-2019">48,000 IU monthly for a year did not help elderly muscles- June 2019&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#sarcopenia-33-x-higher-risk-if-low-bio-available-vitamin-d---august-2021">Sarcopenia: 3.3 X higher risk if low bio-available vitamin D - August 2021&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#some-reduced-muscle-function-associated-with-many-vitamin-d-genes---review-sept-2021">Some reduced muscle function associated with many Vitamin D genes - Review Sept 2021&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#see-also-a-hrefpostsmuscular-dystrophy-probably-treated-by-high-dose-vitamin-d-plus-muscle-rehab-stylecolor-red-text-decoration-underline-titlethis-postcategory-does-not-exist-yet-muscular-dystrophy-probably-treated-by-high-dose-vitamin-d-plus-muscle-rehabmuscular-dystrophy-probably-treated-by-high-dose-vitamin-d-plus-muscle-rehaba">See also: &lt;a href="/posts/muscular-dystrophy-probably-treated-by-high-dose-vitamin-d-plus-muscle-rehab" style="color: red; text-decoration: underline;" title="This post/category does not exist yet: Muscular Dystrophy probably treated by high-dose Vitamin D plus muscle rehab">Muscular Dystrophy probably treated by high-dose Vitamin D plus muscle rehab&lt;/a>&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#creatine-might-help-grow-senior-muscles-when-added-to-exercise">Creatine might help grow senior muscles when added to exercise&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="max-strength-not-improved-by-resistance-training-plus-daily-8000-iu-of-vitamin-d-and-whey-protien--rct-oct-2024">Max strength not improved by resistance training plus daily 8,000 IU of vitamin D and whey protien – RCT Oct 2024&lt;/h4>
&lt;p>&lt;strong>Vitamin D Supplementation Does Not Enhance Gains in Muscle Strength and Lean Body Mass or Influence Cardiorespiratory Fitness in Vitamin D-Insufficient Middle-Aged Men Engaged in Resistance Training&lt;/strong>&lt;/p></description></item><item><title>Vitamin D Global Perspective - Holick</title><link>/posts/vitamin-d-global-perspective-holick.html</link><pubDate>Tue, 02 Jul 2013 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-global-perspective-holick.html</guid><description>&lt;p>It is now generally accepted that vitamin D deficiency is a worldwide health problem that affects not only musculoskeletal health but also a wide range of acute and chronic diseases. However, there remains cynicism about the lack of randomized controlled trials to support the association studies regarding the nonskeletal health benefits of vitamin D. This review was obtained by searching English-language studies published up to April 1, 2013, in PubMed, MEDLINE, and the Cochrane Central Register of Controlled Trials (search terms: vitamin D and supplementation) and focuses on recent challenges regarding the definition of vitamin D deficiency and how to achieve optimal serum 25-hydroxyvitamin D concentrations from dietary sources, supplements, and sun exposure. The effect of vitamin D on fetal programming epigenetics and gene regulation could potentially explain why vitamin D has been reported to have such wide-ranging health benefits throughout life. There is potentially a great upside to increasing the vitamin D status of children and adults worldwide for improving musculoskeletal health and reducing the risk of chronic illnesses, including some cancers, autoimmune diseases, infectious diseases, type 2 diabetes mellitus, neurocognitive disorders, and mortality.&lt;/p></description></item><item><title>Hypovitaminosis D in the Middle East and North Africa</title><link>/posts/hypovitaminosis-d-in-the-middle-east-and-north-africa.html</link><pubDate>Mon, 01 Jul 2013 00:00:00 +0000</pubDate><guid>/posts/hypovitaminosis-d-in-the-middle-east-and-north-africa.html</guid><description>&lt;h3 class="showhide_heading" id="Hypovitaminosis_D_in_the_Middle_East_and_North_Africa:_Prevalence_risk_factors_and_impact_on_outcomes">
&lt;p>Hypovitaminosis D in the Middle East and North Africa: Prevalence, risk factors and impact on outcomes&lt;/h3>&lt;/p>
&lt;p>
&lt;p>Dermato Endocrinology&lt;br />&lt;/p>
&lt;p>Darina Bassil, Maya Rahme, Maha Hoteit, * Ghada El-Hajj Fuleihan&lt;br />&lt;/p>
&lt;p>Submitted January 15, 2013; Revised May 10, 2013; Accepted May 21, 2013; Published Online April 1, 2013&lt;/p>&lt;/p>
&lt;p>
&lt;p>Background: The Middle East and North Africa (MENA) region registers some of the highest rates of hypovitaminosis D worldwide.&lt;/p>&lt;/p>
&lt;p>
&lt;p>Aim: We systematically reviewed the prevalence of hypovitaminosis D, rickets and osteomalacia, their predictors and impact on major outcomes, in the region.&lt;/p></description></item><item><title>Rickets: Calcium, Genes, etc</title><link>/posts/rickets-calcium-genes-etc.html</link><pubDate>Mon, 01 Jul 2013 00:00:00 +0000</pubDate><guid>/posts/rickets-calcium-genes-etc.html</guid><description>&lt;p>
&lt;p>&lt;strong>&lt;span class="citation-abbreviation">Indian J Endocrinol Metab. &lt;/span>&lt;span class="citation-publication-date">2013 Jan-Feb; &lt;/span>&lt;span class="citation-volume">17&lt;/span>&lt;span class="citation-issue">(1)&lt;/span>&lt;span class="citation-flpages">: 1–4. &lt;/span>&lt;/strong>&lt;/p>&lt;/p>
&lt;div class="fm-citation-pmcid">
&lt;p>&lt;span class="doi">doi:  &lt;a href="http://dx.doi.org/10.4103%2F2230-8210.107789">10.4103/2230-8210.107789&lt;/a>&lt;/span>&lt;span class="fm-citation-ids-label">PMCID: &lt;/span>&lt;span>PMC3659873&lt;/span>&lt;/div>&lt;/p>
&lt;h1 class="content-title">
&lt;p>Rickets: Twists and turns in the Gordian knot&lt;/h1>&lt;/p>
&lt;div class="half_rhythm">
&lt;div class="contrib-group fm-author">
&lt;p>&lt;a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Garg%20MK%5Bauth%5D">M. K. Garg&lt;/a> and &lt;a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Kalra%20S%5Bauth%5D">Sanjay Kalra&lt;/a>&lt;sup>1&lt;/sup>&lt;/div>&lt;/p>
&lt;/div>
&lt;div class="fm-panel small half_rhythm">
&lt;div class="fm-authors-info fm-panel half_rhythm">
&lt;div class="fm-affl">
&lt;p>&lt;em>Department of Endocrinology, Command Hospital, Southern Command, Pune, Maharashtra, India&lt;/em>&lt;/div>&lt;/p>
&lt;div class="fm-affl">
&lt;p>&lt;sup>1&lt;/sup>&lt;em>Department of Endocrinology, Bharti Hospital and B.R.I.D.E., Karnal, Haryana, India&lt;/em>&lt;/div>&lt;/p>
&lt;div id="cor1">
&lt;p>&lt;strong>Corresponding Author:&lt;/strong> Col. M. K. Garg, Department of Endocrinology, Command Hospital, Southern Command, Pune, Maharashtra, India. E-mail: &lt;span class="e_id352731">&lt;a href="mailto:mkgargs@gmail.com">&lt;a href="mailto:mkgargs@gmail.com">mkgargs@gmail.com&lt;/a>&lt;/a>&lt;/span>&lt;/div>&lt;/p>
&lt;/div>
&lt;div class="fm-cpl-info fm-panel half_rhythm">
&lt;div class="fm-copyright half_rhythm">
&lt;p>&lt;a href="http://www.ncbi.nlm.nih.gov/pmc/about/copyright.html">Copyright&lt;/a> : © Indian Journal of Endocrinology and Metabolism&lt;/div>&lt;/p></description></item><item><title>Vitamin D deficiency in Middle East and North Africa</title><link>/posts/vitamin-d-deficiency-in-middle-east-and-north-africa.html</link><pubDate>Fri, 21 Jun 2013 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-deficiency-in-middle-east-and-north-africa.html</guid><description>&lt;h4 id="hypovitaminosis-d-in-the-middle-east-and-north-africa-prevalence-risk-factors-and-impact-on-outcomes">Hypovitaminosis D in the Middle East and North Africa: Prevalence, risk factors and impact on outcomes&lt;/h4>
&lt;p>&lt;strong>&lt;i class="fas fa-file-pdf" style="margin-right: 0.3em;">&lt;/i>&lt;a href="https://d378j1rmrlek7x.cloudfront.net/attachments/pdf/hypovitaminosis-d-in-the-middle-east-and-north-africa.pdf">Download the PDF from VitaminDWiki&lt;/a>&lt;/strong>&lt;/p>
&lt;h4 id="xml-file">XML File&lt;/h4>
&lt;ul>
&lt;li>&lt;a href="http://www.landesbioscience.com/article/25111/full_text_xml/">&lt;img src="http://www.landesbioscience.com/new_landes_images/icon_xml.png" alt="image">&lt;/a> &lt;a href="http://www.landesbioscience.com/article/25111/full_text_xml/">Full Text XML&lt;/a>&lt;/li>
&lt;/ul>
&lt;blockquote>
&lt;p>387.24 KB XML Document&lt;/p>
&lt;/blockquote>
&lt;p>&lt;img src="http://www.landesbioscience.com/images/OA-icon.gif" alt="image"> This is an open access article.&lt;/p>
&lt;p>&lt;a href="%7Bimg%20src=%22http://www.landesbioscience.com/icons/crystal_project/24x24/apps/printer.png%22%7D%20Print%20this%20page%20">&lt;img src="http://www.landesbioscience.com/icons/crystal_project/24x24/apps/printer.png" alt="image"> Print this page &lt;/a>&lt;a href="%7Bimg%20src=%22http://www.landesbioscience.com/icons/crystal_project/24x24/actions/mail_forward.png%22%7D%20Email%20this%20page%20">&lt;img src="http://www.landesbioscience.com/icons/crystal_project/24x24/actions/mail_forward.png" alt="image"> Email this page &lt;/a>&lt;/p>
&lt;p>&amp;mdash;Article Citation&lt;/p>
&lt;p>&lt;a href="http://www.landesbioscience.com/api/articles/citation_ris/25111/">&lt;img src="http://www.landesbioscience.com/icons/table_go.png" alt="image"> RIS&lt;/a>&lt;/p>
&lt;p>&lt;a href="http://www.landesbioscience.com/marc/article/25111/">&lt;img src="http://www.landesbioscience.com/icons/table_go.png" alt="image"> MARC (XML)&lt;/a>&lt;/p>
&lt;p>{ANAME()}show_full_citation&lt;img src="http://www.landesbioscience.com/icons/table_go.png" alt="image"> FULL CITATION{ANAME}&lt;/p>
&lt;p>&amp;mdash;&lt;a href="http://www.facebook.com/sharer.php?u=http://www.landesbioscience.com/journals/dermatoendocrinology/article/25111/?show_full_text=true&amp;amp;">&lt;img src="http://www.landesbioscience.com/icons/facebook_24.png" alt="image"> Share on Facebook&lt;/a>&lt;/p>
&lt;p>&lt;a href="http://www.linkedin.com/shareArticle?mini=true&amp;amp;ur">&lt;img src="http://www.landesbioscience.com/icons/linkedin.png" alt="image">&lt;/a>&lt;/p>
&lt;p>&lt;a href="https://twitter.com/share?ur">&lt;img src="http://www.landesbioscience.com/icons/tweet_button.png" alt="image">&lt;/a>&lt;a href="http://www.landesbioscience.com/journals/dermatoendocrinology/toc/volume/5/issue/2/">Volume 5, Issue 2&lt;/a>   April/May/June 2013   &lt;strong>Dermato-Endocrinology&lt;/strong>&lt;/p>
&lt;p>&lt;a href="http://dx.doi.org/10.4161/derm.25111"> &lt;strong>http://dx.doi.org/10.4161/derm.25111&lt;/strong> &lt;/a>&lt;/p></description></item><item><title>Vitamin D is important for the central nervous system and cognition</title><link>/posts/vitamin-d-is-important-for-the-central-nervous-system-and-cognition.html</link><pubDate>Thu, 06 Jun 2013 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-is-important-for-the-central-nervous-system-and-cognition.html</guid><description>&lt;h3 id="vitamin-d-and-the-central-nervous-system">Vitamin D and the central nervous system&lt;/h3>
&lt;p>Pharmacological Reports, 2013, 65, 271-278 ISSN 1734-1140&lt;/p>
&lt;p>Matgorzata Wrzosek1, Jacek tukaszkiewicz2, Michat Wrzosek3, Andrzej Jakubczyk4, Halina Matsumoto4, Pawet Piatkiewicz3, Maria Radziwoh-Zaleska4, Marcin Wojnar4,5, Grazyna Nowicka1&lt;/p>
&lt;p>department of Pharmacogenomics, department of Biochemistry and Clinical Chemistry,&lt;/p>
&lt;p>department of Internal Medicine and Diabetology, department of Psychiatry, Medical University of Warsaw, Zwirki i Wigury 61, PL 02-091 Warszawa, Poland&lt;/p>
&lt;p>department of Psychiatry, University of Michigan, 4250 Plymouth Rd., Ann Arbor, MI 48109, USA Correspondence: Grazyna Nowicka, e-mail: &lt;a href="mailto:grazyna.nowicka@wum.edu.p">grazyna.nowicka@wum.edu.p&lt;/a>&lt;/p></description></item><item><title>Vitamin D tester falsely said half of hemodialysis patients had less than 30 ng</title><link>/posts/vitamin-d-tester-falsely-said-half-of-hemodialysis-patients-had-less-than-30-ng.html</link><pubDate>Sat, 01 Jun 2013 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-tester-falsely-said-half-of-hemodialysis-patients-had-less-than-30-ng.html</guid><description>&lt;h2 id="accuracy-of-three-automated-25-hydroxyvitamin-d-assays-in-hemodialysis-patients">Accuracy of three automated 25-hydroxyvitamin D assays in hemodialysis patients.&lt;/h2>
&lt;p>Clin Chim Acta. 2013 Jan 16;415:255-60. &lt;a href="https://doi.org/10.1016/j.cca.2012.10.056.">doi: 10.1016/j.cca.2012.10.056.&lt;/a> Epub 2012 Nov 14.&lt;/p>
&lt;p>Depreter B, Heijboer AC, Langlois MR.&lt;/p>
&lt;p>Department of Laboratory Medicine, AZ Sint-Jan Bruges-Ostend AV, 8000 Bruges, Belgium.&lt;/p>
&lt;p>INTRODUCTION: We evaluated the accuracy of three automated assays for 25(OH)D measurement in comparison to ID-XLC-MS/MS in hemodialysis patients, considering the importance of their vitamin D status and reported discrepant results obtained with automated assays.&lt;/p></description></item><item><title>16th Vitamin D Workshop and Vitamin D portion of ENDO</title><link>/posts/16th-vitamin-d-workshop-and-vitamin-d-portion-of-endo.html</link><pubDate>Tue, 30 Apr 2013 00:00:00 +0000</pubDate><guid>/posts/16th-vitamin-d-workshop-and-vitamin-d-portion-of-endo.html</guid><description>&lt;h4 id="preliminary-workshop-program-as-of-spring-2013">Preliminary Workshop Program as of Spring 2013&lt;/h4>
&lt;p>updated version is attached as PDF file at the bottom of this page&lt;/p>
&lt;p>See also &lt;a href="/posts/international-congress-on-vitamin-d-vitamind-workshop-ny" style="color: red; text-decoration: underline;" title="This post/category does not exist yet: International Congress on Vitamin D (VitaminD Workshop) – NY May 2019">International Congress on Vitamin D (VitaminD Workshop) – NY May 2019&lt;/a> has links to many previous workshops&lt;/p>
&lt;h5 id="vitamin-d-workshop-slides---june-2013postsvitamin-d-workshop-slides">&lt;a href="/posts/vitamin-d-workshop-slides">Vitamin D Workshop Slides - June 2013&lt;/a>&lt;/h5>
&lt;h4 id="june-12">June 12&lt;/h4>
&lt;h4 id="830am-1015am-d-code-encode-chair---j-wesley-pike-phd">8:30am-10:15am: D-Code ENCODE: Chair - J Wesley Pike, PhD&lt;/h4>
&lt;p>8:30-9:15: Plenary Speaker: John Stamatoyannopoulos, MD - What is ENCODE&lt;/p></description></item><item><title>Summary of Vitamin D portion of Bone and Mineral Research Meeting</title><link>/posts/summary-of-vitamin-d-portion-of-bone-and-mineral-research-meeting.html</link><pubDate>Thu, 25 Apr 2013 00:00:00 +0000</pubDate><guid>/posts/summary-of-vitamin-d-portion-of-bone-and-mineral-research-meeting.html</guid><description>&lt;h2 id="meeting-report-from-the-34th-annual-meeting-of-the-american-society-for-bone-and-mineral-research">Meeting report from the 34th Annual Meeting of the American Society for Bone and Mineral Research,&lt;/h2>
&lt;p>Minneapolis, MN, USA, 12–15 October 2012&lt;/p>
&lt;p>&lt;strong>Report on recent vitamin D research (ASBMR 2012)&lt;/strong>&lt;/p>
&lt;p>IBMS BoneKEy, (2013), 10, Article number: 329; doi:10.1038/bonekey.2013.63; Published online, 10 April 2013&lt;/p>
&lt;p>Roger Bouillon&lt;/p>
&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>&lt;a href="#meeting-report-from-the-34th-annual-meeting-of-the-american-society-for-bone-and-mineral-research">Meeting report from the 34th Annual Meeting of the American Society for Bone and Mineral Research,&lt;/a>
 &lt;ul>
 &lt;li>&lt;a href="#125-dihydroxyvitamin-d-and-bone">1,25-Dihydroxyvitamin D and bone&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#2425-dihydroxyvitamin-d">24,25-Dihydroxyvitamin D&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-and-the-intestine">Vitamin D and the intestine&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#extra-renal-cyp27b1-expression-and-production-of-125-dihydroxyvitamin-d">Extra renal cyp27b1 expression and production of 1,25-dihydroxyvitamin D&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#fgf23-and-production-of-125-dihydroxyvitamin-d">FGF23 and production of 1,25-dihydroxyvitamin D&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#skin-synthesis-of-vitamin-d">Skin synthesis of vitamin D&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-status-worldwide">Vitamin D status worldwide&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-supplementation-and-vitamin-d-status">Vitamin D supplementation and vitamin D status&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#intermittent-high-dose-vitamin-d-supplementation-and-vitamin-d-status">Intermittent high-dose vitamin D supplementation and vitamin D status&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#pregnancy-and-second-generation-effects">Pregnancy and second-generation effects&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-supplementation-muscle-and-falls">Vitamin D supplementation: muscle and falls&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-and-the-metabolic-syndrome">Vitamin D and the metabolic syndrome&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#assay-methodology-for-vitamin-d-metabolites">Assay methodology for vitamin D metabolites&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;li>&lt;a href="#references-numbers-are-approximate">References (numbers are approximate)&lt;/a>
 &lt;ul>
 &lt;li>&lt;a href="#ion-line-index-to-abstracts">IOn-line index to abstracts&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;h3 id="125-dihydroxyvitamin-d-and-bone">1,25-Dihydroxyvitamin D and bone&lt;/h3>
&lt;p>Vitamin D is well known for its effects on promoting bone mineralization as the primary characteristic of rickets, and osteomalacia refers to decreased mineralization of the bone matrix. However, the direct effects of the vitamin D endocrine system on bone cells need further clarification. Earlier studies revealed that overexpression of VDR in osteoblasts (driven by osteocalcin promoter) increased bone mass and strength.1 Deletion of VDR in osteocytes (using a dmp1 cre system) did not influence bone mass or other parameters of bone metabolism.2 Deletion of VDR in osteoblasts using an osteocalcin cre system, however, increased (&amp;gt;20%) bone mass (total and trabecular femoral bone, mainly by increase in the number of trabeculae) as reported by Anderson et al.3 and by S Kato (presented at the 2012 Endocrine Society Meeting as summarized in Bouillon4). However, the mechanisms involved are not clear, as preliminary data suggested increase bone formation (as reported by Anderson et al.3) and decreased bone resorption in the Japanese osteoblast-selective VDR mice. These observations imply that VDR activation can have beneficial effects (prevent rickets and osteomalacia) but can also impair bone formation or mineralization in case of exposure to very high serum concentrations of 1,25(OH)2D.2, 5 Such negative effects of vitamin D on mineral deposition were also observed by studying the gene expression profile after exposure to 1,25(OH)2D (Pike’s group, as reported in the previous BoneKey Report4) and now in a series of in vitro experiments using osteoblasts from different regions (calvaria and femur). Exposure to 1,25(OH)2D could inhibit mineral deposition in early-stage calvaria-derived osteoblasts, whereas it enhanced mineral deposition in more mature cortical-bone-derived osteoblasts, at least in the presence of high extracellular calcium concentration.6 The direct effects of the vitamin D endocrine system on bone cells were also explored by analyzing mice with transgenic overexpression of cyp27b1 in osteoblasts using an osteocalcin promoter region. At 20 weeks of age, such mice displayed a 10% increase in bone volume as well in the lumbar vertebrae as in the femoral metaphysis.7 This beneficial effect was due to increased bone formation with unaltered bone resorption, indicating a direct bone anabolic effect of locally produced 1,25(OH)2D in osteoblasts. All these new observations indicate that the vitamin D endocrine system has a yin/yang effect on bone: in most circumstances it enhances mineral deposition but in the presence of low calcium supply the vitamin D endocrine system tries to maintain serum calcium homeostasis at the expense of bone (increased resorption and decreased mineralization).&lt;/p></description></item><item><title>Vitamin D and multiple sclerosis (technical, outline only)</title><link>/posts/vitamin-d-and-multiple-sclerosis-technical-outline-only.html</link><pubDate>Thu, 25 Apr 2013 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-and-multiple-sclerosis-technical-outline-only.html</guid><description>&lt;p>Journal of Clinical Neuroscience; Available online 26 March 2013&lt;/p>
&lt;p>Sarah Hewer a,&lt;/p>
&lt;p>Robyn Lucas b,&lt;/p>
&lt;p>Ingrid van der Mei c,&lt;/p>
&lt;p>Bruce V. Taylor c, &lt;a href="mailto:bruce.taylor@utas.edu.au">bruce.taylor@utas.edu.au&lt;/a>&lt;/p>
&lt;p>a Royal Hobart Hospital, Department of Neurology, Hobart, Tasmania, Australia&lt;/p>
&lt;p>b National Centre for Epidemiology and Population Health, The Australian National University, Canberra, Australian Capital Territory, Australia&lt;/p>
&lt;p>c Menzies Research Institute Tasmania, University of Tasmania, Locked Bag 23, Hobart, Tasmania 7000, Australia&lt;/p>
&lt;p>The role of vitamin D supplementation in preventing multiple sclerosis (MS) and/or treating MS progression is an area of significant research interest. We detail the current status of the ongoing research in this field, and note the lack of class 1 evidence from well-conducted, large, double-blind, placebo-controlled studies of vitamin D supplementation in the prevention and/or treatment of MS. We have been able to &lt;strong>provide some guidelines for practitioners&lt;/strong> based on the substantial burden of supportive evidence for the use of vitamin D in MS as summarised here. These guidelines may provide some support to those clinicians who treat people with MS and their families.&lt;/p></description></item><item><title>Common Vitamin D gene variants and resulting diseases</title><link>/posts/common-vitamin-d-gene-variants-and-resulting-diseases.html</link><pubDate>Sat, 13 Apr 2013 00:00:00 +0000</pubDate><guid>/posts/common-vitamin-d-gene-variants-and-resulting-diseases.html</guid><description>&lt;p>&lt;strong>Abstract&lt;/strong>&lt;/p>
&lt;p>The vitamin D binding protein (DBP) is the major plasma carrier for vitamin D and its metabolites, but it is also an actin scavenger, and is the precursor to the immunomodulatory protein, Gc-MAF. Two missense variants of the DBP gene - rs7041 encoding Asp432Glu and rs4588 encoding Thr436Lys - change the amino acid sequence and alter the protein function.&lt;/p>
&lt;p>They are common enough to generate population-wide constitutive differences in vitamin D status, based on assay of the serum metabolite, 25-hydroxyvitamin D (25OHD).&lt;/p></description></item><item><title>Factors (including skin temperature) Influencing Vitamin D Status – 2011</title><link>/posts/factors-including-skin-temperature-influencing-vitamin-d-status-2011.html</link><pubDate>Thu, 04 Apr 2013 00:00:00 +0000</pubDate><guid>/posts/factors-including-skin-temperature-influencing-vitamin-d-status-2011.html</guid><description>&lt;h1 id="factors-influencing-vitamin-d-status">Factors Influencing Vitamin D Status&lt;/h1>
&lt;p>Acta Derm Venereol 2011; 91: 115–124. (Accepted June 27, 2010)&lt;/p>
&lt;p>William G. Tsiaras and Martin A. Weinstock&lt;/p>
&lt;p>Dermatoepidemiology Unit, VA Medical Center, the Department of Dermatology, Rhode Island Hospital, and the Departments of Dermatology and Community Health, Brown University, Providence, Rhode Island&lt;/p>
&lt;p>Martin A. Weinstock, MD, PhD, Dermatoepidemiology Unit, VA Medical Center-111D, 830 Chalkstone Ave, Providence, RI 02908, USA. E-mail: &lt;a href="mailto:maw@brown.edu">maw@brown.edu&lt;/a>&lt;/p>
&lt;p>{&lt;a href="http://www.medicaljournals.se/acta/content/?doi=10.2340/00015555-0980&amp;amp;html=1">&lt;span style="color:#00F;">CLICK HERE for on-line version&lt;/span>&lt;/a>}&lt;/p></description></item><item><title>Important interactions between the liver and vitamin D</title><link>/posts/important-interactions-between-the-liver-and-vitamin-d.html</link><pubDate>Wed, 03 Apr 2013 00:00:00 +0000</pubDate><guid>/posts/important-interactions-between-the-liver-and-vitamin-d.html</guid><description>&lt;h3 id="d-livering-the-message-the-importance-of-vitamin-d-status-in-chronic-liver-disease">D-livering the message: the importance of vitamin D status in chronic liver disease.&lt;/h3>
&lt;p>Kitson MT, Roberts SK. &lt;a href="mailto:S.Roberts@alfred.org.au">S.Roberts@alfred.org.au&lt;/a>&lt;/p>
&lt;p>J Hepatol. 2012 Oct;57(4):897-909. &lt;a href="https://doi.org/10.1016/j.jhep.2012.04.033.">doi: 10.1016/j.jhep.2012.04.033.&lt;/a> Epub 2012 May 23.&lt;/p>
&lt;p>Department of Gastroenterology, The Alfred, Melbourne, Australia.&lt;/p>
&lt;hr>
&lt;h2 id="see-also-vitamindwiki">See also VitaminDWiki&lt;/h2>
&lt;ul>
&lt;li>
&lt;p>&lt;a href="/posts/overview-liver-and-vitamin-d" style="color: red; text-decoration: underline;" title="This post/category does not exist yet: Overview Liver and vitamin D">Overview Liver and vitamin D&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/non-alcoholic-fatty-liver-disease-4-in-10-seniors-and-vitamin-d">Non-alcoholic Fatty Liver Disease (4 in 10 seniors) and Vitamin D &lt;/a> &lt;strong>40%:&lt;/strong> is this a part of the reason that seniors have low vitamin D?&lt;/p></description></item><item><title>Free vitamin D (VDR) may be more important than total for bladder cancer</title><link>/posts/free-vitamin-d-vdr-may-be-more-important-than-total-for-bladder-cancer.html</link><pubDate>Fri, 22 Mar 2013 00:00:00 +0000</pubDate><guid>/posts/free-vitamin-d-vdr-may-be-more-important-than-total-for-bladder-cancer.html</guid><description>&lt;h4 id="influence-of-vitamin-d-binding-protein-on-the-association-between-circulating-vitamin-d-and-risk-of-bladder-cancer">Influence of vitamin D binding protein on the association between circulating vitamin D and risk of bladder cancer.&lt;/h4>
&lt;p>Br J Cancer. 2012 Oct 23;107(9):1589-94. &lt;a href="https://doi.org/10.1038/bjc.2012.417.">doi: 10.1038/bjc.2012.417.&lt;/a> Epub 2012 Sep 18.&lt;/p>
&lt;p>Mondul AM, Weinstein SJ, Virtamo J, Albanes D.&lt;/p>
&lt;p>Nutritional Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Department of Health and Human Services, 6120 Executive Boulevard, Suite 320, Rockville, MD, USA. &lt;a href="mailto:mondulam@mail.nih.gov">mondulam@mail.nih.gov&lt;/a>&lt;/p>
&lt;p>BACKGROUND: There is little research investigating the role of &lt;strong>vitamin D binding protein (DBP)&lt;/strong> in the association between 25-hydroxyvitamin D (25(OH)D) and disease risk.&lt;/p></description></item><item><title>Vitamin D – Continuing Medical Education – 2013</title><link>/posts/vitamin-d-continuing-medical-education-2013.html</link><pubDate>Tue, 05 Mar 2013 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-continuing-medical-education-2013.html</guid><description>&lt;h1 id="vitamin-d-in-clinical-practice">Vitamin D in clinical practice&lt;/h1>
&lt;p>&lt;a href="http://www.cmej.org.za/index.php/cmej/article/view/2682/2763%20">Continuing Medical Education, Vol 31, No 2 (2013)&lt;/a> South Africa&lt;/p>
&lt;p>A E Zemlin &lt;a href="mailto:azemlin@sun.ac.za">azemlin@sun.ac.za&lt;/a>, MB ChB, MMed (Chem Path), FC Path (SA) Chem&lt;/p>
&lt;p>Senior Specialist/Senior Lecturer, Department of Chemical Pathology, Stellenbosch University and National Health Laboratory Service, Tygerberg Hospital and Green Point Laboratories&lt;/p>
&lt;p>C Meyer, MB ChB, MMed (Chem Path), Senior Specialist/Senior Lecturer, Department of Chemical Pathology, Stellenbosch University and National Health Laboratory Service, Tygerberg Hospital and Green Point Laboratories&lt;/p></description></item><item><title>A look at inner workings of committee looking at vitamin D for UK</title><link>/posts/a-look-at-inner-workings-of-committee-looking-at-vitamin-d-for-uk.html</link><pubDate>Sun, 24 Feb 2013 00:00:00 +0000</pubDate><guid>/posts/a-look-at-inner-workings-of-committee-looking-at-vitamin-d-for-uk.html</guid><description>&lt;h2 id="context-by-vitamindwiki">Context by VitaminDWiki&lt;/h2>
&lt;p>A &lt;a href="http://www.sacn.gov.uk/">committee&lt;/a> meets several times a year in the period 2011-2014 to establish new recommendations for vitamin D for the UK&lt;/p>
&lt;p>Their past and future meetings: 04/12/2013, 24/04/2013, 19/02/2013, 07/12/2012, 18/09/2012, 28/06/2012, 28/03/2012, 07/12/2011, 08/09/2011, 26/05/2011&lt;/p>
&lt;p>The draft of their meeting minutes for Dec 2012 is below&lt;/p>
&lt;h3 id="observation-by-vitamindwiki-it-is-amazing">Observation by VitaminDWiki: It is amazing:&lt;/h3>
&lt;ol>
&lt;li>
&lt;p>how long it takes,&lt;/p>
&lt;/li>
&lt;li>
&lt;p>how little of the literature they consider,&lt;/p>
&lt;/li>
&lt;li>
&lt;p>how they seem to allow no rebuttal&lt;/p></description></item><item><title>Death from acute kidney injury 84 percent more likely if have low vitamin D</title><link>/posts/death-from-acute-kidney-injury-84-percent-more-likely-if-have-low-vitamin-d.html</link><pubDate>Tue, 19 Feb 2013 00:00:00 +0000</pubDate><guid>/posts/death-from-acute-kidney-injury-84-percent-more-likely-if-have-low-vitamin-d.html</guid><description>&lt;h2 id="dysregulated-mineral-metabolism-in-patients-with-acute-kidney-injury-and-risk-of-adverse-outcomes">Dysregulated Mineral Metabolism in Patients with Acute Kidney Injury and Risk of Adverse Outcomes.&lt;/h2>
&lt;p>Clin Endocrinol (Oxf). 2013 Feb 18. &lt;a href="https://doi.org/10.1111/cen.12172.">doi: 10.1111/cen.12172.&lt;/a>&lt;/p>
&lt;p>Leaf DE, Waikar SS, Wolf M, Cremers S, Bhan I, Stern L.&lt;/p>
&lt;p>Division of Nephrology, Columbia University Medical Center, New York, NY; Division of Renal Medicine, Brigham and Women&amp;rsquo;s Hospital, Boston, MA.&lt;/p>
&lt;p>OBJECTIVE: Numerous studies have evaluated the prevalence and importance of vitamin D deficiency among patients with chronic kidney disease and end-stage renal disease, however, little is known about vitamin D levels in acute kidney injury (AKI). We evaluated the association between vitamin D metabolites and clinical outcomes among patients with AKI.&lt;/p></description></item><item><title>Vitamin D with or before a meal: small Swiss study, no conclusion</title><link>/posts/vitamin-d-with-or-before-a-meal-small-swiss-study-no-conclusion.html</link><pubDate>Sat, 16 Feb 2013 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-with-or-before-a-meal-small-swiss-study-no-conclusion.html</guid><description>&lt;h1 id="oral-vitamin-d---is-it-necessary-to-be-taken-with-meals-containing-fat">Oral vitamin D - Is it Necessary to be taken with Meals Containing Fat?&lt;/h1>
&lt;p>&lt;a href="http://www.webmedcentral.com/article_view/4023%20">WebMed Central&lt;/a> Post Publication Peer Review&lt;/p>
&lt;p>By Dr. Markus P Gnadinger , Dr. Frank Bossert , Dr. Felix Eichmann , Dr. Bruno Haug , Dr. Martin Krüsi , Dr. Markus Nadig , Dr. Stefan Pazeller , Dr. Theo Ringli , Dr. Martin Ruppli , Dr. Michael Salzgeber , Dr. Ivo Schmid , Dr. Roman Schöb , Dr. Bernhard Wälti , Dr. Markus Zeller&lt;/p></description></item><item><title>Vitamin D: one sided debate is published in Multiple Sclerosis Journal</title><link>/posts/vitamin-d-one-sided-debate-is-published-in-multiple-sclerosis-journal.html</link><pubDate>Thu, 07 Feb 2013 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-one-sided-debate-is-published-in-multiple-sclerosis-journal.html</guid><description>&lt;h2 id="if-i-had-a-clinically-isolated-syndrome-with-mri-diagnostic-of-ms-i-would-take-vitamin-d-10000-iu-daily-no">If I had a clinically isolated syndrome with MRI diagnostic of MS, I would take vitamin D 10,000 IU daily: No&lt;/h2>
&lt;p>Mult Scler February 2013 vol. 19 no. 2 140-142&lt;/p>
&lt;p>Caroline Papeix, Catherine Lubetzki&lt;/p>
&lt;p>Université Pierre et Marie Curie AP-HP, France&lt;/p>
&lt;p>Catherine Lubetzki, Department of Neurology, Pitié-Salpêtrière Hospital, 75013 Paris, France. Email: &lt;a href="mailto:catherine.lubetzki@psl.aphp.fr">catherine.lubetzki@psl.aphp.fr&lt;/a>&lt;/p>
&lt;hr>
&lt;h3 id="observation-by-vitamindwiki">Observation by VitaminDWiki&lt;/h3>
&lt;p>We see MS professionals, with a lot a stake to keep the status quo (note the conflict of interest section) valiently state why vitamin D has not yet been absolutely proven, and can never be absolutely proven to help MS (people in the placebo group can get vitamin D from food and sun).&lt;/p></description></item><item><title>Late-stage MS associated with protein in spinal cord which blocks vitamin D</title><link>/posts/late-stage-ms-associated-with-protein-in-spinal-cord-which-blocks-vitamin-d.html</link><pubDate>Tue, 29 Jan 2013 00:00:00 +0000</pubDate><guid>/posts/late-stage-ms-associated-with-protein-in-spinal-cord-which-blocks-vitamin-d.html</guid><description>&lt;h2 id="vitamin-d-binding-protein-in-cerebrospinal-fluid-is-associated-with-multiple-sclerosis-progression">Vitamin D-binding Protein in Cerebrospinal Fluid is Associated with Multiple Sclerosis Progression.&lt;/h2>
&lt;p>Mol Neurobiol. 2013 Jan 22.&lt;/p>
&lt;p>Yang M, Qin Z, Zhu Y, Li Y, Qin Y, Jing Y, Liu S.&lt;/p>
&lt;p>Institute of Biochemistry and Molecular Biology, School of Medicine, Shandong University, 44 Wenhuaxi Road, Jinan, Shandong, 250012, People&amp;rsquo;s Republic of China.&lt;/p>
&lt;p>Multiple sclerosis is a neurological disorder that presents with symptoms including inflammation, neurodegeneration, and demyelination of the central nervous system (CNS).&lt;/p></description></item><item><title>Vitamin D review – Holick</title><link>/posts/vitamin-d-review-holick.html</link><pubDate>Thu, 10 Jan 2013 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-review-holick.html</guid><description>&lt;h3 id="vitamin-deffects-on-skeletal-and-extraskeletal-health-and-the-need-for-supplementation">Vitamin D—Effects on Skeletal and Extraskeletal Health and the Need for Supplementation&lt;/h3>
&lt;p>Nutrients 2013, 5(1), 111-148; doi:10.3390/nu5010111 (doi registration under processing)&lt;/p>
&lt;p>Received: 15 October 2012; in revised form: 21 November 2012 / Accepted: 13 December 2012 / Published: 10 January 2013&lt;/p>
&lt;p>Matthias Wacker and Michael F. Holick* email&lt;/p>
&lt;p>Nutrition, and Diabetes, Vitamin D, Skin and Bone Research Laboratory, Section of Endocrinology, Department of Medicine, Boston University Medical Center, 85 East Newton Street, M-1013, Boston, MA 02118, USA&lt;/p></description></item><item><title>After bone fracture, vitamin D unchanged but 1,25(OH)(2) D decreased</title><link>/posts/after-bone-fracture-vitamin-d-unchanged-but-125oh2-d-decreased.html</link><pubDate>Fri, 04 Jan 2013 00:00:00 +0000</pubDate><guid>/posts/after-bone-fracture-vitamin-d-unchanged-but-125oh2-d-decreased.html</guid><description>&lt;h1 id="longitudinal-study-of-vitamin-d-metabolites-following-long-bone-fracture">Longitudinal study of vitamin D metabolites following long bone fracture.&lt;/h1>
&lt;p>J Bone Miner Res. 2012 Dec 21. &lt;a href="https://doi.org/10.1002/jbmr.1855.">doi: 10.1002/jbmr.1855.&lt;/a>&lt;/p>
&lt;p>Briggs AD, Kuan V, Greiller CL, Maclaughlin BD, Ramachandran M, Harris T, Timms PM, Venton TR, Vieth R, Norman AW, Griffiths CJ, Martineau AR.&lt;/p>
&lt;p>Centre for Primary Care and Public Health, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London E1 2AB, UK.&lt;/p>
&lt;p>Animal models suggest a key role for dihydroxylated vitamin D metabolites in fracture healing, as evidenced by increases in serum concentration of 24R,25-dihydroxyvitamin D (24R,25&lt;span>[OH]&lt;/span>(2) D) following long bone fracture. Human studies investigating the kinetics of serum concentrations of 24R,25&lt;span>[OH]&lt;/span>(2) D, 1,25-dihydroxyvitamin D (1,25&lt;span>[OH]&lt;/span>(2) D) and their parent metabolite 25-hydroxyvitamin D (25&lt;span>[OH]&lt;/span>D) are lacking. We therefore conducted a longitudinal study to determine whether &lt;strong>total, free or bioavailable&lt;/strong> concentrations of these vitamin D metabolites fluctuate in humans following long bone fracture.&lt;/p></description></item><item><title>10,000 IU vitamin D daily is safe, toxicity start at 150 ng (for monotherapy)</title><link>/posts/10000-iu-vitamin-d-daily-is-safe-toxicity-start-at-150-ng-for-monotherapy.html</link><pubDate>Wed, 05 Dec 2012 00:00:00 +0000</pubDate><guid>/posts/10000-iu-vitamin-d-daily-is-safe-toxicity-start-at-150-ng-for-monotherapy.html</guid><description>&lt;h4 id="anti-cancer-agents-in-medicinal-chemistry-volume-13-issue-1-pp4-10-7">Anti-Cancer Agents in Medicinal Chemistry Volume 13 Issue 1 pp.4-10 (7)&lt;/h4>
&lt;p>Authors: Armin Zittermann, Sylvana Prokop, Jan F. Gummert, Jochen Borgermann&lt;/p>
&lt;div class="border" style="background-color:#FFFAE2;padding:15px;margin:10px 0;border-radius:5px;width:800px">
&lt;p>&lt;a href="/posts/overview-toxicity-of-vitamin-d" style="color: red; text-decoration: underline;" title="This link has an unknown page_id: 898">Overview Toxicity of vitamin D&lt;/a> which has the following summary&lt;/p>
&lt;blockquote>
&lt;p>&lt;span style="color:#390;">Many weeks for a really large DAILY dose of vitamin D to&lt;/span> &lt;span style="color:#F0C;">become toxic&lt;/span>&lt;/p>
&lt;/blockquote>
&lt;img src="/attachments/d3.mock.jpg" alt="image" width="400">
&lt;h4 id="summary-of-points-of-this-paper-by-vitamin-d-councilhttpblogvitamindcouncilorg20121218vitamin-d-safety-risks-and-benefits-of-fortification-and-supplementation-dec-2012">Summary of points of this paper by &lt;a href="http://blog.vitamindcouncil.org/2012/12/18/vitamin-d-safety-risks-and-benefits-of-fortification-and-supplementation/">Vitamin D Council&lt;/a> Dec 2012&lt;/h4>
&lt;ol>
&lt;li>
&lt;p>Data on skin synthesis of vitamin D indicate oral intake of 10,000 IU/day is safe.&lt;/p></description></item><item><title>Vitamin D, Sunlight and Cancer Connection – Holick</title><link>/posts/vitamin-d-sunlight-and-cancer-connection-holick.html</link><pubDate>Wed, 05 Dec 2012 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-sunlight-and-cancer-connection-holick.html</guid><description>&lt;p>Anti-Cancer Agents in Medicinal Chemistry Volume 13 Issue 1 pp.70-82 (13)&lt;/p>
&lt;p>Author: Michael F. Holick&lt;/p>
&lt;p>&lt;strong>PDF with ALL graphics is attached at the bottom of this page&lt;/strong>&lt;/p>
&lt;p>It has been more than 100 years when it was first appreciated that increased sun exposure reduced risk of dying of cancer. The most beneficial effect of sun exposure is the production of vitamin D in the skin. Recent evidence suggests that most cells in the body not only have a vitamin D receptor but also have the capacity to convert 25-hydroxyvitamin D to 1,25-dihydroxyvitamin D. Once formed 1,25-dihydroxyvitamin D can inhibit cellular proliferation, induce cellular maturation, inhibit angiogenesis and ultimately cause apoptosis to prevent malignancy. A multitude of studies have associated improved vitamin D status with decreased risk for developing several deadly cancers including colon, breast, pancreatic and ovarian cancers. Patients with cancer are at high risk for vitamin D deficiency. Sensible sun exposure, vitamin D fortification and vitamin D supplementation should be encouraged to improve the vitamin D status of children and adults not only for bone health but for reducing risk of developing and dying of cancer. The goal is to achieve a blood level of 25-hydroxyvitamin D of 40-60 ng/mL. This can be accomplished by children taking 600-1000 and adults 1500-2000 international units (IU) vitamin D daily from diet and supplements along with sensible sun exposure when the sun is capable of producing vitamin D in the skin.&lt;/p></description></item><item><title>Hypothesis: Extensive burns reduce vitamin D, which increase bone loss</title><link>/posts/hypothesis-extensive-burns-reduce-vitamin-d-which-increase-bone-loss.html</link><pubDate>Tue, 04 Dec 2012 00:00:00 +0000</pubDate><guid>/posts/hypothesis-extensive-burns-reduce-vitamin-d-which-increase-bone-loss.html</guid><description>&lt;h4 id="does-vitamin-d-deficiency-contribute-to-post-burn-bone-loss">Does vitamin D deficiency contribute to post-burn bone loss?&lt;/h4>
&lt;p>&lt;a href="http://f1000research.com/articles/does-vitamin-d-deficiency-contribute-to-post-burn-bone-loss/%20">URL&lt;/a>&lt;/p>
&lt;p>Gordon L Klein &lt;a href="mailto:gordonklein@ymail.com">gordonklein@ymail.com&lt;/a>&lt;/p>
&lt;p>Department of Orthopaedic Surgery and Rehabilitation and Shriners Burns Hospital, University of Texas Medical Branch, Galveston, Texas 77555, USA&lt;/p>
&lt;p>Burn injury results in the acute loss of bone as well as the development of progressive vitamin D deficiency. Bone loss occurs acutely due to resorption, which is then followed by apoptosis of osteoblasts preventing repair of the bone loss. The acute resorption is due to a combination of the inflammatory response and the stress response to the burn injury. The resultant production of inflammatory cytokines and endogenous glucocorticoids initially stimulate the osteoblasts to produce RANK ligand, which stimulates marrow stem cell differentiation into osteoclasts. As the stress response persists for approximately one year post-burn the glucocorticoids produced by the body will cause osteoblast apoptosis and adynamic bone, impairing the ability of bone to recover its resorptive losses.&lt;/p></description></item><item><title>Role of vitamin D in insulin resistance</title><link>/posts/role-of-vitamin-d-in-insulin-resistance.html</link><pubDate>Wed, 26 Sep 2012 00:00:00 +0000</pubDate><guid>/posts/role-of-vitamin-d-in-insulin-resistance.html</guid><description>&lt;p>J Biomed Biotechnol. 2012;2012:634195. Epub 2012 Sep 3.&lt;/p>
&lt;p>Sung CC, Liao MT, Lu KC, Wu CC.&lt;/p>
&lt;p>Division of Nephrology, Department of Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei 114, Taiwan.&lt;/p>
&lt;p>Vitamin D is characterized as a regulator of homeostasis of bone and mineral metabolism, but it can also provide nonskeletal actions because vitamin D receptors have been found in various tissues including the brain, prostate, breast, colon, pancreas, and immune cells.&lt;/p></description></item><item><title>Vitamin D levels in healthy populations around the globe</title><link>/posts/vitamin-d-levels-in-healthy-populations-around-the-globe.html</link><pubDate>Fri, 31 Aug 2012 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-levels-in-healthy-populations-around-the-globe.html</guid><description>&lt;h2 id="a-global-representation-of-vitamin-d-status-in-healthy-populations">A global representation of vitamin D status in healthy populations&lt;/h2>
&lt;p>ARCHIVES OF OSTEOPOROSIS, 2012, DOI: 10.1007/s11657-012-0093-0&lt;/p>
&lt;p>D. A. Wahl, C. Cooper, P. R. Ebeling, M. Eggersdorfer, J. Hilger, K. Hoffmann, R. Josse, J. A. Kanis, A. Mithal and D. D. Pierroz, et al.&lt;/p>
&lt;hr>
&lt;h2 id="see-also-vitamindwiki">See also VitaminDWiki&lt;/h2>
&lt;ul>
&lt;li>
&lt;p>&lt;a href="/posts/overview-deficiency-of-vitamin-d" style="color: red; text-decoration: underline;" title="This link has an unknown page_id: 889">Overview Deficiency of vitamin D&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/vitamin-d-deficiency-is-a-major-global-public-health-problem-maps">Vitamin D deficiency is a major global public health problem – Maps Nov 2013&lt;/a>&lt;/p></description></item><item><title>Calcium and bone disorders in pregnancy</title><link>/posts/calcium-and-bone-disorders-in-pregnancy.html</link><pubDate>Sun, 12 Aug 2012 00:00:00 +0000</pubDate><guid>/posts/calcium-and-bone-disorders-in-pregnancy.html</guid><description>&lt;p>Indian J Endocrinol Metab. 2012 May-Jun; 16(3): 358–363, &lt;a href="https://doi.org/10.4103/2230-8210.95665">doi: 10.4103/2230-8210.95665&lt;/a>, PMCID: PMC3354840&lt;/p>
&lt;p>Shriraam Mahadevan, V. Kumaravel,1 and R. Bharath2&lt;/p>
&lt;p>Department of Clinical Endocrinology, Dr. E. V. Kalyani Medical Centre, Chennai, India&lt;/p>
&lt;p>1 Department of Clinical Endocrinology, Alpha Hospital and Research Centre, Madurai, India&lt;/p>
&lt;p>2 Department of Endocrinology, Chettinad Medical College and Research Institute, Chennai, India&lt;/p>
&lt;p>Corresponding Author: Dr. Shriraam Mahadevan, Department of Clinical Endocrinology, Dr. E. V. Kalyani Medical Centre, 4, Radhakrishnan Salai, Mylapore, Chennai 600004, India. E-mail: &lt;a href="mailto:mshriraam@gmail.com">mshriraam@gmail.com&lt;/a>&lt;/p></description></item><item><title>European adults can take 4000 IU of vitamin D</title><link>/posts/european-adults-can-take-4000-iu-of-vitamin-d.html</link><pubDate>Mon, 30 Jul 2012 00:00:00 +0000</pubDate><guid>/posts/european-adults-can-take-4000-iu-of-vitamin-d.html</guid><description>&lt;h4 id="table-of-contents">Table of contents&lt;/h4>
&lt;p>Abstract &amp;hellip;. 1&lt;/p>
&lt;p>Summary .. 2&lt;/p>
&lt;p>Table of contents&amp;hellip;&amp;hellip;4&lt;/p>
&lt;p>Background as provided by the European Commission &amp;hellip;&amp;hellip;&amp;hellip;. 5&lt;/p>
&lt;p>Terms of reference as provided by the European Commission&amp;hellip;&amp;hellip;&amp;hellip;&amp;hellip;&amp;hellip;5&lt;/p>
&lt;p>Assessment &amp;hellip;&amp;hellip;&amp;hellip;&amp;hellip;&amp;hellip; 6&lt;/p>
&lt;ol>
&lt;li>
&lt;p>Introduction&amp;hellip;..6&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Dietary intakes.7&lt;/p>
&lt;/li>
&lt;/ol>
&lt;p>2.1. Adults&amp;hellip;&amp;hellip;7&lt;/p>
&lt;p>2.2. Infants (&amp;lt;1 year)&amp;hellip;&amp;hellip;7&lt;/p>
&lt;p>2.3. Children (approximately 1-14 years)&amp;hellip;&amp;hellip;8&lt;/p>
&lt;p>2.4. Adolescents &amp;hellip;&amp;hellip;&amp;hellip;&amp;hellip;. 8&lt;/p>
&lt;ol start="3">
&lt;li>Hazard identification &amp;hellip;&amp;hellip;. 8&lt;/li>
&lt;/ol>
&lt;p>3.1. Vitamin D physiology&amp;hellip;&amp;hellip;&amp;hellip;&amp;hellip;.8&lt;/p>
&lt;p>3.2. Biomarkers of vitamin D intake&amp;hellip;&amp;hellip;&amp;hellip;&amp;hellip;..9&lt;/p>
&lt;p>3.3. Biomarkers of vitamin D status and activity&amp;hellip;&amp;hellip;&amp;hellip;.9&lt;/p>
&lt;p>3.4. Mechanisms of toxicity&amp;hellip;&amp;hellip;&amp;hellip;10&lt;/p></description></item></channel></rss>